https://www.gerpac.eu/ hourly https://www.gerpac.eu/en https://www.gerpac.eu/news https://www.gerpac.eu/ https://www.gerpac.eu/actualites https://www.gerpac.eu/congres-gerpac https://www.gerpac.eu/gerpac-conference https://www.gerpac.eu/archives https://www.gerpac.eu/2025-conference https://www.gerpac.eu/short-oral-communications-610 https://www.gerpac.eu/e-posters-session-d-624 https://www.gerpac.eu/archives-des-congres-16 https://www.gerpac.eu/congres-2025 https://www.gerpac.eu/e-posters-session-d-623 https://www.gerpac.eu/2024-conference https://www.gerpac.eu/conclusion-568 https://www.gerpac.eu/testimonials https://www.gerpac.eu/videos https://www.gerpac.eu/opening-of-the-conference-598 https://www.gerpac.eu/pharmaceutical-technology-master-award https://www.gerpac.eu/gerpac-award-2025-for-the-best-oral-communication https://www.gerpac.eu/concurrent-workshops-600 https://www.gerpac.eu/ateliers-en-sessions-paralleles-599 https://www.gerpac.eu/laureats-masters-de-pharmacotechnie-hospitaliere-613 https://www.gerpac.eu/prix-comunications-orales-gerpac-2025 https://www.gerpac.eu/photos-629 https://www.gerpac.eu/photos-628 https://www.gerpac.eu/feedback-from-606 https://www.gerpac.eu/pharmaceutical-issues-and-compounding-in-new-zealand-for-paedriatrics https://www.gerpac.eu/preparations-pharmaceutiques-pediatriques-en-nouvelle-zelande-applications-et-problemes https://www.gerpac.eu/eco-conception-in-pharmaceutical-technologies https://www.gerpac.eu/eco-conception-en-pharmacotechnie https://www.gerpac.eu/etude-de-cas https://www.gerpac.eu/interactive-case-study-636 https://www.gerpac.eu/ouverture-des-journees-597 https://www.gerpac.eu/communications-scientifiques-orales-courtes-609 https://www.gerpac.eu/feedback-from https://www.gerpac.eu/artificial-intelligence-ai-in-hospital-pharmacy-and-its-applications-to-pharmaceutical-manufacturing https://www.gerpac.eu/intelligence-artificielle-ia-en-pharmacie-hospitaliere-et-applications-a-la-production-hospitaliere https://www.gerpac.eu/toward-standardisation-parenteral-nutrition-in-neonatology https://www.gerpac.eu/convergence-vers-la-standardisation-cas-de-nutrition-parenterale-en-neonatologie https://www.gerpac.eu/e-posters-session-e-626 https://www.gerpac.eu/e-posters-session-e-627 https://www.gerpac.eu/e-posters-session-c-622 https://www.gerpac.eu/e-posters-session-c-621 https://www.gerpac.eu/e-posters-session-b-619 https://www.gerpac.eu/e-posters-session-b-620 https://www.gerpac.eu/e-posters-session-a-618 https://www.gerpac.eu/e-posters-session-a-617 https://www.gerpac.eu/training https://www.gerpac.eu/l-association https://www.gerpac.eu/2007-conference https://www.gerpac.eu/clinical-oncology-pharmacy https://www.gerpac.eu/debate-good-manufacturing-practices https://www.gerpac.eu/2006-conference https://www.gerpac.eu/congres-2024 https://www.gerpac.eu/photos-559 https://www.gerpac.eu/photos-566 https://www.gerpac.eu/ateliers-en-sessions-paralleles https://www.gerpac.eu/congres-2023 https://www.gerpac.eu/laureats-masters-de-pharmacotechnie-hospitaliere-548 https://www.gerpac.eu/2023-conference https://www.gerpac.eu/pharmaceutical-technology-master-course-s-award-549 https://www.gerpac.eu/presentation-of-works https://www.gerpac.eu/presentation-de-travaux-et-d-ouvrages https://www.gerpac.eu/concurrent-workshops-565 https://www.gerpac.eu/short-oral-communications-570 https://www.gerpac.eu/laureats-masters-de-pharmacotechnie-hospitaliere-580 https://www.gerpac.eu/communications-scientifiques-orales-courtes-569 https://www.gerpac.eu/pharmaceutical-technology-master-course-s-award-581 https://www.gerpac.eu/remote-session-564 https://www.gerpac.eu/conclusion-567 https://www.gerpac.eu/e-posters-session-d-577 https://www.gerpac.eu/e-posters-session-d-576 https://www.gerpac.eu/quel-avenir-pour-les-technologies-pharmaceutiques-hospitalieres https://www.gerpac.eu/e-posters-session-b-573 https://www.gerpac.eu/e-posters-session-b-572 https://www.gerpac.eu/ouverture-des-journees-556 https://www.gerpac.eu/opening-of-the-conference-563 https://www.gerpac.eu/interactive-case-study-590 https://www.gerpac.eu/etudes-de-cas https://www.gerpac.eu/special-practice-feedbacks https://www.gerpac.eu/retour-d-experiences https://www.gerpac.eu/what-is-the-future-of-hospital-pharmaceutical-technologies https://www.gerpac.eu/gerpac-award-2024-for-the-best-oral-communication https://www.gerpac.eu/prix-comunications-orales-gerpac-2024 https://www.gerpac.eu/quel-avenir-pour-les-technologies-pharmaceutiques-hospitalieres-593 https://www.gerpac.eu/what-is-the-future-of-hospital-pharmaceutical-technologies-594 https://www.gerpac.eu/symposium-562 https://www.gerpac.eu/symposium-555 https://www.gerpac.eu/e-posters-session-e-579 https://www.gerpac.eu/e-posters-session-e-578 https://www.gerpac.eu/e-posters-session-c-575 https://www.gerpac.eu/e-posters-session-c-574 https://www.gerpac.eu/e-posters-session-a-quality-assurance-risk-analysis-and-csr https://www.gerpac.eu/e-posters-session-a-571 https://www.gerpac.eu/evaluation-591 https://www.gerpac.eu/formation https://www.gerpac.eu/association https://www.gerpac.eu/testimonials-551 https://www.gerpac.eu/interviews https://www.gerpac.eu/symposium-curifylabs https://www.gerpac.eu/symposium-curifylabs-546 https://www.gerpac.eu/ateliers-en-sessions-parallele https://www.gerpac.eu/short-oral-communications-517 https://www.gerpac.eu/communications-scientifiques-orales-courtes-503 https://www.gerpac.eu/e-posters-session-a-518 https://www.gerpac.eu/innovation-research https://www.gerpac.eu/controles https://www.gerpac.eu/hot-topics-2023-hospital-pharmaceutical-technologies https://www.gerpac.eu/eu-guidance-for-safe-management-of-hazardous-medicinal-products-at-work-544 https://www.gerpac.eu/european-experience-round-table https://www.gerpac.eu/printing-3d https://www.gerpac.eu/photos-524 https://www.gerpac.eu/gerpac-award-2023-for-the-best-oral-communication https://www.gerpac.eu/prix-comunications-orales-gerpac-2023 https://www.gerpac.eu/opening-of-the-conference-512 https://www.gerpac.eu/photos-523 https://www.gerpac.eu/controles-environnementaux-et-gestion-du-risque-en-zac https://www.gerpac.eu/table-ronde-experience-europeenne-situations-critiques-plans-de-continuite-d-activites https://www.gerpac.eu/eu-guidance-for-safe-management-of-hazardous-medicinal-products-at-work https://www.gerpac.eu/innovation-recherche https://www.gerpac.eu/actualites-en-pharmacotechnie-hospitaliere-509 https://www.gerpac.eu/impression-3d https://www.gerpac.eu/ouverture-des-journees-501 https://www.gerpac.eu/concours-support-multimedia-535 https://www.gerpac.eu/gerpac-2023-multimedia-support-contest https://www.gerpac.eu/e-posters-session-e-522 https://www.gerpac.eu/e-posters-session-e-508 https://www.gerpac.eu/e-posters-session-d-521 https://www.gerpac.eu/e-posters-session-d-507 https://www.gerpac.eu/e-posters-session-c-520 https://www.gerpac.eu/e-posters-session-c-506 https://www.gerpac.eu/e-posters-session-b-519 https://www.gerpac.eu/e-posters-session-b-505 https://www.gerpac.eu/e-posters-session-a-504 https://www.gerpac.eu/concurrent-workshops-514 https://www.gerpac.eu/tests-fr https://www.gerpac.eu/congres-distanciel-511 https://www.gerpac.eu/tests-en https://www.gerpac.eu/publications-318 https://www.gerpac.eu/publications https://www.gerpac.eu/2013-conference https://www.gerpac.eu/short-oral-scientific-communications-183 https://www.gerpac.eu/congres-2013 https://www.gerpac.eu/communications-scientifiques-orales-courtes-182 https://www.gerpac.eu/focus-on-pharmaceutical-technology https://www.gerpac.eu/focus-sur-la-technologie-pharmaceutique https://www.gerpac.eu/risk-management-for-sterile-preparation-in-hospital-pharmacies-part-ii https://www.gerpac.eu/gestion-des-risques-lors-de-la-preparation-des-medicaments-injectables-en-pharmacie-hospitaliere-ii https://www.gerpac.eu/gestion-des-risques-lors-de-la-preparation-des-medicaments-injectables-en-pharmacie-hospitaliere-i https://www.gerpac.eu/2016-conference-242 https://www.gerpac.eu/short-oral-communications-245 https://www.gerpac.eu/congres-2016 https://www.gerpac.eu/communications-scientifiques-orales-courtes-244 https://www.gerpac.eu/20-hot-topics-in-hospital-pharmaceutical-technology-2 https://www.gerpac.eu/actualites-en-pharmacotechnie-2 https://www.gerpac.eu/chemical-contamination https://www.gerpac.eu/contaminations-chimiques https://www.gerpac.eu/hot-topics-in-hospital-pharmaceutical-technology-1 https://www.gerpac.eu/actualites-en-pharmacotechnie-1 https://www.gerpac.eu/parenteral-nutrition-admixtures https://www.gerpac.eu/melanges-de-nutrition-parenterale https://www.gerpac.eu/2021-conference https://www.gerpac.eu/gerpac-2021-video-competition https://www.gerpac.eu/2022-conference https://www.gerpac.eu/testimonials-498 https://www.gerpac.eu/congres-2022 https://www.gerpac.eu/interviews-497 https://www.gerpac.eu/photos-478 https://www.gerpac.eu/photos-466 https://www.gerpac.eu/conclusion https://www.gerpac.eu/remise-des-prix-conclusions https://www.gerpac.eu/opening-of-the-conference-494 https://www.gerpac.eu/ouverture-des-journees-493 https://www.gerpac.eu/pharmaceutical-technology-master-course-s-award-480 https://www.gerpac.eu/laureats-masters-de-pharmacotechnie-hospitaliere https://www.gerpac.eu/hot-topics-2022-hospital-pharmaceutical-technologies https://www.gerpac.eu/actualites-en-pharmacotechnie-hospitaliere-465 https://www.gerpac.eu/allergology https://www.gerpac.eu/allergologie https://www.gerpac.eu/paediatrics https://www.gerpac.eu/pediatrie https://www.gerpac.eu/european-experience-round-table-improving-the-stability-of-reconstituted-injectable-solutions https://www.gerpac.eu/preparations-injectables-reconstituees-modifiees https://www.gerpac.eu/formation-evaluation https://www.gerpac.eu/training-and-evaluation https://www.gerpac.eu/gerpac-award-2022-for-the-best-oral-communication https://www.gerpac.eu/prix-comunications-orales-gerpac-2022 https://www.gerpac.eu/short-oral-communications-488 https://www.gerpac.eu/communications-scientifiques-orales-courtes-456 https://www.gerpac.eu/remote-session-490 https://www.gerpac.eu/gerpac-2022-video-competition https://www.gerpac.eu/concours-support-multimedia https://www.gerpac.eu/e-posters-session-b-482 https://www.gerpac.eu/concurrent-workshops-471 https://www.gerpac.eu/sessions-paralleles-454 https://www.gerpac.eu/e-posters-session-a-481 https://www.gerpac.eu/e-posters-session-a-457 https://www.gerpac.eu/e-posters-session-e-485 https://www.gerpac.eu/e-posters-session-e-461 https://www.gerpac.eu/e-posters-session-d-484 https://www.gerpac.eu/e-posters-session-d-460 https://www.gerpac.eu/e-posters-session-c-459 https://www.gerpac.eu/e-posters-session-c-483 https://www.gerpac.eu/e-posters-session-b-458 https://www.gerpac.eu/symposium-gilead https://www.gerpac.eu/congres-distanciel https://www.gerpac.eu/round-table-431 https://www.gerpac.eu/congres-2021 https://www.gerpac.eu/table-ronde-419 https://www.gerpac.eu/photos-439 https://www.gerpac.eu/photos-428 https://www.gerpac.eu/prix-com-orales-gerpac-2021 https://www.gerpac.eu/e-posters-session-a-controles-424 https://www.gerpac.eu/prix-comunications-orales-gerpac-2021 https://www.gerpac.eu/concours-video-2021 https://www.gerpac.eu/rna-based-vaccines https://www.gerpac.eu/vaccins-a-base-d-arn https://www.gerpac.eu/communications-scientifiques-orales-courtes-423 https://www.gerpac.eu/hot-topics-2021 https://www.gerpac.eu/actualites-en-pharmacotechnie-hospitaliere https://www.gerpac.eu/quebec-asstsas-guide https://www.gerpac.eu/short-oral-communications-434 https://www.gerpac.eu/guide-atttsas-du-quebec https://www.gerpac.eu/travaux-presentes-par-les-etudiants-laureats-des-masters-de-pharmacotechnie-hospitaliere https://www.gerpac.eu/e-posters-session-e https://www.gerpac.eu/e-posters-session-e-microbio-formation-preparation-dm https://www.gerpac.eu/pharmaceutical-technology-master-course-s-award https://www.gerpac.eu/e-posters-session-b-436 https://www.gerpac.eu/e-posters-session-b-425 https://www.gerpac.eu/e-posters-session-c-437 https://www.gerpac.eu/e-posters-session-c-426 https://www.gerpac.eu/e-posters-session-d-438 https://www.gerpac.eu/e-posters-session-d-427 https://www.gerpac.eu/e-posters-session-a-435 https://www.gerpac.eu/symposium-arxium-448 https://www.gerpac.eu/symposium-arxium https://www.gerpac.eu/concurrent-workshops https://www.gerpac.eu/sessions-paralleles-418 https://www.gerpac.eu/congres-2020-387 https://www.gerpac.eu/e-posters-session-a-controles https://www.gerpac.eu/2020-conference https://www.gerpac.eu/industrial-communication-space https://www.gerpac.eu/espace-communication-industriels https://www.gerpac.eu/pharmaceutical-technologies-during-covid-19-crisis-what-we-done-and-what-we-learned https://www.gerpac.eu/pharmaceutical-technologies-during-covid-19-crisis-what-we-done-and-what-we-learned-389 https://www.gerpac.eu/conclusion-des-journees-scientifiques-416 https://www.gerpac.eu/communications-orales-courtes-388 https://www.gerpac.eu/les-technologies-pharmaceutiques-pendant-la-crise-covid-19-experiences-et-perspectives https://www.gerpac.eu/short-oral-communications-397 https://www.gerpac.eu/hot-topics-2020-413 https://www.gerpac.eu/actualites-2020 https://www.gerpac.eu/video-competitions https://www.gerpac.eu/concours-videos https://www.gerpac.eu/official-opening-of-the-23rd-conference https://www.gerpac.eu/ouverture-des-journees-scientifiques https://www.gerpac.eu/e-posters-session-d-403 https://www.gerpac.eu/e-posters-session-c-402 https://www.gerpac.eu/e-posters-session-b-401 https://www.gerpac.eu/e-posters-session-a-400 https://www.gerpac.eu/e-posters-session-d-395 https://www.gerpac.eu/e-posters-session-c-393 https://www.gerpac.eu/e-posters-sesssion-b https://www.gerpac.eu/2019-conference https://www.gerpac.eu/hot-news-from-gerpac https://www.gerpac.eu/congres-2019-328 https://www.gerpac.eu/e-posters-session-c-374 https://www.gerpac.eu/e-posters-session-c-376 https://www.gerpac.eu/photos-340 https://www.gerpac.eu/e-posters-session-a https://www.gerpac.eu/photos-349 https://www.gerpac.eu/short-oral-presentations https://www.gerpac.eu/e-posters-session-b-372 https://www.gerpac.eu/les-actualites-du-gerpac https://www.gerpac.eu/e-posters-session-d-377 https://www.gerpac.eu/e-posters-session-d-375 https://www.gerpac.eu/e-presentations-348 https://www.gerpac.eu/latest-developments-in-pharmaceutical-technology https://www.gerpac.eu/les-actualites-en-pharmacotechnie https://www.gerpac.eu/contamination-where-do-we-stand https://www.gerpac.eu/le-point-sur-les-contaminations https://www.gerpac.eu/communications-scientifiques-orales-courtes-337 https://www.gerpac.eu/round-table-343 https://www.gerpac.eu/table-ronde-334 https://www.gerpac.eu/e-posters-session-b-373 https://www.gerpac.eu/sessions-paralleles-330 https://www.gerpac.eu/consensus-stabilite-microbiologique https://www.gerpac.eu/microbiological-stability-consensus https://www.gerpac.eu/parallel-workshops https://www.gerpac.eu/laureats-2018-communications-scientifiques-orales-courtes https://www.gerpac.eu/congres-2018 https://www.gerpac.eu/automation-stadardization-for-injectable-preparation https://www.gerpac.eu/2018-conference https://www.gerpac.eu/photos-321 https://www.gerpac.eu/photos-304 https://www.gerpac.eu/hot-topics-2 https://www.gerpac.eu/actualites-2 https://www.gerpac.eu/preparations-in-paediatrics https://www.gerpac.eu/les-preparations-pediatriques https://www.gerpac.eu/using-medication-dispensing-systems https://www.gerpac.eu/preparation-des-doses-a-administrer https://www.gerpac.eu/oral-scientific-communications https://www.gerpac.eu/hot-topics-310 https://www.gerpac.eu/actualites-1 https://www.gerpac.eu/communications-scientifiques-orales-courtes-295 https://www.gerpac.eu/breakout-sessions https://www.gerpac.eu/sessions-paralleles-296 https://www.gerpac.eu/round-table https://www.gerpac.eu/table-ronde https://www.gerpac.eu/e-presentations-299 https://www.gerpac.eu/e-presentations-297 https://www.gerpac.eu/2017-conference https://www.gerpac.eu/oral-communications-awards https://www.gerpac.eu/short-oral-communications-270 https://www.gerpac.eu/congres-2017 https://www.gerpac.eu/laureats-communications-scientifiques-orales-courtes https://www.gerpac.eu/photos-288 https://www.gerpac.eu/conference-opening-286 https://www.gerpac.eu/ouverture-des-journees-285 https://www.gerpac.eu/photos-287 https://www.gerpac.eu/communications-scientifiques-orales https://www.gerpac.eu/rubrique283 https://www.gerpac.eu/theme-4-evolution-et-perspectives-dans-les-etudes-de-stabilite-et-d-interactions https://www.gerpac.eu/theme-4-stability-and-interaction-studies-recent-trends-and-future-prospects https://www.gerpac.eu/communications-affichees-282 https://www.gerpac.eu/posters-281 https://www.gerpac.eu/theme-3-evolution-et-perspectives-dans-l-etude-des-contaminations-chimiques https://www.gerpac.eu/theme-3-chemical-contamination-studies-recent-trends-and-future-prospects https://www.gerpac.eu/theme-2-preparation-and-controls-in-hospital-aseptic-units-recent-trends-and-future-prospects https://www.gerpac.eu/theme-2-evolution-et-perspectives-dans-la-fabrication-et-le-controle-en-pharmacotechnie-hospitaliere https://www.gerpac.eu/theme-1-training-in-hospital-pharmaceutical-technology-recent-trends-and-future-prospects https://www.gerpac.eu/theme-1-evolution-et-perspectives-dans-la-formation-en-pharmacotechnie-hospitaliere https://www.gerpac.eu/communications-scientifiques-orales-courtes-269 https://www.gerpac.eu/sessions-paralleles https://www.gerpac.eu/breakout-sessions-268 https://www.gerpac.eu/photos-261 https://www.gerpac.eu/photos https://www.gerpac.eu/espace-d-echanges-du-cuap https://www.gerpac.eu/automation-group-for-ready-to-administer-oral-forms https://www.gerpac.eu/posters https://www.gerpac.eu/communications-affichees-256 https://www.gerpac.eu/workshops-253 https://www.gerpac.eu/ateliers-252 https://www.gerpac.eu/2015-conference https://www.gerpac.eu/photos-225 https://www.gerpac.eu/congres-2015 https://www.gerpac.eu/photos-217 https://www.gerpac.eu/posters-229 https://www.gerpac.eu/communications-affichees https://www.gerpac.eu/hot-topics-in-pharmaceutical-technology https://www.gerpac.eu/actualites-en-pharmacotechnie https://www.gerpac.eu/short-oral-communications-223 https://www.gerpac.eu/communications-scientifiques-orales-courtes https://www.gerpac.eu/contaminations-chimiques-213 https://www.gerpac.eu/chemical-contaminations https://www.gerpac.eu/microbiologie https://www.gerpac.eu/microbial-contamination https://www.gerpac.eu/oral-preparations-and-prepared-oral-unit-dose https://www.gerpac.eu/preparations-orales-et-doses-a-administrer https://www.gerpac.eu/workshops-224 https://www.gerpac.eu/ateliers-216 https://www.gerpac.eu/opening-ceremony https://www.gerpac.eu/ouverture-du-congres-230 https://www.gerpac.eu/2014-conference https://www.gerpac.eu/photos-207 https://www.gerpac.eu/congres-2014 https://www.gerpac.eu/photos-206 https://www.gerpac.eu/hot-topics https://www.gerpac.eu/actualites-travaux-recents https://www.gerpac.eu/communications-scientifiques-orales-courtes-196 https://www.gerpac.eu/short-oral-scientific-communications https://www.gerpac.eu/disinfection-simulation https://www.gerpac.eu/desinfection-simulation https://www.gerpac.eu/chemical-contamination-risks https://www.gerpac.eu/risques-de-contamination-chimique https://www.gerpac.eu/workshops-205 https://www.gerpac.eu/ateliers-204 https://www.gerpac.eu/photos-192 https://www.gerpac.eu/photos-191 https://www.gerpac.eu/risk-management-for-sterile-preparation-in-hospital-pharmacies-part-i https://www.gerpac.eu/workshops-181 https://www.gerpac.eu/ateliers-179 https://www.gerpac.eu/2012-conference https://www.gerpac.eu/photos-164 https://www.gerpac.eu/congres-2012 https://www.gerpac.eu/photos-163 https://www.gerpac.eu/futur-et-innovations-des-zones-d-atmosphere-controlees https://www.gerpac.eu/future-for-facilities-and-controlled-areas https://www.gerpac.eu/short-oral-scientific-communications-165 https://www.gerpac.eu/communications-scientifiques-orales-courtes-166 https://www.gerpac.eu/bilan-sur-les-contaminations-chimiques-par-les-cytotoxiques https://www.gerpac.eu/reviews-on-chemical-contamination-risks https://www.gerpac.eu/preparations-past-and-future https://www.gerpac.eu/preparation-steriles-passe-et-futur https://www.gerpac.eu/ateliers-160 https://www.gerpac.eu/workshops-162 https://www.gerpac.eu/congres-2011 https://www.gerpac.eu/ateliers-152 https://www.gerpac.eu/2011-conference https://www.gerpac.eu/photos-156 https://www.gerpac.eu/photos-154 https://www.gerpac.eu/short-oral-scientific-communications-151 https://www.gerpac.eu/workshops-153 https://www.gerpac.eu/communications-scientifiques-orales-courtes-150 https://www.gerpac.eu/hyperthermic-in-traperitoneal-chemo-therapy-hipec https://www.gerpac.eu/chimiotherapie-hyperthermique-intraperitoneale-chip https://www.gerpac.eu/filling-process-in-aseptic-compounding https://www.gerpac.eu/remplissage-aseptique https://www.gerpac.eu/contamination-risks-highlights https://www.gerpac.eu/points-sur-les-contaminations https://www.gerpac.eu/procedure-evaluation-for-aseptic-compouding https://www.gerpac.eu/evaluation-des-procedes-en-preparation-aseptique https://www.gerpac.eu/2002-conference https://www.gerpac.eu/abstracts-139 https://www.gerpac.eu/congres-2002 https://www.gerpac.eu/resumes-des-conferences-137 https://www.gerpac.eu/2000-conference https://www.gerpac.eu/short-oral-communications-135 https://www.gerpac.eu/congres-2000 https://www.gerpac.eu/communications-orales-courtes-136 https://www.gerpac.eu/1998-conference https://www.gerpac.eu/abstracts-131 https://www.gerpac.eu/congres-1998 https://www.gerpac.eu/resumes-des-conferences-126 https://www.gerpac.eu/2004-conference https://www.gerpac.eu/anticancer-drugs-preparation-for-home-chemotherapy https://www.gerpac.eu/1999-conference https://www.gerpac.eu/abstracts-132 https://www.gerpac.eu/congres-1999 https://www.gerpac.eu/resumes-des-conferences-124 https://www.gerpac.eu/abstracts-133 https://www.gerpac.eu/resumes-des-conferences-122 https://www.gerpac.eu/2001-conference https://www.gerpac.eu/abstracts https://www.gerpac.eu/congres-2001 https://www.gerpac.eu/resumes-des-conferences https://www.gerpac.eu/2010-conference https://www.gerpac.eu/microbiology-controls-in-sterile-compounding https://www.gerpac.eu/imaging-tool-for-quality-control https://www.gerpac.eu/cytotoxic-oral-therapy https://www.gerpac.eu/ophtlamic-therapy https://www.gerpac.eu/short-oral-communications-112 https://www.gerpac.eu/workshops-111 https://www.gerpac.eu/photos-110 https://www.gerpac.eu/congres-2010 https://www.gerpac.eu/ateliers-109 https://www.gerpac.eu/photos-108 https://www.gerpac.eu/controles-microbiologiques-dans-le-cadre-des-preparations-steriles https://www.gerpac.eu/traitements-ophtalmiques https://www.gerpac.eu/communications-orales-courtes-104 https://www.gerpac.eu/traitements-cytotoxiques-par-voie-orale https://www.gerpac.eu/l-image-dans-le-controle-de-qualite https://www.gerpac.eu/short-oral-communications-46 https://www.gerpac.eu/congres-2007 https://www.gerpac.eu/communications-orales-courtes-42 https://www.gerpac.eu/2003-conference https://www.gerpac.eu/short-oral-communications-99 https://www.gerpac.eu/congres-2003 https://www.gerpac.eu/communications-orales-courtes https://www.gerpac.eu/european-experiences-ii-quality-assurance https://www.gerpac.eu/experiences-europeennes-ii-assurance-qualite https://www.gerpac.eu/french-good-manufacturing-practice-gmp-guidelines-in-hospital-pharmacy https://www.gerpac.eu/les-bonnes-pratiques-de-preparation-a-l-hopital-bpprh https://www.gerpac.eu/case-study-intallation-design-for-cytotoxic-drugs-preparation-in-hospital-pharmacy https://www.gerpac.eu/etude-de-cas-conception-d-installation-en-pharmacie-hospitaliere-pour-la-preparation-des-anticancereux https://www.gerpac.eu/congres-2005 https://www.gerpac.eu/contaminations-chimiques-et-protection-du-manipulateur-69 https://www.gerpac.eu/2005-conference https://www.gerpac.eu/chemical-contamination-and-safe-handling-76 https://www.gerpac.eu/short-oral-communications https://www.gerpac.eu/communications-orales-courtes-70 https://www.gerpac.eu/dose-banding-for-cytotoxics https://www.gerpac.eu/faisabilite-de-la-standardisation-des-doses-d-anticancereux https://www.gerpac.eu/chemical-contamination-and-safe-handling https://www.gerpac.eu/congres-2004 https://www.gerpac.eu/contaminations-chimiques-et-protection-du-manipulateur https://www.gerpac.eu/centralized-preparation-in-hospital-pharmacy-methodology https://www.gerpac.eu/centralisation-des-anticancereux-a-l-hopital-methodologie https://www.gerpac.eu/preparation-des-anticancereux-et-hospitalisation-a-domicile-had https://www.gerpac.eu/short-oral-communications-89 https://www.gerpac.eu/communications-orales-courtes-82 https://www.gerpac.eu/specialized-training-in-oncology-european-experiences-85 https://www.gerpac.eu/formation-en-oncologie-experiences-europeennes https://www.gerpac.eu/chemical-contamination-83 https://www.gerpac.eu/congres-2006 https://www.gerpac.eu/contaminations-chimiques-78 https://www.gerpac.eu/debate-chemical-contamination-with-cytotoxic-drugs-in-hospital-pharmacies https://www.gerpac.eu/plenary-sessions https://www.gerpac.eu/debat-bonnes-pratiques-de-fabrication https://www.gerpac.eu/conferences-plenieres https://www.gerpac.eu/debat-contaminations-chimiques-par-les-anticancereux-en-pharmacie-hospitaliere https://www.gerpac.eu/automatisation-standardisation-pour-la-preparation-des-injectables https://www.gerpac.eu/short-oral-communications-49 https://www.gerpac.eu/communications-orales-courtes-45 https://www.gerpac.eu/2008-conference https://www.gerpac.eu/compliance-with-good-manufacturing-pratices https://www.gerpac.eu/news-in-chemotherapy-scientific-and-practice https://www.gerpac.eu/congres-2008 https://www.gerpac.eu/mise-en-application-des-bonnes-pratiques-de-fabrication https://www.gerpac.eu/actualites-scientifiques-et-professionnelles-en-chimiotherapie https://www.gerpac.eu/2009-conference https://www.gerpac.eu/centralised-intravenous-additive-services-civas https://www.gerpac.eu/monoclonal-antibodies-preparation-risk-analysis https://www.gerpac.eu/environmental-cytotoxic-contamination-updating https://www.gerpac.eu/congres-2009 https://www.gerpac.eu/preparation-centralisee-des-injectables-civas https://www.gerpac.eu/analyse-de-risque-pour-la-preparation-des-anticorps-monoclonaux https://www.gerpac.eu/actualites-sur-la-contamination-environnementale-par-les-cytotoxiques https://www.gerpac.eu/short-oral-communications-26 https://www.gerpac.eu/pharmacie-clinique-oncologique https://www.gerpac.eu/short-oral-communications-37 https://www.gerpac.eu/control-and-evaluation-of-chemical-contamination https://www.gerpac.eu/maitrise-et-evaluation-des-contaminants-chimiques https://www.gerpac.eu/communications-orales-courtes-34 https://www.gerpac.eu/photos-27 https://www.gerpac.eu/photos-22 https://www.gerpac.eu/communications-orales-courtes-21 https://www.gerpac.eu/nouvelles-formulations-galeniques-des-cytotoxiques https://www.gerpac.eu/new-design-for-cytotoxic-treatments https://www.gerpac.eu/mentions-legales-gestion-des-donnees-personnelles https://www.gerpac.eu/legal-notes https://www.gerpac.eu/travaux-recents https://www.gerpac.eu/recent-work https://www.gerpac.eu/ouverture-du-congres https://www.gerpac.eu/opening-ceremony-243 https://www.gerpac.eu/ouverture-des-21emes-journees https://www.gerpac.eu/conference-opening-301 https://www.gerpac.eu/opening-session https://www.gerpac.eu/les-technologies-pharmaceutiques-pendant-la-crise-covid-19-experiences-et-perspectives-412 https://www.gerpac.eu/symposium-gilead-477 https://www.gerpac.eu/remote-session https://www.gerpac.eu/conclusion-525 https://www.gerpac.eu/conclusion-526 https://www.gerpac.eu/developpement-durable https://www.gerpac.eu/sustainable-development https://www.gerpac.eu/testimonials-552 https://www.gerpac.eu/congres-distanciel-557 https://www.gerpac.eu/congres-2026-637 https://www.gerpac.eu/conclusion-615 https://www.gerpac.eu/conclusion-616 https://www.gerpac.eu/ateliers-en-sessions-paralleles-641 https://www.gerpac.eu/biopharmacy https://www.gerpac.eu/qualite-de-vie-au-travail https://www.gerpac.eu/qvt-uk https://www.gerpac.eu/actualites-des-groupes-de-travail-europeens https://www.gerpac.eu/2026-conferences https://www.gerpac.eu/concurrent-workshops-642 https://www.gerpac.eu/biopharmacie-et-formulation-theorie-et-pratique https://www.gerpac.eu/ouverture-des-journees-639 https://www.gerpac.eu/opening-of-the-conference-640 https://www.gerpac.eu/news-from-european-working-groups https://www.gerpac.eu/debats-contradictoires https://www.gerpac.eu/debats-uk https://www.gerpac.eu/laureats-masters-de-pharmacotechnie-hospitaliere-651 https://www.gerpac.eu/pharmaceutical-technology-master-award-652 https://www.gerpac.eu/prix-comunication-orale-gerpac-2026 https://www.gerpac.eu/gerpac-award-2025-for-the-best-oral-communication-654 https://www.gerpac.eu/communications-scientifiques-orales-courtes-655 https://www.gerpac.eu/short-oral-communications-656 https://www.gerpac.eu/e-posters-session-a-assurance-qualite-analyse-de-risques-et-rse https://www.gerpac.eu/e-posters-session-a-quality-assurance-risk-analysis-and-csr-658 https://www.gerpac.eu/e-posters-session-b-etudes-de-faisabilite-formulations https://www.gerpac.eu/e-posters-session-b-feasibility-studies-formulations https://www.gerpac.eu/e-posters-session-c-etudes-de-stabilite-et-controle-qualite https://www.gerpac.eu/e-posters-session-c-stability-studies-and-quality-control https://www.gerpac.eu/e-posters-session-d-processus-de-production-et-d-automatisation https://www.gerpac.eu/e-posters-session-d-production-and-automation-processes https://www.gerpac.eu/e-posters-session-e-techniques-analytiques-et-microbiologiques https://www.gerpac.eu/e-posters-session-e-analytical-and-microbiological-techniques https://www.gerpac.eu/conclusion-667 https://www.gerpac.eu/conclusion-668 https://www.gerpac.eu/photos-671 https://www.gerpac.eu/photos-670 https://www.gerpac.eu/exhibition https://www.gerpac.eu/exposition https://www.gerpac.eu/les-cancerogenes-en-milieu-hospitalier-identification-construction-de-valeurs-limites-et-prevention-des-expositions https://www.gerpac.eu/industry-registration https://www.gerpac.eu/inscription-industriels https://www.gerpac.eu/presentation-des-29emes-journees https://www.gerpac.eu/the-29th-european-scientific-gerpac-eshpt-conference https://www.gerpac.eu/call-for-papers-22th-european-gerpac-conference https://www.gerpac.eu/appel-a-communications-congres-gerpac-2026 https://www.gerpac.eu/call-for-papers https://www.gerpac.eu/appel-a-communications https://www.gerpac.eu/adhesion-2020 https://www.gerpac.eu/tarifs-congres-2024 https://www.gerpac.eu/inscription-congressistes-format-distanciel https://www.gerpac.eu/conference-registration-for-online-attendance https://www.gerpac.eu/inscription-congressistes-format-presentiel https://www.gerpac.eu/symposiums-satellites https://www.gerpac.eu/evaluating-microbial-viability-differently-impedance-cytometry-versus-culture https://www.gerpac.eu/moderators-3978 https://www.gerpac.eu/optimisation-environnementale-de-la-production-de-chimiotherapies-etude-comparative-de-la-gemcitabine-prete-a-l-emploi-vs-preparee-en-unite-de-reconstitution-de-cytotoxiques https://www.gerpac.eu/21emes-journees-du-gerpac-1660 https://www.gerpac.eu/la-covid-et-votre-congres-2482 https://www.gerpac.eu/view-presentations-from-the-2025-congress https://www.gerpac.eu/conditions-generales-de-vente https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3898 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3914 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3922 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3910 https://www.gerpac.eu/acceder-au-replay-de-cette-session-3902 https://www.gerpac.eu/acces-au-replay-de-cette-session-3913 https://www.gerpac.eu/acces-au-replay-de-cette-session-3911 https://www.gerpac.eu/acces-au-replay-de-cette-session-3909 https://www.gerpac.eu/acces-au-replay-de-cette-session-3905 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3906 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3919 https://www.gerpac.eu/acces-au-replay-de-cette-session-3918 https://www.gerpac.eu/workshop-3666 https://www.gerpac.eu/ouverture-des-journees-3619 https://www.gerpac.eu/opening-of-the-conference-3648 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3873 https://www.gerpac.eu/acces-au-replay-de-cette-session-3872 https://www.gerpac.eu/board-of-directors-3072 https://www.gerpac.eu/conseil-d-administration https://www.gerpac.eu/outils-de-simulation https://www.gerpac.eu/mise-en-place-de-la-standardisation-des-doses-dans-notre-etablissement-poches-pretes-a-l-administration-ou-lots-de-doses-standardisees https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3630 https://www.gerpac.eu/2024-conference-3682 https://www.gerpac.eu/access-the-replay-of-this-4th-session https://www.gerpac.eu/access-the-replay-of-this-2nd-session https://www.gerpac.eu/access-the-replay-of-this-3rd-session https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3624 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3397 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3395 https://www.gerpac.eu/congres-2024-3683 https://www.gerpac.eu/acces-au-replay-de-cette-2nd-session https://www.gerpac.eu/acces-au-replay-de-cette-4eme-session https://www.gerpac.eu/acces-au-replay-de-cette-3eme-session https://www.gerpac.eu/accedez-au-replay-de-cette-session-3623 https://www.gerpac.eu/acceder-au-replay-de-cette-session-3396 https://www.gerpac.eu/acceder-au-replay-de-cette-session-3398 https://www.gerpac.eu/acceder-au-replay-de-cette-session https://www.gerpac.eu/acces-au-replay-de-cette-session-3637 https://www.gerpac.eu/ouverture-des-journees-3647 https://www.gerpac.eu/opening-of-the-video-contest-gerpac-2020 https://www.gerpac.eu/evaluation-of-in-use-physicochemical-stability-of-diluted-isatuximab-isa https://www.gerpac.eu/licensed-ready-to-use-gemcitabine-bags-cut-carbon-emissions-versus-in-house-vial-compounding https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3930 https://www.gerpac.eu/development-of-a-method-for-the-quantification-of-bacterial-endotoxins-in-parenteral-vitamin-lipid-emulsion-preparations-using-the-recombinant-c-factor https://www.gerpac.eu/french-national-external-quality-assessment-campaign-for-parenteral-nutrition-controls https://www.gerpac.eu/formulation-of-a-cyclodextrin-based-ophthalmic-drug-solution-of-chlorhexidine-for-the-treatment-of-acanthamoeba https://www.gerpac.eu/feasibility-study-of-an-oral-formulation-of-pyridoxine-in-the-treatment-of-pharmacoresistant-epilepsies https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-managing-extractables-and-leachables-in-hospital-pharmacy-practices-challenges-and-insights https://www.gerpac.eu/workshop2-managing-extractables-and-leachables-in-hospital-pharmacy-practices-challenges-and-insights-3689 https://www.gerpac.eu/integrating-an-automated-compounding-system-into-an-isolator-the-relevance-of-microbiological-requalification https://www.gerpac.eu/polyethersulfone-in-line-filters-an-extractible-study-in-the-context-of-chemotherapy-administration https://www.gerpac.eu/assessment-of-a-fun-training-course-on-good-manufacturing-practice-for-pharmacy-technicians-feedback-on-the-use-of-the-bpp-quiz-r https://www.gerpac.eu/feasibility-study-of-a-cardioplegia-solution-using-the-del-nido-formulation https://www.gerpac.eu/evaluation-of-the-impact-of-formulations-and-preparation-conditions-of-reconstituted-pemetrexed-peme-specialties-on-its-stability-in-infusion-bags https://www.gerpac.eu/innovative-formulation-of-cyclophosphamide-chewable-gummies-produced-using-3d-printing-for-pediatric-administration https://www.gerpac.eu/bilan-a-1-an-de-la-surveillance-microbiologique-et-particulaire-des-equipements-dans-une-nouvelle-unite-de-preparation-de-medicaments-radiopharmaceutiques https://www.gerpac.eu/one-year-assessment-of-microbiological-and-particulate-environnemental-monitoring-of-equipment-in-a-new-radiopharmaceutical-compounding-unit https://www.gerpac.eu/can-we-limit-our-impact-on-the-planet-while-producing-chemotherapies https://www.gerpac.eu/what-is-the-future-of-fused-deposition-modeling-3d-printing-in-hospital-pharmacies-for-the-production-of-oral-solid-dosage-forms https://www.gerpac.eu/development-of-fenfluramine-in-albumin-nanoparticles-for-nasal-administration https://www.gerpac.eu/techno-economic-comparison-between-semi-solid-extrusion-3d-printing-of-oral-forms-and-capsule-compounding-in-a-hospital-setting https://www.gerpac.eu/analytical-control-of-anticancer-agents-via-sample-free-near-infrared-spectroscopy-first-feedback https://www.gerpac.eu/low-temperature-sterilization-of-novelia-r-eye-drops-vials-feasibility-content-container-interactions-and-functional-impact https://www.gerpac.eu/surface-contamination-in-127-canadian-hospitals-results-from-the-2025-surveillance-program https://www.gerpac.eu/usp-nf-packaging-system-suitability-a-simple-yet-powerful-tool-for-differentiating-packaging-performances-in-terms-of-water-permeability-3831 https://www.gerpac.eu/new-openable-softgel-use-in-oral-need-for-suitable-forms-in-pediatrics-and-proof-of-concept https://www.gerpac.eu/mapping-of-sterile-anticancer-drug-preparations-in-hospital-pharmacies-in-nouvelle-aquitaine-current-status-territorial-disparities-and-opportunities-for-cooperation https://www.gerpac.eu/quel-est-le-future-de-l-impression-3d-de-type-modelisation-par-depot-fondu-fdm-fans-les-pharmacies-hospitalieres https://www.gerpac.eu/developpement-de-fenfluramine-dans-des-nanoparticules-d-albumine-pour-administration-par-voie-nasale https://www.gerpac.eu/comparaison-technico-economique-entre-l-impression-3d-semi-solide-de-formes-orales-et-la-fabrication-de-gelules-a-l-hopital https://www.gerpac.eu/controle-analytique-des-anticancereux-via-une-solution-connectee-de-spectroscopie-proche-infrarouge-sans-echantillonnage-retour-d-experience https://www.gerpac.eu/evaluation-de-la-stabilite-physico-chimique-de-l-isatuximab-isa-apres-dilution https://www.gerpac.eu/sterilisation-a-basse-temperature-des-flacons-de-collyre-novelia-r-faisabilite-interactions-contenu-contenant-et-impacts-fonctionnels https://www.gerpac.eu/nouvelle-capsule-molle-ouvrable-pour-la-voie-orale-necessite-de-formes-adaptees-en-pediatrie-et-preuve-de-concept https://www.gerpac.eu/contamination-de-surfaces-des-hopitaux-canadiens-resultats-du-programme-de-surveillance-de-127-hopitaux-en-2025 https://www.gerpac.eu/filtres-en-ligne-en-polyethersulfone-une-etude-des-extractible-dans-le-cadre-de-l-administration-de-chimiotherapies https://www.gerpac.eu/cartographie-de-l-offre-en-preparations-steriles-d-anticancereux-dans-les-pui-de-nouvelle-aquitaine-etat-des-lieux-disparites-territoriales-et-opportunites-de-cooperation https://www.gerpac.eu/peut-on-limiter-notre-impact-sur-la-planete-en-produisant-des-chimiotherapies https://www.gerpac.eu/formulation-d-une-solution-ophtalmique-a-base-de-cyclodextrine-et-de-chlorhexidine-pour-le-traitement-de-la-keratite-a-acanthamoeba-spp https://www.gerpac.eu/campagne-nationale-francaise-d-evaluation-externe-de-la-qualite-des-controles-en-nutrition-parenterale https://www.gerpac.eu/evaluation-d-une-formation-ludique-sur-les-bonne-pratiques-de-preparation-destinee-aux-preparateurs-en-pharmacie-retour https://www.gerpac.eu/evaluer-la-viabilite-microbienne-autrement-la-cytometrie-d-impedance-face-a-la-culture-3827 https://www.gerpac.eu/integration-d-un-automate-dans-un-isolateur-pertinence-de-la-requalification-microbiologique https://www.gerpac.eu/etude-de-faisabilite-d-une-formulation-buvable-de-pyridoxine-dans-le-traitement-des-epilepsies-pharmacoresistances https://www.gerpac.eu/acces-au-replay-de-cette-session-3929 https://www.gerpac.eu/acces-au-replay-de-l-atelier-no2 https://www.gerpac.eu/acces-au-replay-de-cette-session-3903 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3917 https://www.gerpac.eu/contributions-of-artificial-intelligence-to-hospital-pharmacy https://www.gerpac.eu/apports-de-l-intelligence-artificielle-en-pharmacie-hospitaliere https://www.gerpac.eu/workshop-5-training-in-the-management-of-cytotoxic-breakage-through-simulation-a-team-challenge https://www.gerpac.eu/workshop-3-microbiological-environmental-monitoring https://www.gerpac.eu/workshop1-eu-guidance-for-safe-management-of-hazardous-medicinal-products-at-work https://www.gerpac.eu/interactive-case-study-3896 https://www.gerpac.eu/real-hope-project https://www.gerpac.eu/gerpac-special-interest-groups-automation https://www.gerpac.eu/gerpac-special-interest-groups https://www.gerpac.eu/southern-pacific-approach https://www.gerpac.eu/eco-conception-in-pharmaceutical-technologies-3673 https://www.gerpac.eu/moderators-3921 https://www.gerpac.eu/pediatric-pharmaceutical-preparations-in-new-zealand-applications-and-problems https://www.gerpac.eu/moderators-3885 https://www.gerpac.eu/moderateurs-3884 https://www.gerpac.eu/moderateurs-3920 https://www.gerpac.eu/moderateurs-3888 https://www.gerpac.eu/atelier-5-se-former-a-la-gestion-du-bris-de-flacon-cytotoxique-par-la-simulation-un-challenge-d-equipe https://www.gerpac.eu/atelier-4-concevoir-une-urc-pour-limiter-les-troubles-musculo-squelettiques https://www.gerpac.eu/atelier-3-monitoring-environnemental-et-microbiologique https://www.gerpac.eu/workshop2-managing-extractables-and-leachables-in-hospital-pharmacy-practices-challenges-and-insights https://www.gerpac.eu/workshop1-eu-guidance-for-safe-management-of-hazardous-medicinal-products-at-work-3686 https://www.gerpac.eu/moderateurs-3890 https://www.gerpac.eu/etude-de-cas-3897 https://www.gerpac.eu/contributions-of-artificial-intelligence-to-hospital-pharmacy-3887 https://www.gerpac.eu/apports-de-l-intelligence-artificielle-en-pharmacie-hospitaliere-3886 https://www.gerpac.eu/l-ia-c-est-quoi https://www.gerpac.eu/demarche-nationale-francaise-l-histoire-des-12-standards https://www.gerpac.eu/demarche-oceanique-australie https://www.gerpac.eu/eco-conception-en-pharmacotechnie-3672 https://www.gerpac.eu/french-national-approach-the-history-of-the-12-standards https://www.gerpac.eu/preparations-pharmaceutiques-pediatriques-en-nouvelle-zelande-applications-et-problemes-3864 https://www.gerpac.eu/development-and-characterization-of-a-hydrocortisone-gummy-formulation-for-the-treatment-of-corticotropic-insufficiency-in-pediatric-congenital-adrenal-hyperplasia https://www.gerpac.eu/formulation-et-caracte%CC%81risation-d-une-pre%CC%81paration-de-gummies-d-hydrocortisone-pour-le-traitement-pe%CC%81diatrique-de-l-insuffisance-corticotrope-associe%CC%81e-a%CC%80-une-hyperplasie-conge%CC%81nitale-des-surre%CC%81nales https://www.gerpac.eu/developpement-d-une-methode-uplc-ms-ms-appliquee-a-une-etude-pharmacocinetique-de-deux-inhibiteurs-de-recepteurs-a-domaine-discoidine-evaluation-du-passage-de-la-barriere-hemato-encephalique https://www.gerpac.eu/development-of-an-uplc-ms-ms-method-applied-to-a-pharmacokinetic-study-of-two-discoidin-domain-receptor-inhibitors-assessment-of-blood-brain-barrier-penetration https://www.gerpac.eu/3d-printed-topotecan-and-antiemetic-gummies-for-pediatric-neuroblastoma https://www.gerpac.eu/formulations-imprimees-en-3d-de-topotecan-et-de-gummies-antiemetiques-pour-le-traitement-du-neuroblastome-pediatrique https://www.gerpac.eu/ateliers-3665 https://www.gerpac.eu/e-posters-3925 https://www.gerpac.eu/e-posters-3926 https://www.gerpac.eu/in-plenary-session-3924 https://www.gerpac.eu/seance-pleniere-3923 https://www.gerpac.eu/coin-detente-3927 https://www.gerpac.eu/the-relaxation-area-3928 https://www.gerpac.eu/moderators-3889 https://www.gerpac.eu/session-labellisee-dpc-parcours-cnp-3710 https://www.gerpac.eu/session-labellisee-dpc-parcours-cnp-3711 https://www.gerpac.eu/processus-de-selection-des-communications https://www.gerpac.eu/selection-of-short-oral-and-e-posters-communications https://www.gerpac.eu/formulation-innovante-de-gommes-a-macher-de-cyclophosphamide-par-impression-3d-pour-une-administration-pediatrique-adaptee https://www.gerpac.eu/gerpac-special-interest-groups-3862 https://www.gerpac.eu/gerpac-special-interest-groups-automation-3900 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3399 https://www.gerpac.eu/moderateurs-3892 https://www.gerpac.eu/developpement-d-une-methode-de-quantification-des-endotoxines-bacteriennes-dans-des-preparations-injectables-d-emulsions-vitamino-lipidiques-par-le-facteur-c-recombinant https://www.gerpac.eu/usp-nf-packaging-system-suitability-a-simple-yet-powerful-tool-for-differentiating-packaging-performances-in-terms-of-water-permeability https://www.gerpac.eu/etude-de-faisabilite-d-une-solution-de-cardioplegie-selon-la-formulation-del-nido https://www.gerpac.eu/moderators-3891 https://www.gerpac.eu/workshop-4-designing-a-centralized-cytotoxic-preparation-unit-cpu-to-minimize-musculoskeletal-disorders-msds https://www.gerpac.eu/ai-what-is-it-really https://www.gerpac.eu/evaluation-de-l-impact-des-formulations-et-des-conditions-de-preparation-de-specialites-de-pemetrexed-peme-sur-sa-stabilite-dans-des-poches-reconstituees https://www.gerpac.eu/real-hope-project-3704 https://www.gerpac.eu/activity-continuity-plan-for-aseptic-preparations https://www.gerpac.eu/le-plan-de-continuite-des-activites-des-activites-de-preparation-aseptique https://www.gerpac.eu/continuity-of-cancer-treatment-preparation-what-resources-are-available-at-the-regional-level https://www.gerpac.eu/continuite-d-activite-de-preparation-des-traitements-anticancereux-quelles-ressources-a-l-echelle-d-une-region https://www.gerpac.eu/controle-de-sterilite-de-collyres-acqueux-et-huileux-par-automate-bactec-r-faisabilite-et-validation https://www.gerpac.eu/sterility-testing-of-aqueous-and-oily-eye-drops-using-the-bactec-r-automated-system-feasibility-and-validation https://www.gerpac.eu/qualification-of-pharmaceutical-staff-for-handling-cytotoxic-safety-cabinets-simulation-at-the-heart-of-certification https://www.gerpac.eu/qualification-du-personnel-pharmaceutique-a-la-manipulation-en-poste-de-securite-cytotoxique-la-simulation-au-coeur-de-l-habilitation https://www.gerpac.eu/3d-printing-of-antiemetics-rheology-serving-personalized-medicine https://www.gerpac.eu/impression-3d-d-antiemetique-la-rheologie-au-service-de-la-medecine-personnalisee https://www.gerpac.eu/feasibility-study-of-centralizing-biotherapy-preparations-at-the-annecy-genevois-hospital-center https://www.gerpac.eu/etude-de-faisabilite-de-la-centralisation-des-preparations-de-biotherapies-au-centre-hospitalier-d-annecy-genevois https://www.gerpac.eu/case-of-non-compliant-eye-drops-investigation-on-non-visible-particles https://www.gerpac.eu/cas-d-un-collyre-non-conforme-enquete-sur-les-particules-non-visibles https://www.gerpac.eu/development-and-validation-of-the-sterility-test-for-a-new-1mg-ml-ropivacaine-preparation-3809 https://www.gerpac.eu/developpement-et-validation-de-l-essai-de-sterilite-pour-une-nouvelle-preparation-de-ropivacaine-a-1-mg-ml-3808 https://www.gerpac.eu/analytical-control-by-uv-spectrophotometry-with-druglog-r-relevance-for-in-house-calibration-ranges https://www.gerpac.eu/controle-analytique-par-spectrophotometrie-uv-druglog-r-quelle-pertinence-pour-des-gammes-internes https://www.gerpac.eu/a-blood-gas-analyzer-for-parenteral-nutrition-bags-analysis-performance-evaluation-and-method-validation https://www.gerpac.eu/un-analyseur-de-gaz-du-sang-au-service-du-dosage-des-poches-de-nutrition-parenterale-evaluation-des-performances-et-validation-de-la-methode-de-dosage https://www.gerpac.eu/method-development-for-the-quantification-of-erythromycin-in-250-mg-capsules https://www.gerpac.eu/developpement-d-une-methode-de-dosage-de-gelules-d-erythromycine-250mg https://www.gerpac.eu/development-of-a-gamma-counter-calibration-protocol-for-radiopharmaceutical-applications https://www.gerpac.eu/developpement-d-un-protocole-de-calibration-des-compteurs-gamma-pour-des-applications-radiopharmaceutiques https://www.gerpac.eu/characterisation-of-polymer-films-for-intravenous-solvent-bags-packaging https://www.gerpac.eu/caracterisation-des-films-de-polymere-d-une-poche-de-perfusion https://www.gerpac.eu/qualification-du-bionettoyage-des-atmospheres-controlees https://www.gerpac.eu/qualification-of-biocleaning-in-cleanrooms https://www.gerpac.eu/robustness-evaluation-of-a-semi-solid-extrusion-3d-printing-process-for-oral-dosage-forms-a-case-study-with-melatonin https://www.gerpac.eu/evaluation-de-la-robustesse-du-procede-de-fabrication-de-formes-orales-imprimees-en-3d-par-extrusion-semi-solide-application-a-la-melatonine https://www.gerpac.eu/comparative-study-of-content-uniformity-between-capsules-and-3d-printed-oral-forms-manufactured-by-semi-solid-extrusion https://www.gerpac.eu/etude-comparative-de-l-uniformite-de-teneur-entre-des-gelules-et-des-formes-orales-fabriquees-par-impression-3d-semi-solide https://www.gerpac.eu/qualification-of-the-aseptic-process-for-preparing-10-5-glycerol-fructose-bags https://www.gerpac.eu/qualification-du-procede-aseptique-de-preparation-de-poches-de-glycerol-fructose-10-5 https://www.gerpac.eu/physico-chemical-stability-of-ceftazidime-fortified-eye-drops-20-mg-ml-stored-at-20oc https://www.gerpac.eu/stabilite-physico-chimique-des-collyres-fortifies-de-ceftazidime-a-20-mg-ml-conserves-a-20-oc https://www.gerpac.eu/developpement-d-une-methode-de-fabrication-automatisee-de-68ga-fapi-46-dans-un-hopital-universitaire https://www.gerpac.eu/development-of-an-automatized-production-of-68ga-fapi-46-in-an-hospital https://www.gerpac.eu/implementation-of-a-protocol-to-induce-tolerance-to-nirogacestat-in-a-responder-patient-stability-of-a-drinkable-liquid-form https://www.gerpac.eu/mise-en-place-d-un-protocole-d-induction-de-tolerance-au-nirogacestat-chez-un-patient-repondeur-etude-de-stabilite-d-une-forme-buvable-en-solution https://www.gerpac.eu/validation-of-an-automated-method-for-cyclophosphamide-reconstitution-and-comparison-with-the-manual-process https://www.gerpac.eu/validation-d-une-methode-automatisee-de-reconstitution-du-cyclophosphamide-et-comparaison-avec-le-processus-manuel https://www.gerpac.eu/preliminary-risk-assessment-of-the-design-of-facilities-for-the-preparation-of-advanced-therapy-medicinal-products https://www.gerpac.eu/analyse-des-risques-a-priori-de-la-conception-des-locaux-de-reconstitution-des-medicaments-de-therapie-innovante https://www.gerpac.eu/implementation-of-datamatrix-codes-on-vials-a-time-saving-measure https://www.gerpac.eu/mise-en-place-des-datamatrix-sur-les-flacons-un-gain-de-temps https://www.gerpac.eu/technical-and-regulatory-feasibility-of-a-new-sterile-preparation-posing-health-and-environmental-risk-the-case-of-30-ethanol-eye-drops https://www.gerpac.eu/faisabilite-technico-reglementaire-d-une-nouvelle-preparation-sterile-presentant-un-risque-pour-la-sante-et-l-environnement-exemple-du-collyre-d-ethanol-a-30-v-v-3782 https://www.gerpac.eu/development-of-a-new-formulation-for-preparing-oral-provocation-tests-opt-for-nuts-in-allergology https://www.gerpac.eu/elaboration-d-une-nouvelle-formulation-pour-la-preparation-des-tests-de-provocation-orale-aux-fruits-a-coque-en-allergologie https://www.gerpac.eu/cytotoxiques-casser-pour-mieux-gerer https://www.gerpac.eu/cytotoxic-agents-breaking-to-manage-better https://www.gerpac.eu/cytotoxic-drugs-on-the-loose-alert-prevention-action https://www.gerpac.eu/cytotoxiques-en-fuite-alerte-prevention-action https://www.gerpac.eu/paclitaxel-desensitization-protocol-stability-study https://www.gerpac.eu/protocole-de-desensibilisation-du-paclitaxel-etude-de-stabilite https://www.gerpac.eu/container-content-interactions-tests-for-automated-dispensing-of-radiopharmaceuticals-who-s-gonna-stick-to-it https://www.gerpac.eu/tests-d-interactions-contenant-contenu-des-automates-de-dispensation-pour-les-medicaments-radiopharmaceutiques-qui-s-y-colle https://www.gerpac.eu/validation-of-a-stability-indicating-assay-method-for-epalrestat-using-uv-detection-high-performance-liquid-chromatography https://www.gerpac.eu/validation-d-une-methode-de-dosage-indicatrice-de-stabilite-par-chromatographie-liquide-a-haute-performance-a-detection-ultra-violet-de-l-epalrestat https://www.gerpac.eu/identification-of-critical-parameters-for-an-automatic-film-applicator-to-produce-orodispersible-hydrocortisone-hemisuccinate-films https://www.gerpac.eu/identification-des-parametres-critiques-d-un-applicateur-de-film-dans-le-cadre-de-la-production-de-films-orodispersibles-d-hemi-succinate-d-hydrocortisone https://www.gerpac.eu/stability-study-of-several-insulins-in-a-binary-parenteral-nutrition-mixture https://www.gerpac.eu/etude-de-stabilite-de-differentes-insulines-dans-un-melange-binaire-de-nutrition-parenterale https://www.gerpac.eu/evaluation-of-a-reception-and-thawing-assistance-tool-for-securing-the-car-t-cells-circuit https://www.gerpac.eu/evaluation-d-un-outil-d-aide-a-la-reception-et-decongelation-pour-la-securisation-du-circuit-des-car-t-cells https://www.gerpac.eu/e-posters-session-a-3654 https://www.gerpac.eu/preparations-non-steriles-dangereuses-comment-evaluer-le-risque-pour-le-manipulateur https://www.gerpac.eu/marquages-gallies-a-l-aide-de-generateurs-de-fournisseurs-differents https://www.gerpac.eu/gallium-radioactive-labelling-using-radionuclide-generators-from-different-suppliers https://www.gerpac.eu/one-atmp-two-hospital-pharmacies-no-compromise https://www.gerpac.eu/un-mti-deux-pui-zero-compromis https://www.gerpac.eu/stabilite-microbiologique-d-une-solution-de-clonidine-a-10-mug-ml-pour-le-service-de-pediatrie https://www.gerpac.eu/microbiological-stability-of-a-10-mug-ml-clonidine-solution-for-paediatric-use https://www.gerpac.eu/optimization-of-repackaging-practices-for-solid-oral-forms https://www.gerpac.eu/optimisation-des-pratiques-de-reconditionnement-des-formes-orales-seches https://www.gerpac.eu/flocculation-of-etoposide-preparations-what-are-the-influencing-factors https://www.gerpac.eu/floculations-des-preparations-d-etoposide-quels-sont-les-facteurs-influencant https://www.gerpac.eu/save-patient-b-an-escape-game-in-a-cytotoxic-production-unit https://www.gerpac.eu/il-faut-sauver-le-patient-b-escape-game-au-sein-d-une-unite-de-reconstitution-centralisee-des-cytotoxiques https://www.gerpac.eu/prospective-assessment-of-the-economic-implications-of-automating-chemotherapy-preparation-in-a-comprehensive-cancer-center https://www.gerpac.eu/evaluation-prospective-de-l-impact-economique-d-une-robotisation-de-la-preparation-des-chimiotherapies-au-sein-d-un-centre-de-lutte-contre-le-cancer https://www.gerpac.eu/conception-et-evaluation-d-un-outil-regional-sur-des-situations-d-erreur-ou-d-exposition-liees-a-l-utilisation-de-cytotoxiques https://www.gerpac.eu/conception-and-evaluation-of-a-regional-tool-for-risk-situations-of-errors-or-exposure-related-to-the-use-of-cytotoxics https://www.gerpac.eu/physicochemical-validation-of-the-sterile-filtration-process-for-hospital-compounded-gentamicin-eye-drops https://www.gerpac.eu/validation-physicochimique-du-processus-de-filtration-sterilisante-lors-de-la-fabrication-de-preparation-hospitaliere-de-collyres-de-gentamicine https://www.gerpac.eu/optimization-of-the-production-of-gallium-68-labeled-peptides-psma-et-dotatoc https://www.gerpac.eu/optimisation-des-productions-des-peptides-marques-au-gallium-68-psma-et-dotatoc https://www.gerpac.eu/implementation-of-a-professional-practice-assessment-within-a-nuclear-pharmacy https://www.gerpac.eu/realisation-d-une-evaluation-des-pratiques-professionnelles-sur-le-theme-de-l-hygiene-au-sein-d-un-service-de-radiopharmacie https://www.gerpac.eu/training-and-qualification-in-the-visual-inspection-and-labelling-of-hospital-compounded-eye-drops https://www.gerpac.eu/formation-et-habilitation-au-mirage-et-a-l-etiquetage-des-preparations-hospitalieres-de-collyres https://www.gerpac.eu/continuing-education-of-hospital-pharmacy-technicians-in-cytotoxic-reconstitution-unit-cru-a-regional-level-answer-results-of-4-cruathlon https://www.gerpac.eu/formation-continue-des-preparateurs-en-unite-de-reconstitution-des-cytotoxiques-urc-au-niveau-regional-bilan-de-4-urcathlon https://www.gerpac.eu/feasibility-study-internal-production-and-controls-of-autologous-serum-eyedrops-ased https://www.gerpac.eu/etude-de-faisabilite-production-et-controle-intramuros-de-collyres-au-serum-autologue-csa https://www.gerpac.eu/microbiological-qualification-of-a-robot-kiro-isolator-grifols-for-the-preparation-of-anticancer-chemotherapies https://www.gerpac.eu/qualification-microbiologique-d-un-robot-kiro-isolator-r-grifols-pour-la-preparation-de-chimiotherapies-anticancereuses https://www.gerpac.eu/organisme-de-formation https://www.gerpac.eu/no-safety-net-in-pharmaceutical-technology-how-the-absence-of-continuous-service-affects-hospital-practice https://www.gerpac.eu/pharmacotechnie-sans-filet-impact-de-l-absence-de-continuite-de-service-sur-les-pratiques-hospitalieres https://www.gerpac.eu/developpement-et-validation-de-l-essai-de-sterilite-pour-une-nouvelle-preparation-de-ropivacaine-a-1-mg-ml https://www.gerpac.eu/development-and-validation-of-the-sterility-test-for-a-new-1mg-ml-ropivacaine-preparation https://www.gerpac.eu/quiz-gerpac https://www.gerpac.eu/dpc https://www.gerpac.eu/ressources-documentaires https://www.gerpac.eu/simulation-tools https://www.gerpac.eu/e-learning https://www.gerpac.eu/general-terms-and-conditions-of-sale https://www.gerpac.eu/conference-registration https://www.gerpac.eu/qualification-of-the-aseptic-process-for-preparing-10-5-glycerol-fructose-bags-3810 https://www.gerpac.eu/validation-d-une-methode-de-dosage-indicatrice-de-stabilite-par-chromatographie-liquide-a-haute-performance-a-detection-ultra-violet-de-l-epalrestat-3802 https://www.gerpac.eu/session-labellisee-dpc-parcours-cnp-3709 https://www.gerpac.eu/e-learning-1881 https://www.gerpac.eu/congres-2023-3680 https://www.gerpac.eu/2023-conference-3681 https://www.gerpac.eu/temoignages https://www.gerpac.eu/testimonials-2176 https://www.gerpac.eu/etudes-de-stabilite-de-preparations-pharmaceutiques-en-pratique-hospitaliere https://www.gerpac.eu/practical-stability-studies-in-hospital-pharmacies https://www.gerpac.eu/bppho https://www.gerpac.eu/pharmacie-clinique-en-oncologie-pediatrique-245 https://www.gerpac.eu/preparation-des-radiopharmaceutiques-a-l-hopital https://www.gerpac.eu/gants-criteres-de-choix-267 https://www.gerpac.eu/chimiotherapies-hyperthermiques-intra-peritoneales-chip https://www.gerpac.eu/developing-clinical-pharmacy-in-oncology https://www.gerpac.eu/role-du-pharmacien-hospitalier-analyse-des-risques-lies-a-la-preparation-des-nouvelles-biotherapies-table-ronde https://www.gerpac.eu/gerpac-award-2025-for-the-best-oral-communication-3669 https://www.gerpac.eu/gerpac-award-2024-for-the-best-oral-communication-3668 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3626 https://www.gerpac.eu/acces-au-replay-de-cette-session-3625 https://www.gerpac.eu/workshop-3640 https://www.gerpac.eu/the-relaxation-area-3646 https://www.gerpac.eu/coin-detente-3645 https://www.gerpac.eu/e-posters-3644 https://www.gerpac.eu/e-posters-3643 https://www.gerpac.eu/in-plenary-session-3642 https://www.gerpac.eu/seance-pleniere-3641 https://www.gerpac.eu/ateliers-3639 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3369 https://www.gerpac.eu/conference-archives https://www.gerpac.eu/moderators-3600 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3340 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3009 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3348 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3008 https://www.gerpac.eu/acces-au-replay-de-cette-session-3400 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3350 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3326 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3347 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3346 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3320 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3345 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3325 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3344 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3324 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3342 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3322 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3341 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3321 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3319 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3343 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3351 https://www.gerpac.eu/opening-of-the-conference-3332 https://www.gerpac.eu/ouverture-des-journees-2023 https://www.gerpac.eu/what-is-the-future-of-hospital-pharmaceutical-technologies-general-introduction https://www.gerpac.eu/quel-avenir-pour-les-technologies-pharmaceutiques-hospitalieres-3370 https://www.gerpac.eu/training-in-the-management-of-cytotoxic-breakage-through-simulation-a-team-challenge https://www.gerpac.eu/hpuzzlc-enhancing-hplc-proficiency-in-sterile-compounding-units-by-implementing-a-serious-game-based-training-approach https://www.gerpac.eu/hpuzzlc-ameliorer-la-maitrise-et-habiliter-a-l-utilisation-de-l-hplc-dans-une-unite-de-reconstitution-sterile-par-la-mise-en-oeuvre-d-une-approche-de-formation-par-jeu-serieux https://www.gerpac.eu/moderators-3602 https://www.gerpac.eu/moderateurs-3601 https://www.gerpac.eu/moderators-3604 https://www.gerpac.eu/moderateurs-3603 https://www.gerpac.eu/moderateurs-3599 https://www.gerpac.eu/moderators-3607 https://www.gerpac.eu/moderateurs-3606 https://www.gerpac.eu/opening-of-the-conference-3620 https://www.gerpac.eu/statistical-process-control-spc-application-to-a-cytotoxic-reconstitution-unit https://www.gerpac.eu/maitrise-statistique-des-procedes-application-a-une-unite-de-reconstitution-des-cytotoxiques https://www.gerpac.eu/design-and-characterization-of-2-propofol-lipid-nanocapsules-formulated-by-microfluidics https://www.gerpac.eu/design-and-characterization-of-2-propofol-lipid-nanocapsules-formulated-by-microfluidics-3616 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3401 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3403 https://www.gerpac.eu/acces-au-replay-de-cette-session-3629 https://www.gerpac.eu/collyre-au-serum-autologue https://www.gerpac.eu/session-labellisee-dpc-parcours-cnp-3628 https://www.gerpac.eu/session-labellisee-dpc-parcours-cnp https://www.gerpac.eu/acces-au-replay-de-cette-session https://www.gerpac.eu/interactive-case-study-3393 https://www.gerpac.eu/etudes-de-cas-3391 https://www.gerpac.eu/gerpac-award-2024-for-the-best-oral-communication-3622 https://www.gerpac.eu/prix-communications-orales-gerpac-2024 https://www.gerpac.eu/moderateurs-3597 https://www.gerpac.eu/poches-bi-compartimentees-un-nouveau-conditionnement-pour-les-preparations-instables-d-anticancereux-injectables https://www.gerpac.eu/two-chamber-bags-a-new-packaging-solution-for-unstable-injectable-anticancer-drug-preparations https://www.gerpac.eu/feedback-from-sixteen-month-experience-of-using-two-robotic-systems-for-sterile-chemotherapy-compounding-in-isolators-and-under-laminar-flow-hoods-in-the-same-unit https://www.gerpac.eu/retour-d-experience-de-16-mois-d-utilisation-de-2-robots-de-production-de-preparations-steriles-de-chimiotherapie-en-isolateur-et-sous-flux-laminaire-dans-une-meme-unite https://www.gerpac.eu/le-tubing-mural-la-solution-pour-arreter-la-contamination-chimique https://www.gerpac.eu/large-scale-compounding-in-a-norwegian-hospital-pharmacy https://www.gerpac.eu/preparations-a-grande-echelle-dans-les-pharmacies-hospitalieres-en-norvege https://www.gerpac.eu/accedez-au-replay-de-cette-session-3323 https://www.gerpac.eu/optimizing-automated-chemotherapy-preparation-determining-the-need-for-practice-review https://www.gerpac.eu/optimisation-de-la-preparation-automatisee-des-chimiotherapies-quand-la-revision-des-pratiques-devient-necessaire https://www.gerpac.eu/a-wall-mounted-tubing-transfer-system-a-solution-to-prevent-chemical-contamination https://www.gerpac.eu/feedback-from-an-error-in-the-preparation-of-intrathecal-analgesia https://www.gerpac.eu/retour-d-experience-d-une-erreur-de-preparation-d-antalgie-intrathecale https://www.gerpac.eu/panic-in-the-cytotoxic-drug-production-unit-simulation-of-an-incident-exposing-to-cytotoxic-contamination-risk https://www.gerpac.eu/panique-a-l-unite-de-chimiotherapie-simulation-d-un-incident-exposant-a-un-risque-de-contamination-cytotoxique https://www.gerpac.eu/carbon-footprint-of-a-chemotherapy-production-unit-assessment-within-a-hospital-pharmacy https://www.gerpac.eu/empreinte-carbone-d-une-unite-de-production-de-chimiotherapie-evaluation-au-sein-d-une-pharmacie-hospitaliere https://www.gerpac.eu/strategy-for-controlling-particulate-contamination-during-renovation-work-while-maintaining-injectable-drug-production-activity https://www.gerpac.eu/strategie-de-maitrise-de-la-contamination-particulaire-lors-de-travaux-avec-maintien-d-activite-de-la-production-de-medicaments-injectables https://www.gerpac.eu/the-quomet-project-quantifying-shock-levels-in-pharmaceutical-transport-to-ensure-medication-safety https://www.gerpac.eu/le-projet-quomet-quantification-des-niveaux-de-chocs-dans-le-transport-pharmaceutique-pour-garantir-la-securite-des-medicaments https://www.gerpac.eu/to-flip-or-not-to-flip-toward-a-change-in-pratices https://www.gerpac.eu/to-flip-or-not-to-flip-vers-un-changement-des-pratiques https://www.gerpac.eu/development-of-a-stability-indicating-predictive-and-prospective-study-of-a-semi-solid-formulation-of-butylscopolamine-bromide-bbs https://www.gerpac.eu/mise-au-point-d-une-etude-indicatrice-de-stabilite-predictive-et-prospective-d-une-formulation-semi-solide-de-butylbromure-de-scopolamine-bbs https://www.gerpac.eu/hospital-pharmacist-role-risk-analysis-for-new-therapeutics-production-round-table https://www.gerpac.eu/etude-de-stabilite-d-un-hydrogel-buccal-de-lidocaine-2-20mg-g-et-clobetasol-0-05-500mug-g-utilise-pour-traiter-et-soulager-les-mucites https://www.gerpac.eu/large-scale-aseptic-hospital-production-in-the-uk-3390 https://www.gerpac.eu/large-scale-aseptic-hospital-production-in-the-uk https://www.gerpac.eu/large-scale-production-in-the-netherlands https://www.gerpac.eu/production-a-grande-echelle-aux-pays-bas https://www.gerpac.eu/specific-features-of-pharmaceutical-technologies-in-french-overseas-territories https://www.gerpac.eu/specificites-des-technologies-pharmaceutiques-dans-les-territoires-francais-d-outre-mer https://www.gerpac.eu/autologous-serum-eye-drops https://www.gerpac.eu/manufacturing-of-new-biotherapies-risk-analysis-example-of-point-of-care-manufacturing-of-car-t-cells https://www.gerpac.eu/prevention-des-contaminations-dans-les-productions-de-therapies-innovantes-cas-des-car-t-cells-produites-au-point-of-care https://www.gerpac.eu/phage-therapy https://www.gerpac.eu/therapie-par-les-phages https://www.gerpac.eu/biotherapies-role-of-the-hospital-pharmacist https://www.gerpac.eu/le-point-sur-les-biotherapies-role-du-pharmacien-hospitalier https://www.gerpac.eu/preliminary-validation-results-of-an-alternative-sterility-test-for-hospital-injectable-anticancer-drugs https://www.gerpac.eu/resultats-preliminaires-d-un-protocole-de-validation-de-methode-alternative-de-controle-de-la-sterilite-de-preparations-hospitalieres-d-anticancereux-injectables https://www.gerpac.eu/stability-indicating-hplc-method-development-of-carbimazole-tablets-and-stability-study-of-the-repackaged-tablet https://www.gerpac.eu/developpement-d-une-methode-clhp-indicatrice-de-stabilite-des-comprimes-de-carbimazole-et-etude-de-stabilite-du-comprime-reconditionne https://www.gerpac.eu/stabilite-physique-des-solutions-de-bevacizumab-pour-injections-intravitreennes-influence-du-dispositif-de-conditionnement-et-des-conditions-de-stockage https://www.gerpac.eu/physical-stability-of-bevacizumab-solutions-for-intravitreal-injections-influence-of-the-packaging-device-and-storage-conditions https://www.gerpac.eu/operational-qualification-of-a-3d-printer-for-drug-manufacturing https://www.gerpac.eu/assessment-of-chemical-stability-of-monoclonal-antibody-and-antibody-drug-conjugate-administered-by-pressured-intraperitoneal-aerosol-chemotherapy https://www.gerpac.eu/evaluation-de-la-stabilite-chimique-des-anticorps-monoclonaux-et-des-conjugues-anticorps-medicament-administres-par-aerosol-intraperitoneal-sous-pression-pipac https://www.gerpac.eu/preliminary-palatability-tests-for-the-use-of-3d-printed-gummies https://www.gerpac.eu/tests-preliminaires-de-palatabilite-pour-l-utilisation-de-gommes-imprimees-en-3d https://www.gerpac.eu/se-former-a-la-gestion-du-bris-de-flacon-cytotoxique-par-la-simulation-un-challenge-d-equipe https://www.gerpac.eu/design-of-centralized-cytotoxic-unit-3366 https://www.gerpac.eu/conception-d-une-unite-centralisee-de-cytotoxiques https://www.gerpac.eu/eu-guidance-for-safe-management-of-hazardous-medicinal-products-at-work-3362 https://www.gerpac.eu/orientations-de-l-ue-pour-une-gestion-sure-des-medicaments-dangereux-sur-le-lieu-de-travail https://www.gerpac.eu/validation-of-aseptic-pharmaceutical-preparations https://www.gerpac.eu/validation-des-preparations-pharmaceutiques-aseptiques https://www.gerpac.eu/discrimination-et-quantification-de-trois-solutions-de-cephalosporines-a-travers-differents-conditionnements-de-perfusion-en-spectroscopie-raman https://www.gerpac.eu/application-of-raman-spectroscopy-for-qualitative-and-quantitative-analysis-of-three-cephalosporin-solutions-through-infusion-containers https://www.gerpac.eu/how-about-3d-films-3d-printing-development-and-characterization-of-an-orodispersible-hydrocortisone-film-formulation https://www.gerpac.eu/et-si-on-en-faisait-des-films-3d-developpement-en-impression-3d-et-caracterisation-d-une-formulation-de-films-orodispersibles-d-hydrocortisone https://www.gerpac.eu/smartcompounders-chemo-r-does-it-well-perform-statistical-study-and-capability-analysi https://www.gerpac.eu/le-smartcompounders-chemo-r-est-il-performant-etude-statistique-et-analyse-de-capabilite https://www.gerpac.eu/development-and-validation-of-a-production-and-a-dosage-methods-of-3d-printed-tablets-containing-prednisolone https://www.gerpac.eu/developpement-et-validation-d-une-methode-de-production-et-d-une-methode-de-dosage-de-tablettes-de-prednisolone-fabriquees-par-imprimante-3d https://www.gerpac.eu/assessment-of-cross-contamination-risk-between-two-products-in-a-robotized-anticancer-drugs-compounding-process-riva-r-arxium-3583 https://www.gerpac.eu/evaluation-du-risque-de-contamination-croisee-entre-deux-produits-lors-d-un-procede-robotise-riva-r-arxium-de-preparation-de-medicaments-anticancereux https://www.gerpac.eu/3d-printing-as-a-way-towards-new-galenic-forms-formulation-and-control-of-gummies-containing-amiodarone-or-diazoxide https://www.gerpac.eu/l-impression-3d-a-l-origine-de-formes-galeniques-innovantes-formulation-et-controle-de-gommes-contenant-de-l-amiodarone-ou-du-diaxozide https://www.gerpac.eu/qualification-operationnelle-d-une-imprimante-3d-pour-la-fabrication-de-medicaments https://www.gerpac.eu/moderators-3598 https://www.gerpac.eu/trend-analysis-of-microbiological-samples-within-isolators https://www.gerpac.eu/analyse-de-tendance-des-prelevements-microbiologiques-a-l-interieur-des-isolateurs https://www.gerpac.eu/awareness-of-errors-undetectable-by-drugcam-r-evaluation-of-recognition-by-operators https://www.gerpac.eu/sensibilisation-aux-erreurs-indetectables-par-drugcam-r-evaluation-de-la-reconnaissance-par-les-manipulateurs https://www.gerpac.eu/development-of-spironolactone-oral-suspension-for-pediatric-use-and-chemicophysical-stability-study-using-capillary-electrophoresis-and-hplc https://www.gerpac.eu/formulation-et-etude-de-stabilite-physico-chimique-d-une-suspension-de-spironolactone-5-mg-ml-interet-de-l-electrophorese-capillaire-vs-clhp https://www.gerpac.eu/the-spectra-of-anthracyclines-analyzed https://www.gerpac.eu/les-spectres-d-anthracyclines-passes-au-crible https://www.gerpac.eu/near-infrared-spectroscopy-multivariate-analysis-a-proof-of-concept-study-for-non-destructive-quality-control-of-pharmaceutical-preparations https://www.gerpac.eu/spectroscopie-en-proche-infrarouge-avec-analyse-multivariee-une-etude-de-faisabilite-pour-le-controle-non-destructif-de-la-qualite-des-preparations-pharmaceutiques https://www.gerpac.eu/stability-study-of-a-buccal-hydrogel-containing-2-lidocaine-20mg-g-and-0-05-clobetasol-500mug-g-used-for-the-treatment-and-relief-of-mucositis https://www.gerpac.eu/intelligence-videonumerique-quel-impact-sur-le-temps-de-mise-a-disposition-des-chimiotherapies https://www.gerpac.eu/artificial-intelligence-management-system-what-impact-on-the-availability-time-of-chemotherapy https://www.gerpac.eu/effectiveness-of-ultraviolet-c-decontamination-identifying-optimal-exposure-times-for-reducing-common-hospital-bacterial-strains https://www.gerpac.eu/efficacite-de-la-decontamination-aux-rayons-ultraviolets-c-identification-des-durees-d-exposition-optimales-pour-degrader-des-souches-bacteriennes-courantes-en-milieu-hospitalier https://www.gerpac.eu/pharmaceutical-aseptic-preparation-on-call-duty-period-setting-up-a-training-and-accreditation-program-for-pharmacists https://www.gerpac.eu/preparation-pharmaceutique-en-astreinte-mise-en-place-d-un-programme-de-formation-et-d-habilitation-pour-les-pharmaciens https://www.gerpac.eu/facing-the-threat-of-cyberattack-developing-an-activity-continuity-software-for-the-production-of-anticancer-drugs-3574 https://www.gerpac.eu/face-a-la-menace-de-cyberattaque-conception-d-un-logiciel-de-continuite-d-activite-pour-la-production-des-medicaments-anticancereux https://www.gerpac.eu/impact-of-the-analytical-optimization-of-a-cation-quantification-method-by-capillary-electrophoresis-using-the-rgb-tool https://www.gerpac.eu/drug-shortage-of-oral-corticosteroids-development-of-a-prednisone-5-mg-capsule-formulation-adapted-to-an-automated-preparation-process https://www.gerpac.eu/rupture-des-corticoides-oraux-developpement-d-une-formulation-de-gelules-de-prednisone-5-mg-adaptee-a-un-procede-automatise-de-preparation https://www.gerpac.eu/quality-control-issues-not-detected-by-chemotherapy-video-monitoring-system https://www.gerpac.eu/erreurs-non-detectees-lors-de-la-preparation-des-chimiotherapies-par-le-systeme-d-assistance-video https://www.gerpac.eu/magistral-preparation-of-chloroquine-phosphate-capsules-for-the-treatment-of-lupus-patients-example-of-an-active-principle-with-a-narrow-therapeutic-range-requiring-manipulation-under-conditions https://www.gerpac.eu/analyse-par-injection-directe-dans-le-flux-couplee-a-la-spectroscopie-uv-fia-uv-vs-spectroscopie-raman-pour-l-analyse-quantitative-du-remdesivir https://www.gerpac.eu/flow-injection-analysis-with-uv-detection-versus-raman-spectroscopy-for-the-quantitative-analysis-of-remdesivir https://www.gerpac.eu/study-of-forced-degradation-by-hplc-uv-and-electrophoresis-of-a-new-synthetic-therapeutic-elastic-protein-formulated-in-isotonic-saline-solution https://www.gerpac.eu/etude-par-hplc-uv-et-electrophorese-de-degradation-forcee-d-une-nouvelle-proteine-elastique-synthetique-therapeutique-conditionnee-en-serum-sale-isotonique https://www.gerpac.eu/development-of-an-experimental-drug-and-implementation-of-its-preparation-on-automatic-capsule-fillers https://www.gerpac.eu/developpement-d-un-medicament-experimental-et-mise-en-oeuvre-de-sa-preparation-sur-gelulier-automatique https://www.gerpac.eu/preparation-magistrale-de-gelules-de-phosphate-de-chloroquine-pour-le-traitement-des-patients-lupiques-exemple-d-un-principe-actif-a-index-therapeutique-etroit-requerant-une-manipulation-sous-conditions https://www.gerpac.eu/hospital-preparation-of-sterile-vaseline-oil-a-rapid-response-to-a-worldwide-shortage https://www.gerpac.eu/preparation-hospitaliere-d-huile-de-vaseline-sterile-une-reponse-rapide-a-une-penurie-mondiale https://www.gerpac.eu/life-cycle-analysis-of-the-production-of-three-hospital-preparations-through-an-advanced-pharmaco-technical-eco-audit https://www.gerpac.eu/analyse-du-cycle-de-vie-de-la-production-de-trois-preparations-hospitalieres-par-un-eco-audit-pharmacotechnique-avance https://www.gerpac.eu/stability-study-of-10-mg-ml-cyclophosphamide-solution https://www.gerpac.eu/efficiency-of-an-optimized-decontamination-procedure-for-five-intravenous-antineoplastic-drugs-in-a-compounding-isolator-of-a-hospital-pharmacy-a-real-life-study https://www.gerpac.eu/efficacite-d-une-procedure-de-decontamination-optimisee-concernant-cinq-medicaments-antineoplasiques-intraveineux-dans-un-isolateur-de-preparation-d-une-pharmacie-a-usage-interieur-une-etude-en-vie-reelle https://www.gerpac.eu/development-and-validation-of-a-method-for-the-determination-of-topiramate-by-high-performance-liquid-chromatography-coupled-to-a-charged-aerosol-detector-hplc-cad https://www.gerpac.eu/developpement-et-validation-d-une-methode-de-dosage-du-topiramate-par-chromatographie-liquide-haute-performance-couplee-a-un-detecteur-a-aerosols-charges-hplc-cad https://www.gerpac.eu/drugcam-r-how-to-qualify-it https://www.gerpac.eu/drugcam-r-comment-le-qualifier https://www.gerpac.eu/database-creation-on-the-feasibility-of-galenic-modification-of-oral-anticancer-drugs https://www.gerpac.eu/creation-d-une-base-de-donnees-sur-les-modifications-galeniques-des-medicaments-anticancereux-per-os https://www.gerpac.eu/capability-analysis-of-a-powder-for-filling-by-an-automatic-hard-capsule-filler https://www.gerpac.eu/analyse-de-capabilite-de-poudres-pour-une-production-de-gelules-a-l-aide-d-une-geluleuse-automatique https://www.gerpac.eu/impact-de-l-optimisation-analytique-d-un-dosage-de-cations-par-electrophorese-capillaire-selon-l-outil-rgb https://www.gerpac.eu/development-of-a-sampling-method-to-validate-the-cleaning-process-of-an-automatic-hard-capsule-filler https://www.gerpac.eu/elaboration-d-une-methode-de-prelevement-afin-de-valider-le-processus-de-nettoyage-d-une-geluleuse-automatique https://www.gerpac.eu/determining-a-use-by-date-ubd-on-repackaged-administration-doses-3520 https://www.gerpac.eu/determination-d-une-date-limite-d-utilisation-dlu-sur-les-doses-a-administrer-reconditionnees https://www.gerpac.eu/development-of-automated-capsule-production-for-hospital-pharmacies https://www.gerpac.eu/developpement-de-l-automatisation-de-la-production-de-gelules-en-pharmacie-hospitaliere https://www.gerpac.eu/etude-de-faisabilite-de-l-implementation-de-la-cytometrie-en-flux-dans-une-unite-de-preparation-de-transplants-de-microbiote-fecal-3464 https://www.gerpac.eu/feasibility-study-of-implementing-flow-cytometry-in-a-fecal-microbiota-transplant-preparation-unit https://www.gerpac.eu/feasibility-study-semi-automated-preparation-and-filling-of-continuous-5-fluorouracil-5-fu-administration-devices-3555 https://www.gerpac.eu/etude-de-faisabilite-preparation-et-remplissage-en-systeme-semi-automatise-de-dispositifs-d-administration-en-continu-de-5-fluorouracile-5-fu https://www.gerpac.eu/etude-de-stabilite-d-une-solution-de-cyclophosphamide-10-mg-ml https://www.gerpac.eu/study-of-the-microbiological-stability-and-preservative-efficiency-of-a-2-mg-ml-hydrochlorothiazide-oral-suspension-in-inorpha-r https://www.gerpac.eu/etude-de-la-stabilite-microbiologique-et-de-l-efficacite-du-conservateur-d-une-suspension-buvable-d-hydrochlorothiazide-a-2-mg-ml-dans-l-inorpha-r https://www.gerpac.eu/performance-qualification-of-a-syringe-filling-machine-smartfiller-r https://www.gerpac.eu/qualification-de-performance-d-un-automate-de-remplissage-de-seringues-smartfiller-r https://www.gerpac.eu/analyse-de-risque-sur-le-procede-automatise-de-remplissage-par-un-automate-de-remplissage-de-seringues-smartfiller-r https://www.gerpac.eu/risk-analysis-on-the-automated-syringe-filling-process-using-the-smartfiller-r-filling-machine https://www.gerpac.eu/risk-analysis-of-the-non-sterile-compounding-activity-and-the-impact-of-computerization-in-the-preparation-circuit https://www.gerpac.eu/analyse-de-risque-de-l-activite-de-preparation-non-sterile-et-de-l-impact-de-l-informatisation-dans-le-circuit-des-preparations https://www.gerpac.eu/validation-de-methode-de-dosage-par-chromatographie-liquide-a-haute-performance-a-detection-uv-de-la-lidocaine-prilocaine-et-tetracaine-3544 https://www.gerpac.eu/validation-of-an-assay-method-for-lidocaine-prilocaine-and-tetracaine-using-uv-detection-high-performance-liquid-chromatography-3545 https://www.gerpac.eu/feasibility-study-of-bacterial-endotoxin-testing-in-hospital-preparations-of-10-glycerol-5-fructose https://www.gerpac.eu/etude-de-faisabilite-du-dosage-des-endotoxines-bacteriennes-dans-les-preparations-hospitalieres-de-glycerol-10-fructose-5 https://www.gerpac.eu/comparaison-du-comportement-rheologique-de-vehicules-pour-suspension-prets-a-l-emploi-et-formules-pour-les-patients-atteints-de-troubles-de-la-deglutition https://www.gerpac.eu/comparison-of-the-rheological-behaviour-of-ready-to-use-suspension-vehicles-and-formulated-for-patients-with-swallowing-disorders https://www.gerpac.eu/performance-qualification-of-the-robotic-system-apotecaunit-for-non-toxic-parenteral-preparations-3419 https://www.gerpac.eu/performance-qualification-of-the-robotic-system-apotecaunit-for-non-toxic-parenteral-preparations https://www.gerpac.eu/cartographie-de-la-flore-bacterienne-des-produits-entrant-en-zone-a-atmosphere-controlee-attrapez-les-tous https://www.gerpac.eu/mapping-of-the-bacterial-flora-of-products-entering-the-controlled-atmosphere-zone-catch-them-all https://www.gerpac.eu/preparation-of-etoposide-injection-concentrated-at-10-mg-ml-interest-and-physicochemical-stability-study-3569 https://www.gerpac.eu/preparation-d-etoposide-injectable-concentree-a-10-mg-ml-interets-et-etude-de-stabilite-physicochimique https://www.gerpac.eu/preparation-of-experimental-injectable-drugs-designing-an-e-learning-tool-to-train-tomorrow-s-operators https://www.gerpac.eu/preparation-des-medicaments-experimentaux-injectables-conception-d-un-e-learning-pour-former-les-operateurs-de-demain https://www.gerpac.eu/dans-les-trefonds-du-microbiote-fecal-les-secrets-de-sa-fabrication-devoiles https://www.gerpac.eu/in-the-depths-of-the-fecal-microbiota-unveiling-the-secrets-of-its-production https://www.gerpac.eu/robotics-and-chemotherapy-preparation-what-impacts-on-staff-quality-of-life-and-working-conditions-qwlc https://www.gerpac.eu/robotique-et-preparation-de-chimiotherapies-quels-impacts-sur-la-qualite-de-vie-et-les-conditions-de-travail-qvct-du-personnel https://www.gerpac.eu/focus-on-continuous-training-for-on-call-pharmacists-tailored-resources-and-personalized-training-for-safe-validation-and-manufacturing-of-cytotoxic-products https://www.gerpac.eu/focus-sur-la-formation-continue-des-pharmaciens-d-astreinte-des-supports-adaptes-et-des-formations-personnalisees-pour-une-securite-de-validation-et-fabrication-pharmaceutique-des-produits-cytotoxiques https://www.gerpac.eu/physicochemical-stability-of-diluted-akynzeo-r-infusion-solutions-in-prefilled-0-9-sodium-chloride-infusion-bags https://www.gerpac.eu/physicochemical-stability-of-diluted-akynzeo-r-infusion-solutions-in-prefilled-0-9-sodium-chloride-infusion-bags-3516 https://www.gerpac.eu/stability-study-of-a-standardized-parenteral-nutrition-formulation-for-premature-neonates https://www.gerpac.eu/etude-de-stabilite-d-une-poche-de-nutrition-parenterale-standardisee-destinee-aux-nouveau-nes-prematures https://www.gerpac.eu/control-of-injectable-preparations-in-a-centralized-preparation-unit-identification-of-an-assay-interference-between-monoclonal-antibodies-and-5-fluorouracil-by-uv-raman-spectrophotometry https://www.gerpac.eu/controle-des-preparations-injectables-en-unite-de-preparation-centralisee-mise-en-evidence-d-une-interference-de-dosage-entre-anticorps-monoclonaux-et-5-fluorouracile-par-spectrophotometrie-uv-raman https://www.gerpac.eu/stability-study-of-a-betaxolol-oral-suspension-hospital-preparation https://www.gerpac.eu/etude-de-stabilite-d-une-preparation-hospitaliere-de-betaxolol-en-suspension-buvable https://www.gerpac.eu/validation-of-an-assay-method-for-an-aqueous-solution-of-trichloroacetic-acid-benefits-of-automated-acid-base-titration https://www.gerpac.eu/validation-d-une-methode-de-dosage-d-une-solution-aqueuse-d-acide-trichloroacetique-interet-du-titrage-acido-basique-par-titrimetre-automatique https://www.gerpac.eu/double-blind-phase-i-ii-clinical-trials-preliminary-risk-analysis-applied-to-the-pharmaceutical-circuit-of-injectable-anticancer-drugs-in-a-preparation-unit https://www.gerpac.eu/essais-cliniques-de-phase-i-ii-en-double-aveugle-analyse-preliminaire-des-risques-appliquee-au-circuit-pharmaceutique-des-anticancereux-injectables-dans-une-unite-de-preparation https://www.gerpac.eu/exosquelette-ou-support-de-bras-quel-equipement-pour-limiter-les-troubles-musculo-squelettiques-chez-nos-preparateurs https://www.gerpac.eu/exoskeleton-or-arm-holder-which-equipment-to-limit-musculoskeletal-disorders-among-our-pharmacy-technicians https://www.gerpac.eu/from-the-centralized-cytotoxic-reconstitution-unit-ccru-to-the-day-care-unit-dcu-all-involved-with-chemical-contamination-spread-simulation https://www.gerpac.eu/de-l-unite-de-reconstitution-des-cytotoxiques-urc-a-l-hopital-de-jour-hdj-tous-concernes-par-la-contamination-chimique-simulation-de-la-diffusion https://www.gerpac.eu/development-of-a-flash-method-based-on-thin-layer-chromatography-for-radiochemical-purity-assessment-of-99mtc-tetrofosmin https://www.gerpac.eu/creation-d-une-technique-flash-d-evaluation-de-purete-radiochimique-par-chromatographie-sur-couche-mince-du-99mtc-tetrofosmine https://www.gerpac.eu/the-use-of-raman-spectroscopy-in-a-hospital-pharmacy-setting-3512 https://www.gerpac.eu/the-use-of-raman-spectroscopy-in-a-hospital-pharmacy-setting https://www.gerpac.eu/flow-rate-conservation-test-of-folfusor-sv-2ml-h-diffusers-towards-an-extension-of-expiry-date https://www.gerpac.eu/test-de-conservation-du-debit-des-diffuseurs-folfusor-sv-2ml-h-r-vers-une-extension-de-peremption https://www.gerpac.eu/development-of-a-stability-indicating-assay-and-study-of-the-physico-chemical-stability-of-etoposide-phosphate-in-a-0-9-sodium-chloride-solution https://www.gerpac.eu/developpement-d-une-methode-de-dosage-indicatrice-de-stabilite-et-etude-de-la-stabilite-physico-chimique-de-l-etoposide-phosphate-dans-une-solution-de-chlorure-de-sodium-0-9 https://www.gerpac.eu/contribution-of-dose-harmonization-to-the-reallocation-of-preparations https://www.gerpac.eu/apport-de-l-harmonisation-des-doses-dans-la-reattribution-des-preparations https://www.gerpac.eu/evaluation-audit-of-cytotoxic-preparation-isolator-bio-cleaning-practices-according-to-2022-good-preparation-practices-following-positive-bacteriological-surface-samples https://www.gerpac.eu/audit-d-evaluation-des-pratiques-de-bionettoyage-d-un-isolateur-de-preparations-de-cytotoxiques-selon-les-bonnes-pratiques-de-preparation-2022-suite-au-retour-de-prelevements-de-surfaces-bacteriologiques-positifs https://www.gerpac.eu/evaluation-of-the-feasibility-of-preparing-patches-in-vaseline-for-the-toxidermia-eploration-in-immuno-allergology https://www.gerpac.eu/evaluation-de-la-faisabilite-de-preparation-de-patchs-dans-la-vaseline-pour-l-exploration-des-toxidermies-en-immuno-allergologie https://www.gerpac.eu/comparison-between-two-types-of-water-baths-wet-and-dry-in-the-context-of-the-car-t-cell-reinjection-circuit https://www.gerpac.eu/comparaison-entre-deux-types-de-bains-marie-humide-et-sec-dans-le-cadre-du-circuit-de-reinjection-de-car-t-cells https://www.gerpac.eu/development-and-validation-of-a-photometric-titration-method-spotlighting https://www.gerpac.eu/developpement-et-validation-d-une-methode-de-titrage-photometrique-mise-en-lumiere https://www.gerpac.eu/sterility-assay-by-membrane-filtration-method-suitability-test-for-0-1-edta-eye-drops https://www.gerpac.eu/essai-de-sterilite-par-filtration-sur-membrane-des-collyres-edta-0-1-essai-d-applicabilite https://www.gerpac.eu/sterilization-of-neoprene-gloves-used-to-preparations-shielded-enclosure-and-microbiological-assessment-in-radiopharmacy https://www.gerpac.eu/sterilisation-des-gants-en-neoprene-pour-enceinte-blindee-de-preparation-et-bilan-microbiologique-en-radiopharmacie https://www.gerpac.eu/resumption-of-the-downgraded-circuit-during-a-chemotherapy-prescription-software-breakdown-from-a-to-z https://www.gerpac.eu/quality-review-of-sterile-hospital-preparations-a-recommendation-of-good-preparation-practices https://www.gerpac.eu/revue-qualite-de-preparations-hospitalieres-steriles-une-recommandation-des-bonnes-pratiques-de-preparation https://www.gerpac.eu/decontamination-par-rayons-ultraviolets-c-analyse-de-son-impact-sur-les-contaminations-de-surface-en-zone-a-atmosphere-controlee https://www.gerpac.eu/symposium-asept-in-med https://www.gerpac.eu/symposium-asept-in-med-3422 https://www.gerpac.eu/double-blind-phase-i-ii-clinical-trials-preliminary-risk-analysis-applied-to-the-pharmaceutical-circuit-of-injectable-anticancer-drugs-in-a-preparation-unit-3415 https://www.gerpac.eu/essais-cliniques-de-phase-i-ii-en-double-aveugle-analyse-preliminaire-des-risques-appliquee-au-circuit-pharmaceutique-des-anticancereux-injectables-dans-une-unite-de-preparation-3414 https://www.gerpac.eu/validation-de-methode-de-dosage-par-chromatographie-liquide-a-haute-performance-a-detection-uv-de-la-lidocaine-prilocaine-et-tetracaine https://www.gerpac.eu/validation-of-an-assay-method-for-lidocaine-prilocaine-and-tetracaine-using-uv-detection-high-performance-liquid-chromatography https://www.gerpac.eu/congres-2022-3407 https://www.gerpac.eu/2022-conference-3408 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3007 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3006 https://www.gerpac.eu/certification-qualiopi https://www.gerpac.eu/gerpac-and-you https://www.gerpac.eu/contacts https://www.gerpac.eu/documentation https://www.gerpac.eu/breakage-of-a-cytotoxic-drug-s-vial https://www.gerpac.eu/le-gerpac-et-vous https://www.gerpac.eu/temoignages-edition-2023 https://www.gerpac.eu/contact-us https://www.gerpac.eu/testimonials-2023 https://www.gerpac.eu/ouverture-des-journees-2022 https://www.gerpac.eu/access-the-replay https://www.gerpac.eu/accedez-au-replay-de-cette-session-2999 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations https://www.gerpac.eu/accedez-au-replay-de-cette-session https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3003 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3002 https://www.gerpac.eu/access-to-replay-of-these-recorded-presentations-3005 https://www.gerpac.eu/accedez-au-replay-de-cette-session-3004 https://www.gerpac.eu/impact-of-disposable-syringes-type-choice-on-myocardial-perfusion-imaging-procedures-with-99mtc-tc-tetrofosmin-2976 https://www.gerpac.eu/impact-of-disposable-syringes-type-choice-on-myocardial-perfusion-imaging-procedures-with-99mtc-tc-tetrofosmin https://www.gerpac.eu/qualification-des-preparateurs-par-test-de-remplissage-aseptique-tra-modifie https://www.gerpac.eu/pharmaceutical-technologies-during-covid-19-crisis-what-we-done-and-what-we-learned-1420 https://www.gerpac.eu/recommendations-on-training-objectives-and-staff-qualification-for-the-manual-preparation-of-capsules-in-pharmacy https://www.gerpac.eu/collaboration-work-with-the-sfpc-on-the-infusion-of-injectable-medecines https://www.gerpac.eu/validation-des-methodes-analytiques-pour-le-controle-qualite-et-l-etude-de-la-stabilite-des-preparations-hospitalieres-pourquoi-et-comment https://www.gerpac.eu/sous-traitance-des-chimiotherapies-exercices-pratiques-3025 https://www.gerpac.eu/creation-d-une-unite-de-preparation https://www.gerpac.eu/comment-communiquer-et-valoriser-ses-travaux https://www.gerpac.eu/l-automatisation-en-pharmacie-hospitaliere https://www.gerpac.eu/moderateurs-3060 https://www.gerpac.eu/moderators-3065 https://www.gerpac.eu/moderators-3055 https://www.gerpac.eu/impact-du-procede-de-preparation-sur-la-stabilite-d-un-gel-topique-anesthesiant https://www.gerpac.eu/impact-of-manufacturing-process-on-the-stability-of-an-anesthetic-topical-gel https://www.gerpac.eu/potassium-sorbate-the-ideal-pediatric-preservative https://www.gerpac.eu/le-sorbate-de-potassium-le-conservateur-ideal-en-pediatrie https://www.gerpac.eu/formulation-hospitaliere-d-un-dispositif-transdermique-de-scopolamine-pour-le-traitement-du-rale-agonique https://www.gerpac.eu/man-vs-machine-how-the-pharmacist-must-adapt-to-improve-the-robot-performance-the-example-of-subcutaneous-sc-daratumumab https://www.gerpac.eu/homme-vs-machine-comment-le-pharmacien-doit-s-adapter-pour-ameliorer-les-performances-du-robot-l-exemple-du-daratumumab-sous-cutane-sc https://www.gerpac.eu/conditionnements-secondaires-de-cytotoxiques-quel-circuit-d-elimination-adopter https://www.gerpac.eu/impact-analysis-of-securing-the-chemotherapy-circuit-through-computerization-and-rfid-technology https://www.gerpac.eu/analyse-d-impact-de-la-securisation-du-circuit-des-chimiotherapies-par-l-informatisation-et-la-technologie-rfid https://www.gerpac.eu/escape-game-in-the-cytotoxic-preparation-unit-upc-will-you-manage-to-dispense-chemotherapy-bags-on-time https://www.gerpac.eu/ultraviolet-c-decontamination-analysis-of-its-impact-on-surface-contamination-in-controlled-atmosphere-area https://www.gerpac.eu/overview-of-the-microbiological-contamination-of-eye-dropper-inserts-and-caps-influence-on-the-content-sterility-and-the-risk-of-ocular-infection https://www.gerpac.eu/effect-of-extended-80oc-storage-on-physical-integrity-of-fecal-microbiota-capsules-a-prospective-study https://www.gerpac.eu/microbiological-stability-study-of-atropine-0-01-eye-drops-in-ldpe-packaging-to-produce-hospital-preparations https://www.gerpac.eu/physicochemical-stability-of-nanoparticle-albumin-bound-paclitaxel-pazenir-r-infusion-dispersion-in-original-glass-vials-and-eva-infusion-bags-3276 https://www.gerpac.eu/evaluation-of-the-surface-chemical-contamination-of-gemcitabine-bags-ready-to-use-versus-hospital-compounded-bags https://www.gerpac.eu/radiochemical-purity-calculation-analysis-of-the-variability-of-manual-integration-on-result-rendering-towards-a-harmonization-of-practices https://www.gerpac.eu/control-of-parenteral-nutrition-preparations-in-ternary-mixture-contribution-of-infrared-spectroscopy-for-the-discrimination-of-three-lipid-mixtures https://www.gerpac.eu/preparation-errors-detection-using-gravimetric-control-on-finished-product-despite-compliant-analytical-control-or-in-absence-of-analytical-control-possibilities https://www.gerpac.eu/development-and-validation-capillary-electrophoresis-method-for-the-determination-of-spironolactone-in-a-new-5-mg-ml-oral-formulation https://www.gerpac.eu/methods-for-visual-inspection-of-preparations-for-parenteral-use-between-investment-reliability-and-training-in-hospital-pharmacy https://www.gerpac.eu/methodes-d-inspection-visuelle-de-preparations-a-usage-parenteral-entre-investissement-fiabilite-et-formation-en-pharmacie-hospitaliere https://www.gerpac.eu/detection-des-erreurs-de-preparation-grace-au-controle-gravimetrique-sur-produit-fini-malgre-un-controle-analytique-conforme-ou-en-l-absence-de-possibilite-de-controle-analytique https://www.gerpac.eu/controle-des-preparations-de-nutrition-parenterale-en-melange-ternaire-apport-de-la-spectroscopie-infrarouge-pour-la-discrimination-de-trois-melanges-de-lipides https://www.gerpac.eu/calcul-de-la-purete-radiochimique-analyse-de-la-variabilite-de-l-integration-manuelle-sur-le-rendu-du-resultat-vers-une-harmonisation-des-pratiques https://www.gerpac.eu/developpement-d-une-nouvelle-formulation-pediatrique-de-suppositoires-hydrophiles-de-pentobarbital-et-comparaison-avec-des-formulations-lipophiles https://www.gerpac.eu/quality-review-of-compounded-oral-solution-of-spironolactone-at-5mg-ml-in-inorpha-r https://www.gerpac.eu/revue-qualite-d-une-suspension-buvable-de-spironolactone-dosee-a-5mg-ml-dans-l-inorpha-r https://www.gerpac.eu/production-institutionnelle-de-bacteriophages-therapeutiques https://www.gerpac.eu/public-production-of-therapeutic-bacteriophages-3288 https://www.gerpac.eu/drugcam-r-a-video-analysis-system-its-impact-on-risk-management-in-cytotoxic-drug-production-units https://www.gerpac.eu/etat-des-lieux-de-la-contamination-microbiologique-des-inserts-et-des-bouchons-de-flacons-de-collyre-influence-sur-la-sterilite-du-contenu-et-le-risque-d-infection-oculaire https://www.gerpac.eu/risques-et-prevention-lies-a-la-manipulation-des-cytotoxiques-mise-en-place-et-realisation-d-une-formation-de-developpement-professionnel-continu https://www.gerpac.eu/securing-the-car-t-cells-chimeric-antigenic-receptor-t-supply-chain-management-welcome-to-cognitive-aids https://www.gerpac.eu/contamination-control-strategy-what-use-for-improved-control-and-benchmarking-of-hospital-compounding https://www.gerpac.eu/automation-of-production-in-hospital-pharmacy https://www.gerpac.eu/hommage-a-bernard-saint-martin https://www.gerpac.eu/securisation-du-circuit-car-t-cells-chimeric-antigenic-receptor-t-bienvenue-aux-aides-cognitives https://www.gerpac.eu/drugcam-r-un-systeme-d-analyse-videonumerique-quel-impact-sur-la-maitrise-de-gestion-des-risques-en-unite-de-production-de-medicaments-cytotoxiques https://www.gerpac.eu/the-relaxation-area-3338 https://www.gerpac.eu/coin-detente-3331 https://www.gerpac.eu/analytical-method-validation-for-the-quality-control-and-stability-study-of-hospital-preparations-why-and-how https://www.gerpac.eu/secondary-packaging-of-cytotoxics-which-elimination-process-should-be-adopted https://www.gerpac.eu/practical-pharmaceutics-2nd-edition-an-international-guideline-for-the-preparation-care-and-use-of-medicinal-products https://www.gerpac.eu/impression-3d-et-bioequivalence https://www.gerpac.eu/bioequivalence-of-3d-printed-tablets-produced-at-the-point-of-care https://www.gerpac.eu/design-of-an-innovative-laboratory-dedicated-to-the-analysis-of-conventional-anticancer-agents-cytoxlab https://www.gerpac.eu/conception-d-un-laboratoire-innovant-dedie-a-l-analyse-d-agents-anticancereux-conventionnels-cytoxlab https://www.gerpac.eu/e-posters-3337 https://www.gerpac.eu/bpf-gestion-des-risques-de-qualite-microbiologique-en-zac-la-strategie-du-controle-de-la-contamination https://www.gerpac.eu/bpp-surveillance-de-l-environnement-en-zac-en-pharmacie-hospitaliere https://www.gerpac.eu/training-objectives-for-personnel-involved-in-capsule-preparation https://www.gerpac.eu/objectifs-pedagogiques-pour-l-habilitation-des-personnels-a-la-preparation-de-gelules https://www.gerpac.eu/etat-des-lieux-de-l-impression-3d-de-medicaments https://www.gerpac.eu/3d-printing-in-pediatrics-feed-back-from-nimes-university-hospital https://www.gerpac.eu/impression-3d-en-pediatrie-retour-d-experience-du-chu-de-nimes https://www.gerpac.eu/e-posters-3330 https://www.gerpac.eu/seance-pleniere-3329 https://www.gerpac.eu/workshop-3336 https://www.gerpac.eu/ateliers-3328 https://www.gerpac.eu/in-plenary-session-3335 https://www.gerpac.eu/moderators-3246 https://www.gerpac.eu/moderateurs-3245 https://www.gerpac.eu/physicochemical-stability-of-nanoparticle-albumin-bound-paclitaxel-pazenir-r-infusion-dispersion-in-original-glass-vials-and-eva-infusion-bags https://www.gerpac.eu/gerpac-award-2023-for-the-best-oral-communication-3334 https://www.gerpac.eu/prix-communications-orales-gerpac-2023 https://www.gerpac.eu/transfert-de-microbiote-fecal-par-voie-orale-etude-de-l-integrite-dans-le-temps-des-gelules-conservees-a-80oc https://www.gerpac.eu/robotic-compounding-system-for-sterile-preparations https://www.gerpac.eu/systeme-de-preparation-robotise-pour-preparations-steriles https://www.gerpac.eu/moderateurs-3056 https://www.gerpac.eu/moderators-3057 https://www.gerpac.eu/moderateurs-3296 https://www.gerpac.eu/moderators-3297 https://www.gerpac.eu/moderators-3041 https://www.gerpac.eu/moderateurs-3040 https://www.gerpac.eu/choix-du-public-3318 https://www.gerpac.eu/moderators-3053 https://www.gerpac.eu/moderateurs-3052 https://www.gerpac.eu/french-good-compounding-practices-bpp-environnemental-monitoring-of-cleanrooms-in-hospital-pharmacies https://www.gerpac.eu/escape-game-au-sein-de-l-unite-de-preparation-des-cytotoxiques-upc-arriverez-vous-a-dispenser-a-temps-les-poches-de-chimiotherapies https://www.gerpac.eu/etude-de-stabilite-microbiologique-d-un-collyre-d-atropine-0-01-dans-un-conditionnement-en-pebd-en-vue-d-une-production-en-preparation-hospitaliere https://www.gerpac.eu/moderateurs-3054 https://www.gerpac.eu/simulation-de-crise-cyber-en-urc-un-outil-pour-se-preparer https://www.gerpac.eu/simulation-tool-to-prepare-cyber-attack-in-oncology-preparation-unit https://www.gerpac.eu/state-of-the-art-3d-printring-of-drugs https://www.gerpac.eu/implementation-de-l-impression-3d-dans-un-centre-de-lutte-contre-le-cancer https://www.gerpac.eu/implementation-of-3d-printing-in-a-cancer-centre https://www.gerpac.eu/pylote-technology-innovation-to-control-the-risk-of-microbial-contamination-from-preparation-to-use-of-finished-products https://www.gerpac.eu/la-technologie-antimicrobienne-pylote-innovation-pour-la-maitrise-du-risque-de-la-contamination-microbienne-de-la-preparation-a-l-utilisation-des-produits-finis https://www.gerpac.eu/extracellular-vesicles-as-non-viral-drug-carriers https://www.gerpac.eu/vesicules-extracellulaires-comme-vecteurs-non-viraux-de-medicaments https://www.gerpac.eu/practical-pharmaceutics-2nd-edition-an-international-guideline-for-the-preparation-care-and-use-of-medicinal-products-3108 https://www.gerpac.eu/eu-guidance-for-safe-management-of-hazardous-medicinal-products-at-work-3109 https://www.gerpac.eu/eu-guidance-for-safe-management-of-hazardous-medicinal-products-at-work-3110 https://www.gerpac.eu/identification-of-degradation-products-and-molecular-mechanism-using-experimental-and-theoritical-approchaes-application-to-oral-solution-formulation-case-of-onc201-in-diffuse-intrinsic-pontine-glioma https://www.gerpac.eu/identification-des-produits-de-degradation-et-des-mecanismes-moleculaires-utilisant-des-approches-experimentales-et-theoriques-application-a-la-formulation-d-une-solution-buvable-d-onc201-dans-le-gliome-infiltrant-du-tronc-cerebral https://www.gerpac.eu/monitoring-of-squalenoyl-gemcitabine-nanomedicines-in-single-living-breast-cancer-cells-by-raman-imaging-3310 https://www.gerpac.eu/monitoring-of-squalenoyl-gemcitabine-nanomedicines-in-single-living-breast-cancer-cells-by-raman-imaging https://www.gerpac.eu/risks-and-prevention-associated-with-handling-cytotoxics-setting-up-and-running-a-continuing-professional-development-training-course https://www.gerpac.eu/development-of-a-new-pediatric-formulation-of-hydrophilic-suppositories-of-pentobarbital-and-comparison-with-lipophilic-formulations https://www.gerpac.eu/hospital-formulation-of-scopolamine-transdermal-device-for-the-treatment-of-agonic-rales https://www.gerpac.eu/mise-au-point-d-une-methode-de-dosage-par-electrophorese-capillaire-de-la-spironolactone-pour-une-suspension-buvable-a-5-mg-ml https://www.gerpac.eu/evaluation-de-la-contamination-chimique-de-surface-des-poches-de-gemcitabine-poches-pretes-a-l-emploi-versus-poches-preparees-a-l-hopital https://www.gerpac.eu/open-access-validation-tool-for-dosage-methods-validr https://www.gerpac.eu/un-outil-en-libre-acces-d-aide-pour-la-validation-des-methodes-de-dosage-validr https://www.gerpac.eu/moderators-3314 https://www.gerpac.eu/how-to-write-and-publish-scientific-work https://www.gerpac.eu/outsourcing-of-chemotherapy-preparations-practical-exercises-3028 https://www.gerpac.eu/gerpac-is-now-on-twitter https://www.gerpac.eu/gerpac-est-sur-les-reseaux-sociaux https://www.gerpac.eu/moderateurs-3313 https://www.gerpac.eu/creation-and-implementation-of-a-preparation-billing-tool-at-henri-mondor-hospital https://www.gerpac.eu/creation-et-mise-en-place-d-un-outil-de-facturation-des-preparations-a-l-hopital-henri-mondor https://www.gerpac.eu/robot-assisted-compounding-users-club-the-2025-roadmap https://www.gerpac.eu/un-club-utilisateurs-des-robots-de-production-la-feuille-de-route-pour-2025 https://www.gerpac.eu/collaborative-design-of-a-self-assessment-tool-for-the-advanced-therapy-medicinal-product-circuit https://www.gerpac.eu/conception-collaborative-d-un-outil-d-auto-evaluation-du-circuit-des-medicaments-de-therapie-innovante https://www.gerpac.eu/implementation-of-a-training-course-on-risk-management-for-handling-cytotoxics-in-collaboration-with-a-qualiopi-certified-simulation-center https://www.gerpac.eu/mise-en-place-d-une-formation-sur-la-gestion-des-risques-lies-a-la-manipulation-des-cytotoxiques-en-collaboration-avec-un-centre-de-simulation-certifie-qualiopi https://www.gerpac.eu/qualification-of-an-indicative-stability-method-for-the-detection-of-impurities-in-histidine-at-a-concentration-of-117-20-mg-3ml-ap-hp https://www.gerpac.eu/qualification-d-une-methode-indicatrice-de-stabilite-pour-la-recherche-des-impuretes-de-l-histidine-117-20-mg-3-ml-ap-hp https://www.gerpac.eu/publication-from-french-national-agency-for-health-and-medico-social-performance-anap https://www.gerpac.eu/documents-anap https://www.gerpac.eu/controle-qualite-des-diffuseurs-de-5-fluorouracile-a-travers-leur-conditionnement https://www.gerpac.eu/quality-control-of-5-fluorouracil-infusers-through-packaging https://www.gerpac.eu/feedback-from-2-years-of-reinforced-visual-control-to-secure-the-chemotherapy-compunding https://www.gerpac.eu/retour-d-experiences-de-2-annees-d-un-controle-visuel-renforcee-pour-la-securisation-de-la-preparation-de-medicaments-anticancereux https://www.gerpac.eu/real-life-test-of-a-secure-device-for-the-preparation-and-administration-of-anticancer-drugs-chemolock-r-icu-medical https://www.gerpac.eu/essai-en-conditions-reelles-d-un-dispositif-securise-de-preparation-et-d-administration-des-anticancereux-chemolock-r-icu-medical https://www.gerpac.eu/performance-des-operateurs-dans-la-gestion-du-bris-de-flacons-cytotoxiques https://www.gerpac.eu/outil-chimioprep-r-un-levier-pour-la-securisation-d-une-unite-de-reconstitution-centralisee-des-cytotoxiques https://www.gerpac.eu/chimioprep-r-a-too-to-secure-a-centralized-pharmacy-unit-for-cytotoxic-drugs https://www.gerpac.eu/physicochemical-stability-of-sufentanil-citrate-in-rythmictm-administration-set-reservoirs-or-in-a-polyolefin-infusion-bag-diluted-in-0-9-sodium-chloride-or-in-5-dextrose-at-1-and-10-mug-ml-stored-at-20-25oc-protected-from-light https://www.gerpac.eu/etude-de-stabilite-physico-chimique-du-sufentanil-citrate-en-poches-rythmictm-et-en-poches-polyolefine-dans-du-nacl-0-9-ou-du-g5-a-1-et-10-mug-ml-conservees-a-temperature-ambiante-a-l-abri-de-la-lumiere https://www.gerpac.eu/isolator-renewal-don-t-forget-anything https://www.gerpac.eu/changement-de-vos-isolateurs-n-oubliez-rien https://www.gerpac.eu/ecological-and-economic-impact-of-a-misbelief-in-a-cpu https://www.gerpac.eu/impact-ecologique-et-economique-d-une-fausse-croyance-en-upc https://www.gerpac.eu/change-control-impact-analysis-for-the-setting-up-of-chemotherapy-banded-doses https://www.gerpac.eu/change-control-analyse-d-impact-pour-la-mise-en-place-de-doses-standardisees-de-chimiotherapie https://www.gerpac.eu/validation-of-a-manufacturing-process-within-a-temporary-controlled-atmosphere-area https://www.gerpac.eu/validation-d-un-procede-de-fabrication-au-sein-d-une-zac-temporaire https://www.gerpac.eu/exploration-of-hypersensitivity-to-injectable-chemotherapies-a-14-year-retrospective-monocentric-study-of-the-impact-of-this-activity-in-our-centralized-cytotoxic-preparation-unit https://www.gerpac.eu/exploration-des-hypersensibilites-aux-chimiotherapies-injectables-etude-monocentrique-retrospective-sur-14-ans-de-l-impact-de-cette-activite-au-sein-de-notre-unite-de-preparation-centralisee-des-cytotoxiques-upcc https://www.gerpac.eu/qualification-of-containers-for-cold-storage-of-cytotoxic-vials-remains-in-the-isolator-of-a-centralized-cytotoxic-preparation-unit https://www.gerpac.eu/qualification-de-conteneurs-a-reliquats-refrigeres-pour-isolateur-d-une-unite-de-preparation-de-chimiotherapies https://www.gerpac.eu/implementation-of-an-anticipated-reconstitution-circuit-and-reconstitutions-modalities-of-cyclophosphamide-vials-using-a-pharmashakerv3-r https://www.gerpac.eu/etude-des-modalites-de-reconstitution-des-flacons-de-cyclophosphamide-a-l-aide-d-un-pharmashakerv3-r-et-mise-en-place-d-un-circuit-de-reconstitution-anticipee https://www.gerpac.eu/best-step-to-freeze-faecal-microbiota-transplants-native-faeces-faecal-suspension-or-pharmaceutical-forms https://www.gerpac.eu/selles-natives-suspensions-fecales-ou-formes-pharmaceutiques-quel-est-le-meilleur-moment-pour-congeler-les-transplants-de-microbiote-fecal https://www.gerpac.eu/providing-a-closed-system-transfer-and-administration-device-for-chemoembolisation-ensure-safe-use https://www.gerpac.eu/la-mise-a-disposition-d-un-dispositif-de-transfert-et-d-administration-en-systeme-clos-pour-la-realisation-de-chimio-embolisation-permet-elle-d-assurer-une-utilisation-securisee https://www.gerpac.eu/the-anticipated-compounding-of-injectable-anticancer-drugs-without-physician-s-prescription-a-process-study https://www.gerpac.eu/production-anticipee-d-anticancereux-injectables-sans-prescription-medicale-etude-du-processus https://www.gerpac.eu/feasibility-study-and-preparation-of-polyethylene-glycol-peg-syringes-for-allergological-skin-tests-related-to-covid-vaccination https://www.gerpac.eu/etude-de-faisabilite-et-preparation-de-seringues-de-polyethylene-glycol-peg-pour-des-tests-cutanes-d-allergologies-en-lien-avec-la-vaccination-au-covid https://www.gerpac.eu/musculoskeletal-disorders-personnel-monitoring-and-use-of-romeo-r-handling-aid https://www.gerpac.eu/troubles-musculo-squelettiques-suivi-du-personnel-et-utilisation-du-dispositif-d-aide-a-la-manipulation-romeo-r https://www.gerpac.eu/optimization-of-the-sterile-compounding-preparation-process-example-of-a-filling-compounder-and-its-qualification https://www.gerpac.eu/optimisation-du-processus-de-fabrication-des-preparations-steriles-exemple-d-un-automate-de-preparation-pour-nutrition-parenterale-et-de-sa-qualification https://www.gerpac.eu/computer-blackout-cbo-in-a-chemotherapy-preparation-unit-ct-how-to-cope https://www.gerpac.eu/black-out-informatique-boi-au-sein-d-une-unite-de-preparation-de-chimiotherapie-ct-comment-faire-face https://www.gerpac.eu/pediatric-galenic-adaptation-when-compassionate-use-is-not-enough-the-case-of-clindamycin https://www.gerpac.eu/adaptation-galenique-pediatrique-quand-l-acces-compassionnel-ne-suffit-pas-cas-de-la-clindamycine https://www.gerpac.eu/total-breakdown-in-a-production-unit-how-to-face-the-emergency https://www.gerpac.eu/panne-totale-d-isolateurs-en-unite-de-production-quelle-organisation-face-a-l-urgence https://www.gerpac.eu/assessment-of-exposure-to-hydrogen-peroxide-in-a-parenteral-nutrition-unit-occupational-risks-involved https://www.gerpac.eu/evaluation-de-l-exposition-au-peroxyde-d-hydrogene-dans-une-unite-de-nutrition-parenterale-risques-professionnels-encourus https://www.gerpac.eu/optimization-and-stability-study-of-compounded-oral-suspension-of-spironolactone-at-5mg-ml-for-infants https://www.gerpac.eu/optimisation-d-une-formulation-de-suspension-buvable-de-spironolactone-a-5mg-ml-pour-les-nourrissons-assortie-de-son-etude-de-stabilite https://www.gerpac.eu/formulation-of-an-oral-suspension-of-pyrimethamine-for-pediatric-use https://www.gerpac.eu/formulation-d-une-suspension-buvable-de-pyrimethamine-a-usage-pediatrique https://www.gerpac.eu/parenteral-nutrition-production-audit-of-practices-targeting-the-risk-of-microbiological-contamination https://www.gerpac.eu/production-en-nutrition-parenterale-realisation-d-un-audit-des-pratiques-cible-sur-le-risque-de-contamination-microbiologique https://www.gerpac.eu/mise-en-place-du-radiomarquage-du-68ga-nodaga-exendin-4 https://www.gerpac.eu/control-of-a-pediatric-clonidine-solution-at-10-mug-ml-by-capillary-electrophoresis https://www.gerpac.eu/controle-d-une-solution-pediatrique-de-clonidine-a-10-mug-ml-par-electrophorese-capillaire-3237 https://www.gerpac.eu/preliminary-evaluation-of-the-detectability-potential-of-visible-particles-comparison-between-a-candling-table-in-accordance-with-the-european-pharmacopoeia-and-a-polarized-light-table https://www.gerpac.eu/evaluation-preliminaire-du-potentiel-de-detectabilite-des-particules-visibles-comparaison-entre-une-table-de-mirage-conforme-a-la-pharmacopee-europeenne-et-table-a-lumiere-polarisee https://www.gerpac.eu/immunotherapies-stability-a-costly-race-against-time https://www.gerpac.eu/immunotherapies-stabilite-une-course-contre-la-montre-couteuse https://www.gerpac.eu/etude-de-la-stabilite-du-letermovir-en-solution-diluee-dans-des-poches-de-nacl-0-9-en-polypropylene https://www.gerpac.eu/stability-study-of-letermovir-in-solution-in-0-9-nacl-polypropylene-bags https://www.gerpac.eu/dosage-of-calcium-ca-and-magnesium-mg-by-microwave-plasma-atomic-emission-spectrometry-mp-aes-in-the-control-of-individualized-parenteral-nutrition-ipn-routine-implementation https://www.gerpac.eu/dosage-de-calcium-ca-et-magnesium-mg-par-spectrometrie-d-emission-atomique-a-plasma-microondes-mp-aes-dans-le-controle-des-nutritions-parenterales-individualisees-npi-mise-en-place-en-routine https://www.gerpac.eu/stability-study-of-alternative-formulation-to-sirolimus-0-1-cream-in-a-context-of-raw-material-breakage https://www.gerpac.eu/etude-de-stabilite-d-une-formulation-galenique-alternative-a-la-creme-au-sirolimus-0-1-dans-un-contexte-de-rupture-de-matiere-premiere https://www.gerpac.eu/evaluation-of-the-chemical-contamination-by-antineoplastic-drugs-in-a-chemotherapy-reconstitution-unit-urc-in-a-french-hospital https://www.gerpac.eu/evaluation-de-la-contamination-chimique-par-des-molecules-cytotoxiques-au-sein-d-une-unite-de-reconstitution-des-chimiotherapies-urc-dans-un-hopital-francais https://www.gerpac.eu/assessment-of-the-microbiological-impact-of-an-isolator-failure-on-the-working-environment https://www.gerpac.eu/evaluation-de-l-impact-microbiologique-d-une-defaillance-d-un-isolateur-sur-l-environnement-de-travail https://www.gerpac.eu/synergy-of-the-lean-management-s-approach-and-computerization-implementation-on-manufacturing-circuit-of-individualized-parenteral-nutrition-mixtures-3305 https://www.gerpac.eu/synergie-de-l-approche-lean-management-et-de-l-informatisation-application-au-circuit-de-fabrication-des-melanges-de-nutrition-parenterale-individualisee https://www.gerpac.eu/emergency-preparation-of-sodium-sulfadiazinate-injection-case-report https://www.gerpac.eu/realisation-d-une-preparation-de-sodium-sulfadiazinate-injectable-en-urgence-rapport-de-cas https://www.gerpac.eu/optimization-of-microbiological-sampling-in-a-centralized-anticancer-drugs-preparation-unit https://www.gerpac.eu/optimisation-des-prelevements-microbiologiques-d-une-unite-de-preparation-centralisee-des-anticancereux https://www.gerpac.eu/evaluation-of-the-difficulties-associated-with-the-administration-of-pediatric-drugs-delivered-to-outpatient https://www.gerpac.eu/evaluation-des-difficultes-liees-a-l-administration-des-medicaments-pediatriques-en-retrocession https://www.gerpac.eu/implementation-of-an-outsourcing-activity-for-radiopharmaceutical-preparation https://www.gerpac.eu/mise-en-place-d-une-activite-de-sous-traitance-de-preparations-radiopharmaceutiques https://www.gerpac.eu/equipment-failure-in-a-controlled-atmosphere-zone-caz-maintaining-sterile-drug-preparations-manufacturing https://www.gerpac.eu/panne-d-equipement-dans-une-zone-a-atmosphere-controlee-zac-comment-maintenir-la-production-de-preparations-pharmaceutiques-steriles https://www.gerpac.eu/preparing-eye-drops-from-injectable-specialties-using-a-peristaltic-pump-from-reconstitution-to-distribution https://www.gerpac.eu/preparation-de-collyres-a-partir-de-specialites-injectables-utilisation-d-une-pompe-peristaltique-de-la-reconstitution-a-la-repartition https://www.gerpac.eu/changement-de-design-du-systeme-clos-tevadaptor-r-tests-d-independance-des-flux-d-homogeneisation-et-d-ergonomie-du-nouvel-adaptateur-de-poche-chemforttm https://www.gerpac.eu/tevadaptor-r-closed-system-novel-design-flow-separation-homogenization-and-ergonomic-assessments-on-the-new-chemforttm-transfer-device https://www.gerpac.eu/considering-robotic-production-of-injectable-anti-cancer-drugs-think-ahead https://www.gerpac.eu/vous-optez-pour-une-production-d-anti-cancereux-injectables-robotisee-ca-s-anticipe https://www.gerpac.eu/utilization-of-ready-to-use-rtu-gemcitabine-and-irinotecan-bags-anticipating-change https://www.gerpac.eu/utilisation-de-poches-pretes-a-l-emploi-pae-de-gemcitabine-et-d-irinotecan-anticiper-le-changement https://www.gerpac.eu/implementation-of-a-terminal-analytical-control-in-cytotoxic-reconstitution-unit-cru https://www.gerpac.eu/mise-en-place-d-un-controle-analytique-en-unite-de-reconstitution-des-cytotoxiques-urc https://www.gerpac.eu/design-of-centralized-cytotoxic-unit https://www.gerpac.eu/y-site-injection-compatibility-of-parenteral-medicines-with-balanced-salt-solutions-3156 https://www.gerpac.eu/y-site-injection-compatibility-of-parenteral-medicines-with-balanced-salt-solutions https://www.gerpac.eu/cytotoxics-reconstitution-units-in-the-ecological-era-assessment-of-dematerialization-on-carbon-footprint https://www.gerpac.eu/les-unites-de-reconstitution-des-cytotoxiques-a-l-ere-ecologique-evaluation-de-la-dematerialisation-sur-l-empreinte-carbone https://www.gerpac.eu/etude-de-la-contamination-particulaire-en-zones-d-activite-dediees-a-la-preparation-de-doses-a-administrer-automatisee https://www.gerpac.eu/study-of-particle-contamination-in-activity-areas-dedicated-to-the-automated-preparation-of-doses-to-administer-apda https://www.gerpac.eu/labquest https://www.gerpac.eu/reprise-du-circuit-degrade-lors-de-la-panne-du-logiciel-de-prescription-des-chimiotherapies-de-a-a-z https://www.gerpac.eu/residual-volume-in-semi-rigid-bags-used-to-prepare-anticancer-drugs-myth-or-reality-evaluation-and-impact-in-practice https://www.gerpac.eu/volume-residuel-dans-les-poches-semi-rigides-utilisees-pour-la-preparation-d-anticancereux-mythe-ou-realite-evaluation-et-impact-en-pratique https://www.gerpac.eu/standardization-of-the-manufacturing-process-of-excipient-aliquots-to-covid-19-vaccines https://www.gerpac.eu/standardisation-du-procede-de-fabrication-des-aliquotes-d-excipients-aux-vaccins-du-covid-19 https://www.gerpac.eu/study-of-the-passage-of-hydrogen-peroxide-through-eye-drops-bottles-intended-for-sterility-testing-during-their-decontamination-in-an-isolator https://www.gerpac.eu/etude-du-passage-du-peroxyde-d-hydrogene-au-travers-des-flacons-de-collyres-destines-aux-essais-de-sterilite-lors-de-leur-decontamination-en-isolateur https://www.gerpac.eu/evaluer-le-circuit-des-medicaments-de-therapie-innovante-mti https://www.gerpac.eu/audit-of-pharmacotechnic-pharmacists-s-professional-practices-from-the-validation-of-the-prepation-to-the-release-of-anticancerous-drugs-preparations https://www.gerpac.eu/audit-des-pratiques-professionnelles-des-pharmaciens-de-pharmacotechnie-de-la-validation-de-la-cure-a-la-liberation-des-preparations-d-anticancereux https://www.gerpac.eu/sterility-testing-for-lipid-mixtures-using-the-bact-alert-r-system https://www.gerpac.eu/sterilite-des-preparations-magistrales-de-nutrition-parenterale-individualisee-npi-validation-de-la-methode-bact-alert-r-pour-le-controle-de-sterilite-des-seringues-de-lipides https://www.gerpac.eu/formation-theorique-des-equipes-a-la-manipulation-sous-postes-de-securite-microbiologique-psm-de-type-ii-par-l-utilisation-d-un-outil-ludique https://www.gerpac.eu/administration-of-daratumumab-by-subcutaneous-way-sd-what-solution-to-reduce-the-pain-associated-with-the-administration-of-the-drug https://www.gerpac.eu/administration-du-daratumumab-par-voie-sous-cutanee-dsc-quelle-solution-pour-reduire-les-douleurs-liees-a-l-administration-du-medicament https://www.gerpac.eu/commission-publishes-a-new-guidance-for-the-safe-management-of-hazardous-medicinal-products-at-work https://www.gerpac.eu/2020-conference-gerpac https://www.gerpac.eu/documentary-ressources https://www.gerpac.eu/ressources-documentaires-3298 https://www.gerpac.eu/emergency-treatment-of-nrbc-victims-by-needle-free-percutaneous-administration-of-antidotes-agate-project-atropine-gun-antidote https://www.gerpac.eu/prise-en-charge-en-urgence-des-victimes-nrbc-par-administration-percutanee-sans-aiguille-d-antidotes-projet-agate-atropine-gun-antidote https://www.gerpac.eu/development-and-validation-of-a-method-for-the-analytical-control-of-letermovir-by-high-performance-liquid-chromatography-coupled-with-uv-visible-hplc-uv-within-a-chemotherapy-preparation-unit-upc https://www.gerpac.eu/developpement-et-validation-d-une-methode-de-controle-analytique-du-letermovir-par-chromatographie-en-phase-liquide-a-haute-performance-couplee-a-l-uv-visible-hplc-uv-au-sein-d-une-unite-de-preparation-de-chimiotherapies-upc https://www.gerpac.eu/elaboration-et-validation-d-une-methode-de-dosage-du-tramadol-et-du-nefopam-en-solution-pour-l-etude-de-stabilite-de-medicaments-experimentaux https://www.gerpac.eu/development-and-validation-of-an-assay-method-for-tramadol-and-nefopam-in-solution-to-study-the-stability-of-experimental-drugs https://www.gerpac.eu/synergy-of-the-lean-management-s-approach-and-computerization-implementation-on-manufacturing-circuit-of-individualized-parenteral-nutrition-mixtures https://www.gerpac.eu/synergie-de-l-approche-lean-management-et-de-l-informatisation-application-au-circuit-de-fabrication-des-melanges-de-nutrition-parenterale-individualisee-3206 https://www.gerpac.eu/workshop-3-education-tool-for-hospital-technicians-used-in-an-injectable-cytotoxic-preparation-service-1086 https://www.gerpac.eu/atelier-3-mise-en-oeuvre-d-un-outil-pedagogique-pour-la-formation-des-preparateurs-en-unite-de-preparation-des-cytotoxiques https://www.gerpac.eu/moderators-3093 https://www.gerpac.eu/moderateurs-3092 https://www.gerpac.eu/moderators-3091 https://www.gerpac.eu/moderateurs-3090 https://www.gerpac.eu/moderators-3089 https://www.gerpac.eu/moderateurs-3088 https://www.gerpac.eu/moderators-3087 https://www.gerpac.eu/moderateurs-3086 https://www.gerpac.eu/moderators-3085 https://www.gerpac.eu/moderators-3081 https://www.gerpac.eu/moderateurs-3080 https://www.gerpac.eu/moderators-3077 https://www.gerpac.eu/moderateurs-3076 https://www.gerpac.eu/moderators-3075 https://www.gerpac.eu/moderateurs-3074 https://www.gerpac.eu/moderators-3084 https://www.gerpac.eu/moderateurs-3082 https://www.gerpac.eu/moderators-3079 https://www.gerpac.eu/moderateurs-3078 https://www.gerpac.eu/nouveau-guide-pour-la-gestion-securisee-des-medicaments-dangereux-sur-le-lieu-de-travail https://www.gerpac.eu/membership-3071 https://www.gerpac.eu/la-technologie-rfid-pour-le-circuit-des-chimiotherapies-une-bonne-idee https://www.gerpac.eu/l-automatisation-en-pharmacie-hospitaliere-techniques-et-attentes https://www.gerpac.eu/quel-futur-pour-les-preparations-a-l-hopital https://www.gerpac.eu/preparations-industrielles-des-allergenes-prepares-specialement-pour-un-individu-apsi https://www.gerpac.eu/l-uo-pharma-nouvelle-unite-d-oeuvre-de-l-anap https://www.gerpac.eu/opening-of-the-conference https://www.gerpac.eu/public-s-choice https://www.gerpac.eu/choix-du-public https://www.gerpac.eu/video-award-2021-2601 https://www.gerpac.eu/temoignages-edition-2022 https://www.gerpac.eu/testimonials-3018 https://www.gerpac.eu/optimisation-et-validation-de-l-essai-des-endotoxines-bacteriennes-dans-des-melanges-binaires-de-nutrition-parenterale https://www.gerpac.eu/endotoxin-assay-optimization-and-validation-in-binary-parenteral-nutrition-mixtures https://www.gerpac.eu/symposium-3014 https://www.gerpac.eu/etude-de-l-impact-de-la-production-des-collyres-en-lot https://www.gerpac.eu/impact-study-of-eye-drop-batch-production https://www.gerpac.eu/moderators-2961 https://www.gerpac.eu/gerpac-award-2022-for-the-best-oral-communication-2996 https://www.gerpac.eu/encadrement-de-l-evaluation-de-la-conformite-aux-pratiques-de-manipulation-securitaire-des-medicaments-dangereux https://www.gerpac.eu/framework-for-the-assessment-of-compliance-with-practices-for-the-safe-handling-of-hazardous-drugs https://www.gerpac.eu/travail-collaboratif-avec-la-sfpc-sur-la-perfusion-des-medicaments-injectables https://www.gerpac.eu/automation-in-hospital-pharmacy-technics-and-expectations https://www.gerpac.eu/developpement-et-validation-d-une-methode-analytique-de-dosage-du-thiopental-pour-la-realisation-d-une-etude-de-stabilite-physico-chimique-2987 https://www.gerpac.eu/physicochemical-stability-of-daratumumab-sc-darzalex-r-1800-mg-injection-solution-in-plastic-syringes-over-a-period-of-28-days-stored-refrigerated-or-at-room-temperature-2830 https://www.gerpac.eu/physicochemical-stability-of-daratumumab-sc-darzalex-r-1800-mg-injection-solution-in-plastic-syringes-over-a-period-of-28-days-stored-refrigerated-or-at-room-temperature https://www.gerpac.eu/comparative-study-of-sorption-phenomena-between-syringes-made-of-cyclic-olefin-copolymer-or-polypropylene-and-three-medications https://www.gerpac.eu/development-of-a-letermovir-oral-solution-for-anti-cytomegalovirus-prophylaxis-in-children https://www.gerpac.eu/valistab-r-un-outil-d-aide-a-la-realisation-d-une-etude-de-stabilite-physico-chimique https://www.gerpac.eu/valistab-r-a-new-tool-to-help-carry-out-a-physicochemical-stability-study https://www.gerpac.eu/biological-stability-of-pembrolizumab-after-dilution-and-storage-in-0-9-nacl-infusion-polyolefin-bags https://www.gerpac.eu/creation-and-implementation-of-an-enabling-blended-learning-course-in-a-quality-control-laboratory https://www.gerpac.eu/formulation-d-une-solution-buvable-de-phosphore-adaptee-a-la-neonatalogie https://www.gerpac.eu/symposium https://www.gerpac.eu/e-posters-2798 https://www.gerpac.eu/etude-comparative-des-phenomenes-de-sorption-entre-des-seringues-en-copolymere-d-olefine-cyclique-ou-en-polypropylene-et-trois-medicaments https://www.gerpac.eu/efficacite-des-procedures-de-decontamination-de-surfaces-contaminees-par-des-medicaments-toxiques https://www.gerpac.eu/visual-facilitation-of-procedures-in-the-cytotoxic-reconstitution-unit-cru https://www.gerpac.eu/la-facilitation-visuelle-des-procedures-en-unite-de-reconstitution-des-cytotoxiques-urc https://www.gerpac.eu/interet-de-l-electrophorese-capillaire-pour-le-controle-des-poches-de-nutrition-parenterale-validation-de-deux-methodes-de-dosage-simultanees-acides-amines-glucose-glucose-1-phosphate-et-ka-na-ca-mg https://www.gerpac.eu/update-on-osmolality-of-oral-medications-and-enteral-nutrition-used-in-neonatal-department https://www.gerpac.eu/monitoring-of-potential-endocrine-disruptor-plastic-additives-by-uhplc-hrms-in-prefilled-plastic-packaging-in-a-hospital-setting https://www.gerpac.eu/formulation-et-evaluation-de-la-stabilite-physico-chimique-d-une-suspension-buvable-d-allopurinol-20mg-ml https://www.gerpac.eu/surveillance-de-la-contamination-chimique-surfacique-dans-le-cadre-d-un-procede-robotise-de-preparation-des-chimiotherapies https://www.gerpac.eu/dosage-du-pouvoir-hemolytique-d-une-suspension-de-bacteriophage-purifiee https://www.gerpac.eu/capillary-electrophoresis-in-parenteral-nutrition-control-validation-of-two-analytical-method-amino-acids-glucose-glucose-1-phosphate-and-ka-na-ca-mg https://www.gerpac.eu/efficiency-of-decontamination-procedures-for-surfaces-contaminated-with-hazardous-drugs https://www.gerpac.eu/validation-of-a-compounding-process-for-injectable-dopamine-in-an-anaerobic-chamber-for-a-clinical-trial https://www.gerpac.eu/formulation-of-an-oral-phosphorus-solution-adapted-to-neonatology https://www.gerpac.eu/alertness-of-in-process-controls-feedback-on-two-production-errors https://www.gerpac.eu/implementation-of-a-discrimination-strategy-for-eight-monoclonal-antibodies-by-fia-uv-using-a-confusion-matrix-application-to-pembrolizumab https://www.gerpac.eu/chemotherapy-manufacturing-in-a-rescue-unit-for-6-months-a-big-challenge https://www.gerpac.eu/isolator-seal-breach-assessment-of-the-leak-test-relevance-and-impact-on-microbiological-contamination-risk https://www.gerpac.eu/formulation-and-bioavilability-study-of-a-gemcitabine-intravesical-thermoreversible-gel-for-bladder-carcinoma-treatment https://www.gerpac.eu/evaluation-of-uv-light-shielding-bags-efficiency-on-dacarbazine-photodegradation https://www.gerpac.eu/aerosolisation-s-risk-assessment-of-bacteriophages-handled-in-a-biological-safety-cabinet https://www.gerpac.eu/determination-of-the-residual-hemolytic-activity-of-a-purified-bacteriophage-suspension https://www.gerpac.eu/formulation-and-evaluation-of-physicochemical-stability-of-allopurinol-20mg-ml-oral-suspension https://www.gerpac.eu/produire-dans-une-unite-mobile-pendant-6-mois-une-belle-experience https://www.gerpac.eu/rupture-d-etancheite-de-l-isolateur-evaluation-de-l-interet-du-test-de-fuite-et-du-risque-de-contamination https://www.gerpac.eu/analyse-du-risque-d-aerosolisation-des-bacteriophages-lors-de-manipulations-sous-poste-de-securite-microbiologique https://www.gerpac.eu/mise-en-place-d-une-strategie-de-discrimination-de-huit-anticorps-monoclonaux-par-fia-uv-par-l-utilisation-d-une-matrice-de-confusion-application-au-pembrolizumab https://www.gerpac.eu/vigilance-sur-les-controles-assistes-in-process-retour-d-experience-sur-deux-erreurs-de-fabrication https://www.gerpac.eu/160-developpement-d-une-solution-intra-vesicale-en-gel-thermoreversible-de-gemcitabine-28-5-mg-ml-dans-la-prise-en-charge-des-carcinomes-vesicaux https://www.gerpac.eu/validation-d-un-procede-de-fabrication-de-dopamine-injectable-dans-une-enceinte-en-anaerobie-pour-un-essai-clinique https://www.gerpac.eu/etat-des-lieux-de-l-osmolalite-des-medicaments-et-de-la-nutrition-enterale-administres-en-service-de-neonatalogie https://www.gerpac.eu/creation-et-mise-en-place-d-une-formation-habilitante-en-blended-learning-dans-un-laboratoire-de-controle-qualite https://www.gerpac.eu/evaluation-de-l-efficacite-des-poches-de-protection-anti-uv-sur-la-photodegradation-de-la-dacarbazine https://www.gerpac.eu/developpement-d-une-solution-buvable-de-letermovir-en-prophylaxie-anti-cytomegalovirus-chez-l-enfant https://www.gerpac.eu/etude-de-la-stabilite-biologique-du-pembrolizumab-en-solution-diluee-dans-des-poches-de-nacl-0-9-en-polyolefine https://www.gerpac.eu/etude-de-stabilite-d-une-solution-concentree-de-doxorubicine-a-10-mg-ml https://www.gerpac.eu/stability-study-of-a-10-mg-ml-concentrated-solution-of-doxorubicin https://www.gerpac.eu/monitoring-d-additifs-plastiques-potentiellement-perturbateurs-endocriniens-par-uhplc-hrms-dans-des-contenants-plastiques-pre-remplis-utilises-en-milieu-hospitalier https://www.gerpac.eu/e-posters-2799 https://www.gerpac.eu/the-relaxation-area-2797 https://www.gerpac.eu/in-plenary-session-2795 https://www.gerpac.eu/seance-pleniere https://www.gerpac.eu/coin-detente-2796 https://www.gerpac.eu/monitoring-of-surface-chemical-contamination-in-a-robotized-chemotherapy-preparation-process https://www.gerpac.eu/developpement-et-caracterisation-d-une-formulation-orale-de-nicardipine-preparee-avec-des-excipients-simples-pour-le-traitement-de-l-hypertension-arterielle-pediatrique https://www.gerpac.eu/development-and-characterization-of-an-oral-formulation-of-nicardipine-compounded-with-simple-excipients-for-the-treatment-of-pediatric-hypertension https://www.gerpac.eu/sous-traitance-des-chimiotherapies-exercices-pratiques https://www.gerpac.eu/se-former-par-le-jeu-un-moyen-innovant-pour-apprendre-les-bonnes-pratiques-d-hygiene-en-salle-blanche https://www.gerpac.eu/reassessment-of-practices-around-chemical-contamination-associated-with-the-chemotherapy-production-activity-application-of-fluorescein-tests https://www.gerpac.eu/developpement-d-une-forme-orale-de-vinorelbine-pour-la-prise-en-charge-des-rhabdomyosarcomes-en-pediatrie https://www.gerpac.eu/developement-of-an-oral-form-of-vinorelbine-for-pediatric-use-in-the-treatment-of-rhabdomyosarcoma https://www.gerpac.eu/moderateurs-2960 https://www.gerpac.eu/moderateurs-2957 https://www.gerpac.eu/moderateurs-2962 https://www.gerpac.eu/moderateurs-2958 https://www.gerpac.eu/moderateurs-2959 https://www.gerpac.eu/moderateurs-2956 https://www.gerpac.eu/enseignement-national-de-l-internat https://www.gerpac.eu/moderateurs-2954 https://www.gerpac.eu/expert-discussion https://www.gerpac.eu/moderators-2964 https://www.gerpac.eu/workshop https://www.gerpac.eu/ateliers-2792 https://www.gerpac.eu/bpp-et-procedures-degradees https://www.gerpac.eu/retour-d-experience-le-visionnage-de-l-ensemble-des-videos-drugcam-r-avant-liberation-est-il-utile https://www.gerpac.eu/how-can-the-robustness-and-safety-of-hospital-production-be-optimized-by-monitoring-relevant-indicators https://www.gerpac.eu/comment-optimiser-la-robustesse-et-la-securite-d-une-production-hospitaliere-en-suivant-des-indicateurs-pertinents-2735 https://www.gerpac.eu/moderatos https://www.gerpac.eu/prix-comunications-orales-gerpac-2022-2995 https://www.gerpac.eu/evaluation-de-l-impact-du-dose-banding-en-cancerologie-pediatrique-base-sur-des-criteres-pharmacocinetiques https://www.gerpac.eu/potential-impact-of-dose-banding-for-anticancer-therapy-in-paediatrics-based-on-pharmacokinetics https://www.gerpac.eu/acceptability-of-paediatric-medicines-just-a-matter-of-taste https://www.gerpac.eu/l-acceptabilite-des-medicaments-pediatriques-juste-une-question-de-gout https://www.gerpac.eu/lactarium-bonnes-pratiques-et-lyophilisation https://www.gerpac.eu/lactarium-good-practices-and-freeze-drying https://www.gerpac.eu/medication-in-newborns-and-exposure-to-parabens https://www.gerpac.eu/medicaments-chez-le-nouveau-ne-et-exposition-aux-parabenes https://www.gerpac.eu/ouverture-en-urgence-d-une-unite-de-preparation-sterile-durant-la-pandemie-covid-19 https://www.gerpac.eu/emergency-opening-of-sterile-preparations-unit-during-covid-19-pandemic https://www.gerpac.eu/innovative-educational-approaches-for-pharmaceutical-technology-training https://www.gerpac.eu/approches-pedagogiques-innovantes-pour-la-formation-en-pharmacotechnie https://www.gerpac.eu/development-and-validation-of-an-analytical-method-for-the-determination-of-thiopental-for-a-physicochemical-stability-study-2988 https://www.gerpac.eu/determination-of-ions-in-paediatric-npi-bags-using-a-microwave-plasma-atomic-emission-spectrometer-not-so-easy-for-the-pharmacist https://www.gerpac.eu/dosage-des-ions-des-poches-de-nutrition-parenterale-individualisee-npi-pediatrique-par-un-spectrometre-d-emission-atomique-a-plasma-micro-onde-pas-si-facile-pour-le-pharmacien-2985 https://www.gerpac.eu/medicaments-en-tension-et-bonnes-pratiques-de-preparation https://www.gerpac.eu/le-developpement-de-la-fumagilline-aux-hcl https://www.gerpac.eu/constitution-of-a-national-group-of-external-quality-assesment-for-the-hospitals-control-laboratories https://www.gerpac.eu/constitution-d-un-groupe-d-evaluation-externe-de-la-qualite-des-laboratoires-de-controles-hospitaliers https://www.gerpac.eu/medicinal-preparations-in-allergology-pharmaceutical-issues https://www.gerpac.eu/preparations-medicamenteuses-dans-le-cadre-des-explorations-allergologiques https://www.gerpac.eu/industrial-preparations-of-named-patient-products-npps-in-allergology https://www.gerpac.eu/discussion-des-experts https://www.gerpac.eu/medicines-with-supply-issues-and-bpps https://www.gerpac.eu/outsourcing-of-chemotherapy-preparations-practical-exercises https://www.gerpac.eu/learning-through-games-an-innovative-way-to-learn-good-hygiene-practices-in-cleanrooms https://www.gerpac.eu/moderateurs-2965 https://www.gerpac.eu/moderators-2966 https://www.gerpac.eu/moderators-2993 https://www.gerpac.eu/practical-pharmaceutics-edition-2-2800 https://www.gerpac.eu/practical-pharmaceutics-edition-2 https://www.gerpac.eu/moderators-2963 https://www.gerpac.eu/moderators-2973 https://www.gerpac.eu/analyse-de-risques-liee-a-la-mise-en-place-d-un-circuit-de-medicaments-de-therapie-innovante-dans-un-centre-de-lutte-contre-le-cancer https://www.gerpac.eu/risk-analysis-relating-to-the-implementation-of-a-circuit-of-advanced-therapies-medicinal-products-in-a-comprehensive-cancer-center https://www.gerpac.eu/development-and-validation-of-a-method-for-the-quantitative-determination-of-baclofen-and-its-degradation-products-for-the-stability-study-of-experimental-medicine-2984 https://www.gerpac.eu/gaspillage-des-preparations-hospitalieres-l-exemple-du-collyre-de-ceftazidime-au-chu-d-angers https://www.gerpac.eu/subcontracting-of-the-reconstitution-of-anti-cancer-drugs-feedback-from-the-principal-2-years-after-implementation https://www.gerpac.eu/manufacturing-practices-formulations-and-reimbursement-of-topical-forms-of-apamycin-in-tuberous-sclerosis-of-bourneville-update-on-french-practices https://www.gerpac.eu/etat-des-lieux-des-pratiques-de-preparation-et-de-remboursement-des-formes-topiques-de-rapamycine-dans-la-sclerose-tubereuse-de-bourneville https://www.gerpac.eu/determination-des-causes-de-non-conformite-lors-du-dosage-de-calcium-dans-les-melanges-de-nutrition-parenterale https://www.gerpac.eu/causes-determination-of-noncompliance-in-the-measurement-of-calcium-in-parenteral-nutrition-mixtures https://www.gerpac.eu/the-development-of-fumagillin-at-hcl https://www.gerpac.eu/microbial-contamination-of-isolators-from-risk-analysis-to-decision-making-flowchart https://www.gerpac.eu/contamination-microbienne-des-isolateurs-de-l-analyse-de-risques-au-logigramme-de-prise-de-decision https://www.gerpac.eu/biological-stability-of-durvalumab-solutions-in-its-opened-vials-or-after-dilution-and-storage-in-0-9-nacl-infusion-polyolefin-bags https://www.gerpac.eu/etude-de-la-stabilite-biologique-du-durvalumab-en-solution-diluee-dans-des-poches-de-nacl-0-9-en-polyolefine-et-en-flacon-apres-ouverture https://www.gerpac.eu/development-and-validation-of-an-analytical-method-for-the-assessment-of-methylparaben-and-propylparaben-by-hplc-uv-2971 https://www.gerpac.eu/developpement-et-validation-d-une-methode-de-dosage-du-methyl-et-propylparaben-par-hplc-uv-2915 https://www.gerpac.eu/177lu-itg-psma-1-development-of-a-fully-automatized-in-hospital-production-2849 https://www.gerpac.eu/177lu-itg-psma-1-developpement-d-une-production-entierement-automatisee-en-milieu-hospitalier https://www.gerpac.eu/radiolabelling-of-erythrocytes-with-18fdg-feasibility-study https://www.gerpac.eu/radiomarquage-des-hematies-au-18fdg-etude-de-faisabilite https://www.gerpac.eu/microbiological-stability-of-rituximab-bags https://www.gerpac.eu/etude-de-stabilite-microbiologique-de-poches-de-rituximab https://www.gerpac.eu/mise-en-place-d-un-plan-de-continuite-de-fonctionnement-d-une-unite-de-reconstitution-de-cytotoxiques-urc-en-cas-de-cyberattaque https://www.gerpac.eu/solution-nasale-d-haloperidol-formulation-et-controle-in-vitro https://www.gerpac.eu/haloperidol-nasal-solution-formulation-and-physicochemical-stability-study https://www.gerpac.eu/evaluation-of-surface-contamination-with-cyclophosphamide-and-paclitaxel-to-control-the-risk-of-occupational-exposure-to-hazardous-drugs-in-two-hospitals-of-a-comprehensive-cancer-center https://www.gerpac.eu/evaluation-de-la-contamination-environnementale-par-le-cyclophosphamide-et-le-paclitaxel-pour-limiter-le-risque-d-exposition-professionnelle-aux-medicaments-anticancereux-dans-deux-sites-hospitaliers-d-un-centre-de-lutte-contre-le-cancer https://www.gerpac.eu/waste-of-hospital-preparations-the-example-of-ceftazidime-ophthalmic-solution-at-angers-university-hospital https://www.gerpac.eu/validation-of-an-alternative-method-for-sterility-control-of-parenteral-nutrition-mixtures https://www.gerpac.eu/validation-d-une-methode-alternative-de-controle-de-la-sterilite-des-melanges-de-nutrition-parenterale-mnp https://www.gerpac.eu/development-of-vinorelbine-oral-formulations-for-pediatric-use https://www.gerpac.eu/developpement-de-formulations-buvables-de-vinorelbine-a-usage-pediatrique https://www.gerpac.eu/110-development-and-stability-of-40-mg-ml-amiodarone-oral-suspension https://www.gerpac.eu/developpement-et-stabilite-d-une-suspension-buvable-d-amiodarone-a-40-mg-ml https://www.gerpac.eu/administration-devices-for-oral-compounding https://www.gerpac.eu/dispositifs-d-administration-des-preparations-sous-forme-buvable https://www.gerpac.eu/method-validation-in-preservation-of-sterile-agar-plates-beyond-the-manufacturers-recommendations-for-use-in-a-compounding-unit https://www.gerpac.eu/validation-d-une-methode-de-conservation-des-geloses-de-sedimentation-sterile-au-dela-des-recommandations-fabricants-pour-une-utilisation-en-isotechnie https://www.gerpac.eu/oral-suspension-of-spironolactone-development-and-validation-of-an-analytical-method-by-hplc-uv https://www.gerpac.eu/suspension-buvable-de-spironolactone-elaboration-et-validation-d-une-methode-de-dosage-analytique-par-hplc-uv https://www.gerpac.eu/development-and-validation-of-a-method-for-the-quantitative-determination-of-baclofen-and-its-degradation-products-for-the-stability-study-of-experimental-medicine https://www.gerpac.eu/developpement-et-validation-d-une-methode-de-dosage-quantitatif-du-baclofene-10-mg-20-mg-et-de-ses-produits-de-degradation-pour-l-etude-de-la-stabilite-d-un-medicament-experimental https://www.gerpac.eu/implementation-of-dose-banding-in-our-hospital-ready-to-infuse-bags-or-standardized-dose-batches https://www.gerpac.eu/retrospective-differential-analysis-between-3971-prescriptions-of-individualized-parenteral-nutrition-and-2-commercial-parenteral-nutrition https://www.gerpac.eu/analyse-retrospective-des-ecarts-entre-3971-prescriptions-de-melanges-pour-nutrition-parenterale-pediatrique-et-2-compositions-de-poches-commerciales https://www.gerpac.eu/validation-d-une-methode-de-dosage-d-une-preparation-hospitaliere-de-gelules-de-riboflavine-a-50-mg https://www.gerpac.eu/validation-of-an-assay-method-for-riboflavin-hospital-capsule-preparation-2881 https://www.gerpac.eu/improving-flows-to-limit-particulate-contaminants-in-sterile-preparation-areas https://www.gerpac.eu/ameliorer-les-flux-pour-limiter-les-contaminants-particulaires-des-zones-de-preparations-steriles https://www.gerpac.eu/qualifications-de-performance-d-un-cycle-de-sterilisation-d-isolateur-les-qualifications-realisees-par-le-fabricant-sont-elles-indiscutables https://www.gerpac.eu/performance-qualifications-of-sterilization-cycle-in-isolator-are-the-qualifications-carried-out-by-the-manufacturer-indisputable https://www.gerpac.eu/sous-traitance-de-reconstitution-des-medicaments-anticancereux-retour-d-experience-du-donneur-d-ordre-do-2-ans-apres-la-mise-en-place https://www.gerpac.eu/done-for-mrs-b-comparison-of-a-chemotherapy-oral-validation-versus-a-conventional-validation-circuit https://www.gerpac.eu/c-est-ok-pour-madame-b-comparaison-d-un-circuit-de-validation-orale-des-chimiotherapies-versus-un-circuit-de-validation-classique https://www.gerpac.eu/residual-volume-of-anticancer-drugs-when-administering-a-preparation-with-filter-tubing-what-solution https://www.gerpac.eu/volume-residuel-d-anticancereux-lors-d-administration-de-preparation-avec-tubulure-filtre-quelle-solution https://www.gerpac.eu/development-and-validation-of-18f-dpa714-automated-radiosynthesis-a-pet-radiotracer-for-neuroinflammation-imaging https://www.gerpac.eu/developpement-et-validation-de-la-radiosynthese-automatisee-du-18f-dpa714-un-radiotraceur-pour-l-imagerie-tep-de-la-neuro-inflammation https://www.gerpac.eu/feedback-is-it-useful-to-watch-all-drugcam-r-videos-before-delivery https://www.gerpac.eu/is-the-chemotherapy-circuit-with-rfid-technology-a-good-idea https://www.gerpac.eu/optimisation-of-the-organisation-of-a-chemotherapy-reconstitution-unit-in-a-french-oversea-territory-dose-standardisation-of-paclitaxel https://www.gerpac.eu/optimisation-de-l-organisation-d-une-unite-de-reconstitution-des-chimiotherapies-en-outre-mer-standardisation-des-doses-de-paclitaxel https://www.gerpac.eu/assessment-of-the-bexen-medical-col-system-to-prepare-autologous-serum-eyes-drops https://www.gerpac.eu/evaluation-du-systeme-col-de-bexen-medical-pour-la-preparation-et-le-conditionnement-des-collyres-au-serum-autologue https://www.gerpac.eu/performance-qualification-pq-of-a-new-isolator-for-reconstitution-of-cytotoxics https://www.gerpac.eu/qualification-de-performance-qp-d-un-nouvel-isolateur-pour-reconstitution-de-cytotoxiques https://www.gerpac.eu/development-and-validation-of-sterility-method-by-membrane-filtration-of-5-vancomycin-eye-drops https://www.gerpac.eu/mise-au-point-et-validation-de-l-essai-de-sterilite-par-filtration-sur-membrane-de-collyres-de-vancomycine-5 https://www.gerpac.eu/analytical-validation-of-a-cation-assay-in-binary-parenteral-nutrition-with-capillary-electrophoresis https://www.gerpac.eu/faisabilite-et-validation-d-une-methode-d-analyse-pour-le-dosage-des-cations-dans-des-melanges-binaires-de-nutrition-parenterale-np-par-electrophorese-capillaire-une-amelioration-de-la-securisation-du-circuit-a-l-etape-de-controle https://www.gerpac.eu/preparations-hospitalieres-vers-l-automatisation-de-leur-conditionnement https://www.gerpac.eu/hospital-preparations-towards-the-automation-of-their-packaging https://www.gerpac.eu/development-and-validation-of-a-dosing-method-for-colchicine-capsules-for-a-stability-study https://www.gerpac.eu/developpement-et-validation-d-une-methode-de-dosage-de-gelules-de-colchicine-en-vue-d-une-etude-de-stabilite https://www.gerpac.eu/clean-room-mapping-of-microbiological-samples-of-the-environment-using-a-failure-mode-an-effect-analysis-fmea-method https://www.gerpac.eu/zone-a-atmosphere-controlee-cartographie-des-prelevements-microbiologiques-de-l-environnement-par-une-methode-d-analyse-des-modes-de-defaillance-de-leurs-effets-et-leur-criticite-amdec https://www.gerpac.eu/isothermal-cases-qualified-by-the-suppliers-are-they-suitable-for-the-transport-of-heat-sensitive-cytotoxic-preparations https://www.gerpac.eu/mallettes-isothermes-qualifiees-par-les-laboratoires-sont-elles-vraiment-adpatees-pour-le-transport-de-preparations-cytotoxiques-thermosensibles https://www.gerpac.eu/a-study-of-the-stability-of-ceftriaxone-preparations-in-two-vehicles-for-epicutaneous-allergy-tests https://www.gerpac.eu/etude-de-stabilite-de-preparations-de-ceftriaxone-dans-deux-vehicules-pour-tests-allergologiques-epicutanes-2833 https://www.gerpac.eu/evolution-de-la-contamination-chimique-au-sein-d-une-unite-de-reconstitution-des-cytotoxiques https://www.gerpac.eu/evolution-of-chemical-contamination-in-a-cytotoxic-reconstitution-unit https://www.gerpac.eu/physicochemical-stability-study-of-cabazitaxel-zentiva-r-in-vials-after-opening-and-in-diluted-solutions-in-3-types-infusion-bags https://www.gerpac.eu/etude-de-stabilite-physico-chimique-du-cabazitaxel-zentiva-r-en-flacons-apres-ouverture-et-en-solutions-diluees-en-poches-de-perfusions-de-3-types https://www.gerpac.eu/methotrexate-for-ectopic-pregnancies-a-national-survey-on-pharmacy-practice https://www.gerpac.eu/circuit-du-methotrexate-pour-grossesses-extra-uterines-une-enquete-nationale https://www.gerpac.eu/spiros-r-et-faible-volume-d-administration-la-gravimetrie-permet-de-limiter-les-pertes https://www.gerpac.eu/spiros-r-and-small-administration-volume-gravimetric-control-helps-limit-waste https://www.gerpac.eu/etude-de-la-stabilite-d-un-biosimilaire-du-bevacizumab-dans-les-flacons-et-apres-dilution-dans-du-nacl-0-9-en-poche-de-polyolefine https://www.gerpac.eu/stability-study-of-a-biosimilar-of-bevacizumab-in-vials-and-after-dilution-in-0-9-nacl-in-polyolefin-iv-bags https://www.gerpac.eu/implementation-of-a-continuity-plan-for-cytotoxic-reconstitution-unit-cru-in-case-of-cyberattack https://www.gerpac.eu/dose-capping-dose-adjustment-full-dose-what-to-do-for-antineoplastic-drugs-in-obese-patients https://www.gerpac.eu/dose-capee-dose-ajustee-pleine-dose-que-faire-pour-l-utilisation-des-anticancereux-chez-les-patients-obeses https://www.gerpac.eu/realisation-d-une-preparation-injectable-de-bacteriophages-identification-des-points-critiques-associes https://www.gerpac.eu/production-of-an-injectable-bacteriophage-preparation-identification-of-the-associated-critical-points https://www.gerpac.eu/retour-d-experience-de-la-delocalisation-temporaire-d-une-activite-de-production-sterile https://www.gerpac.eu/feedback-from-temporary-relocation-of-a-sterile-production-activity https://www.gerpac.eu/retour-d-experience-sur-5-mois-d-utilisation-d-un-systeme-de-production-robotise-en-unite-de-reconstitution-des-cytotoxiques https://www.gerpac.eu/feedback-on-5-months-of-use-of-a-robotized-production-system-in-the-cytotoxic-reconstitution-unit https://www.gerpac.eu/visual-management-sqcdp-a-tool-for-monitoring-performance-in-pharmacotechny-unit https://www.gerpac.eu/management-visuel-sqcdp-un-outil-de-supervision-de-la-performance-en-pharmacotechnie https://www.gerpac.eu/moderators-2955 https://www.gerpac.eu/formulation-particle-size-and-rheological-characterization-of-a-pediatric-suspension-of-prazosin-for-the-treatment-of-post-traumatic-night-terrors https://www.gerpac.eu/formulation-caracterisation-granulometrique-et-rheologique-d-une-suspension-pediatrique-de-prazosine-pour-le-traitement-des-terreurs-nocturnes-post-traumatiques https://www.gerpac.eu/contraintes-et-faisabilite-des-controles-d-integrite-des-filtres-pour-la-production-de-preparations-hospitalieres-steriles https://www.gerpac.eu/constraints-and-feasibility-of-filter-integrity-testing-for-the-production-of-sterile-preparations-in-hospital-pharmacy https://www.gerpac.eu/bpps-and-degraded-procedures https://www.gerpac.eu/analyse-des-differentes-methodes-de-controle-des-chimiotherapies-anticancereuses-de-30-hopitaux-francais https://www.gerpac.eu/simulating-errors-a-training-tool-for-staff-entering-a-cleanroom https://www.gerpac.eu/le-film-des-erreurs-un-outil-pedagogique-destine-au-personnel-entrant-en-zone-a-atmosphere-controlee-zac https://www.gerpac.eu/texture-characterization-of-sodium-thiosulfate-hydrogels https://www.gerpac.eu/caracterisation-de-la-texture-d-hydrogels-de-thiosulfate-de-sodium https://www.gerpac.eu/assessment-of-psychosocial-risks-in-a-production-unit https://www.gerpac.eu/evaluation-des-risques-psychosociaux-en-unite-de-production https://www.gerpac.eu/qualification-of-the-noodis-r-robot-for-liquid-oral-medications-doses-filling-and-tapering https://www.gerpac.eu/performances-du-robot-noodis-r-pour-la-preparation-de-doses-de-medicaments-oraux-liquides-et-les-protocoles-de-sevrage https://www.gerpac.eu/lean-six-sigma-method-application-in-chemotherapy-reconstitution-unit-urc https://www.gerpac.eu/methode-lean-six-sigma-application-en-unite-de-reconstitution-des-chimiotherapies-urc https://www.gerpac.eu/evaluation-of-a-novel-rapid-chemical-contaminationdetection-device-bd-hd-check-r https://www.gerpac.eu/evaluation-d-un-nouveau-dispositif-de-detection-rapide-de-la-contamination-chimique-bd-hd-check-r https://www.gerpac.eu/application-of-a-new-medicoeconomic-evaluation-tool-for-intravenous-cytotoxic-preparatoon https://www.gerpac.eu/application-d-un-nouvel-outil-d-evaluation-medico-economique-pour-les-unites-de-production-de-chimiotherapies https://www.gerpac.eu/uvc-based-decontamination-of-skin-flora-contaminated-materials-a-fast-and-complementary-method-to-oxidant-aerolization https://www.gerpac.eu/decontamination-surfacique-de-materiaux-pharmaceutiques-par-irradiation-uvc-une-methode-rapide-et-complementaire-a-la-decontamination-par-aerosolisation-oxydative https://www.gerpac.eu/design-of-a-self-assessment-questionnaire-on-safe-handling-practices-for-hazardous-drugs-in-quebec https://www.gerpac.eu/conception-d-un-questionnaire-d-auto-evaluation-des-pratiques-de-manipulation-securitaire-des-medicaments-dangereux-au-quebec https://www.gerpac.eu/bioburden-determination-for-sterile-process-validation-in-the-context-of-drug-shortage-during-the-covid-19-pandemic https://www.gerpac.eu/determination-de-la-biocharge-pour-la-validation-d-un-procede-de-preparation-sterile-dans-un-contexte-de-penurie-de-medicaments-liee-a-la-pandemie-de-covid-19 https://www.gerpac.eu/formulation-of-a-new-paediatric-phenobarbital-oral-solution https://www.gerpac.eu/formulation-d-une-solution-buvable-de-phenobarbital-a-usage-pediatrique https://www.gerpac.eu/optimisation-of-the-use-of-picomix-r-for-amiodarone-and-lactose-powders-mixing https://www.gerpac.eu/optimisation-de-l-utilisation-du-picomix-r-pour-le-melange-des-poudres-d-amiodarone-et-de-lactose https://www.gerpac.eu/cyber-attack-in-an-injectable-chemotherapy-reconstitution-unit-what-about-the-production-in-absence-of-prescription-software https://www.gerpac.eu/cyberattaque-dans-une-unite-de-reconstitution-des-chimiotherapies-injectables-quid-de-la-production-en-l-absence-de-logiciel-d-aide-a-la-prescription https://www.gerpac.eu/covid-19-essential-medication-hospital-production-of-rocuronium-bromide-50mg-5ml https://www.gerpac.eu/medicaments-essentiels-a-la-prise-en-charge-de-la-covid-19-production-hospitaliere-de-bromure-de-rocuronium-50mg-5ml https://www.gerpac.eu/determination-of-the-ideal-protection-of-peristaltic-pump-while-maintening-the-sterility-of-the-isolateur https://www.gerpac.eu/transfert-d-une-pompe-peristaltique-sensible-a-l-acide-peracetique-validation-d-une-methode https://www.gerpac.eu/intravenous-hospital-preparations-for-treatment-of-covid19-an-inter-laboratory-comparison-of-cisatracurium-quantification https://www.gerpac.eu/preparations-hospitalieres-intraveineuses-pour-le-traitement-de-la-covid19-une-comparaison-inter-laboratoire-de-la-quantification-du-cisatracurium https://www.gerpac.eu/cord-blood-serum-eye-drops-application-of-the-collection-circuit-and-of-the-qualification-of-donations https://www.gerpac.eu/collyre-de-serum-de-sang-de-cordon-mise-en-place-du-circuit-de-recueil-et-de-qualification-des-dons https://www.gerpac.eu/identification-and-risk-analysis-of-a-robotized-chemotherapy-manufacturing-process https://www.gerpac.eu/identification-et-analyse-des-risques-d-un-processus-robotise-de-fabrication-des-chimiotherapies-2554 https://www.gerpac.eu/anti-uv-external-packaging-bags-are-they-really-useful https://www.gerpac.eu/sachets-de-conditionnement-externe-anti-uv-sont-ils-vraiment-utiles https://www.gerpac.eu/accurate-prediction-of-the-chemical-stability-of-the-pancuronium-and-its-degradation-products-in-injectable-solution https://www.gerpac.eu/prediction-reussie-de-la-stabilite-chimique-du-pancuronium-et-de-ses-produits-de-degradation-en-solution-injectable https://www.gerpac.eu/optimization-of-a-secured-pharmaceutical-control-of-intravenous-chemotherapy-elaboration-of-a-decision-tree-model-for-every-new-referencement https://www.gerpac.eu/optimisation-d-une-liberation-pharmaceutique-securisee-de-production-des-anticancereux-injectables-mise-en-place-d-un-arbre-decisionnel-de-controle-a-chaque-nouveau-referencement https://www.gerpac.eu/evaluation-of-radiopharmaceuticals-sorption-to-2-and-3-pieces-syringes https://www.gerpac.eu/evaluation-de-la-sorption-des-medicaments-radiopharmaceutiques-sur-des-seringues-2-et-3-pieces https://www.gerpac.eu/validation-of-a-visual-inspection-table-with-training-and-accreditation-of-operators-for-the-control-of-sterile-injectable-preparations-of-curares https://www.gerpac.eu/validation-d-une-table-de-mirage-avec-formation-et-habilitation-des-operateurs-pour-le-controle-des-preparations-injectables-steriles-de-curares https://www.gerpac.eu/kinetics-of-amoxicillin-and-clavulanic-acid-degradation https://www.gerpac.eu/etude-de-la-cinetique-de-degradation-de-l-amoxicilline-et-de-l-acide-clavulanique https://www.gerpac.eu/impression-3d-par-extrusion-semi-solide-de-films-orodispersibles-de-cafeine-a-base-d-alginate-de-sodium-destines-a-etre-administres-a-des-nouveau-nes https://www.gerpac.eu/development-and-preformulation-of-an-injectable-solution-of-propofol-complexed-with-cyclodextrin https://www.gerpac.eu/developpement-et-preformulation-d-une-solution-injectable-de-propofol-complexee-avec-cyclodextrine https://www.gerpac.eu/point-d-actualites-de-l-ansm https://www.gerpac.eu/dispofill-system-r-dfs-isolateur-usage-unique https://www.gerpac.eu/solution-against-msd https://www.gerpac.eu/la-solution-contre-les-tms https://www.gerpac.eu/development-by-ile-de-france-regional-health-agency-idf-rha-of-a-self-assessment-tool-chimioprep-to-secure-production-of-sterile-chemotherapy-cytotoxic-and-other-anticancer-drugs https://www.gerpac.eu/developpement-par-l-ars-ile-de-france-de-l-outil-chimioprep-pour-l-auto-evaluation-de-la-securisation-de-l-activite-de-preparation-des-medicaments-anticancereux-steriles https://www.gerpac.eu/pre-filled-syringes-made-of-cyclic-olefin-copolymers-for-the-hospital-environment-2692 https://www.gerpac.eu/pre-filled-syringes-made-of-cyclic-olefin-copolymers-for-the-hospital-environment https://www.gerpac.eu/formulation-and-stability-of-mrna-vaccines-the-pharmacist-s-point-of-view https://www.gerpac.eu/formulation-et-stabilite-des-vaccins-arnm-le-point-de-vue-du-pharmacien https://www.gerpac.eu/shortage-of-curares-in-france-during-the-covid-19-crisis-what-were-the-findings https://www.gerpac.eu/penurie-de-curares-en-france-pendant-la-crise-covid-19-quels-constats https://www.gerpac.eu/robotics-for-the-preparation-of-ready-to-administer-parenterals-in-hospital-pharmacies-2695 https://www.gerpac.eu/robotics-for-the-preparation-of-ready-to-administer-parenterals-in-hospital-pharmacies https://www.gerpac.eu/3d-printing-of-personalised-medicines https://www.gerpac.eu/3d-printing-of-personalised-medicines-2700 https://www.gerpac.eu/preparations-and-formulations-for-phage-therapy-2691 https://www.gerpac.eu/preparations-and-formulations-for-phage-therapy https://www.gerpac.eu/use-of-isolators-as-part-of-the-future-technology-in-the-hospital-pharmacies-in-denmark-2689 https://www.gerpac.eu/use-of-isolators-as-part-of-the-future-technology-in-the-hospital-pharmacies-in-denmark https://www.gerpac.eu/interactions-contenant-contenu https://www.gerpac.eu/comment-optimiser-la-robustesse-et-la-securite-d-une-production-hospitaliere-en-suivant-des-indicateurs-pertinents https://www.gerpac.eu/civas-centralized-intravenous-additive-service https://www.gerpac.eu/civas-centralized-intravenous-additive-service-2462 https://www.gerpac.eu/expertise-de-l-anses-travaux-exposant-aux-cytotoxiques https://www.gerpac.eu/2021-conference-2728 https://www.gerpac.eu/congres-2021-2727 https://www.gerpac.eu/future-for-the-pharmaceutical-technologies-in-hospital-pharmacy https://www.gerpac.eu/moderators-2672 https://www.gerpac.eu/moderateurs-2669 https://www.gerpac.eu/revision-des-bonnes-pratiques-de-preparation-2448 https://www.gerpac.eu/stability-of-25-mg-ml-5-azacitidine-suspensions-kept-in-fridge-after-freezing https://www.gerpac.eu/stabilite-de-la-suspension-de-5-azacitidine-25-mg-ml-refrigeree-apres-congelation https://www.gerpac.eu/reglement-interieur https://www.gerpac.eu/statuts https://www.gerpac.eu/adhesion https://www.gerpac.eu/qui-sommes-nous https://www.gerpac.eu/who-are-we https://www.gerpac.eu/symposium-e-posters https://www.gerpac.eu/symposium-e-presentations https://www.gerpac.eu/developpement-d-une-formation-habilitante-pour-les-preparations-non-steriles https://www.gerpac.eu/the-relaxation-area-2720 https://www.gerpac.eu/coin-detente https://www.gerpac.eu/in-plenary-session-2721 https://www.gerpac.eu/ateliers-2718 https://www.gerpac.eu/workshops-2723 https://www.gerpac.eu/en-seance-pleniere-2716 https://www.gerpac.eu/unite-d-oeuvre-pour-la-pharmacie-hospitaliere-application-a-la-pharmacotechnie https://www.gerpac.eu/gerpac-award-for-the-best-oral-communication https://www.gerpac.eu/prix-gerpac-2021 https://www.gerpac.eu/production-hospitaliere-de-nanoemulsion-de-propofol-a-l-hopital-preuve-de-concept https://www.gerpac.eu/hospital-production-of-propofol-injectable-nanoemulsion-proof-of-concept https://www.gerpac.eu/content-container-interactions https://www.gerpac.eu/new-best-practices-for-preparation-french-regulations https://www.gerpac.eu/moderateurs-2670 https://www.gerpac.eu/semi-solid-extrusion-3d-printing-of-orodispersible-caffeine-films-based-on-sodium-alginate-for-neonates https://www.gerpac.eu/preparation-of-advanced-therapy-medicinal-products-2649 https://www.gerpac.eu/moderators-2671 https://www.gerpac.eu/laureat-concours-video-2021 https://www.gerpac.eu/maitrise-pre-analytique-des-controles-des-preparations-hospitalieres-de-suspensions-buvables-pediatriques https://www.gerpac.eu/pre-analytic-optimization-of-api-assays-in-compounded-oral-suspensions-for-pediatrics https://www.gerpac.eu/feedback-on-nominative-parenteral-lipids-vitamins-admixtures-production-using-logipren-r-software https://www.gerpac.eu/retour-d-experience-sur-la-production-de-seringues-de-lipides-vitamines-a-la-carte-en-utilisant-le-logiciel-logipren-r https://www.gerpac.eu/medical-economic-study-and-practical-assessment-of-standard-sleeves-gloves-gms-versus-secure-connector-ring-bcs-sleeves-gloves https://www.gerpac.eu/etude-medico-economique-et-evaluation-pratique-des-gants-manchettes-standards-versus-gants-manchettes-a-bagues-de-connexion-securisees-bcs https://www.gerpac.eu/evaluation-of-the-romeo-r-handling-aid-and-its-impact-on-the-prevention-of-musculoskeletal-disorders https://www.gerpac.eu/evaluation-du-dispositif-d-aide-a-la-manipulation-romeo-r-et-impact-sur-la-prevention-des-troubles-musculo-squelettiques https://www.gerpac.eu/fmeca-failure-modes-effects-and-criticality-analysis-in-manufacturing-pediatric-individualized-parenteral-nutrition-ipn-bags-process-4-years-review-of-corrective-actions https://www.gerpac.eu/amdec-analyse-des-risques-de-leurs-effets-et-de-leur-criticite-sur-le-circuit-de-production-des-poches-de-nutrition-parenterale-individualisees-en-pediatrie-bilan-a-4-ans-des-actions-correctives https://www.gerpac.eu/stabilite-physicochimique-de-la-piperacilline-tazobactam-en-seringue-et-en-diffuseur-portable-pour-une-administration-continue-en-service-de-soins-critiques-et-a-domicile https://www.gerpac.eu/physicochemical-stability-of-piperacillin-tazobactam-in-syringe-and-elastomeric-device-for-continuous-administration-in-critical-care-and-at-home https://www.gerpac.eu/implementation-of-dotatoc-gallium-68-68ga-radiolabelling https://www.gerpac.eu/mise-en-place-du-radiomarquage-dotatoc-gallium68-68ga https://www.gerpac.eu/moderateurs-2675 https://www.gerpac.eu/guide-de-prevention-sur-la-manipulation-de-medicaments-dangereux-faits-saillants-de-la-2eme-edition-du-guide https://www.gerpac.eu/prevention-guide-on-handling-hazardous-drugs-highlights-from-the-2nd-edition-of-the-guide https://www.gerpac.eu/moderateurs-2673 https://www.gerpac.eu/moderators-2674 https://www.gerpac.eu/fabrication-industrielle https://www.gerpac.eu/industrial-manufacturing https://www.gerpac.eu/hot-topics-from-french-supervisory-authorities https://www.gerpac.eu/automated-oral-liquid-compounding-technology-with-internal-engineering-controls-for-hazardous-compounding https://www.gerpac.eu/automated-oral-liquid-compounding-technology-with-internal-engineering-controls-for-hazardous-compounding-2693 https://www.gerpac.eu/moderators-2676 https://www.gerpac.eu/development-of-an-accreditation-program-in-nonsterile-compounded-drugs https://www.gerpac.eu/how-to-optimise-the-robustness-and-safety-of-a-hospital-compounding-by-monitoring-relevant-indicators https://www.gerpac.eu/innovations-in-pharmaceuticals-technologies https://www.gerpac.eu/video-award-2021-2602 https://www.gerpac.eu/preparation-of-advanced-therapy-medicinal-products https://www.gerpac.eu/updating-from-french-national-agency-for-medicines-and-health-products-safety https://www.gerpac.eu/dispofill-system-r-dfs-single-use-isolator https://www.gerpac.eu/innovations-en-pharmacotechnie https://www.gerpac.eu/la-parole-aux-tutelles https://www.gerpac.eu/moderators-2686 https://www.gerpac.eu/efficacite-de-la-conservation-antimicrobienne-des-sirops-de-glucose-et-de-maltitol-avec-et-sans-conservateur-pour-les-preparations-pediatriques https://www.gerpac.eu/antimicrobial-preservation-efficacy-of-glucose-and-maltitol-syrups-with-and-without-preservatives-for-paediatric-formulations https://www.gerpac.eu/etude-comparative-des-differents-systemes-clos-disponibles-sur-le-marche-francais-pour-la-preparation-d-immunotherapies-injectables https://www.gerpac.eu/magistral-preparation-of-fumagillin-for-the-treatment-of-enterocytozoon-bieneusi-microsporidiosis-between-active-pharmaceutical-ingredient-shortage-and-major-therapeutic-need https://www.gerpac.eu/preparation-magistrale-de-fumagilline-pour-le-traitement-de-microsporidiose-a-e-bieneusi-entre-penurie-de-matieres-premieres-et-besoin-therapeutique-majeur https://www.gerpac.eu/vaccination-against-covid-19-feedback-on-the-reconstitution-of-doses-of-comirnaty-r-vaccine https://www.gerpac.eu/vaccination-contre-le-covid-19-retour-d-experience-sur-la-reconstitution-des-doses-de-vaccin-comirnaty-r https://www.gerpac.eu/comparative-qualitative-study-between-specialties-of-azacitidine-available-in-france https://www.gerpac.eu/etude-comparative-qualitative-entre-les-differentes-references-d-azacitidine-presentes-sur-le-marche-francais https://www.gerpac.eu/physical-stability-of-0-02-chlorhexidine-digluconate-eye-drops-in-5-glucose-or-phosphate-buffer-at-refrigerated-and-room https://www.gerpac.eu/daratumumab-subcutaneous-formulation-impact-of-its-stability-period-on-a-dispensation-and-administration-process https://www.gerpac.eu/impact-de-la-stabilite-du-daratumumab-en-sous-cutane-sur-son-circuit-de-dispensation-et-d-administration https://www.gerpac.eu/development-of-a-camera-assisted-educational-tool-for-the-training-and-evaluation-of-operators-in-a-cytotoxic-production-unit https://www.gerpac.eu/mise-au-point-d-un-outil-pedagogique-assiste-par-camera-pour-la-formation-et-l-evaluation-des-operateurs-au-sein-d-une-unite-de-production-de-cytotoxiques https://www.gerpac.eu/comparative-study-of-the-different-closed-system-transfer-devices-available-in-france-for-the-preparation-of-injectable-immunotherapies https://www.gerpac.eu/design-of-assistance-tools-to-manage-robotic-production-with-kiro-oncology-r https://www.gerpac.eu/elaboration-d-outils-d-aide-a-la-gestion-de-la-production-robotisee-avec-kiro-oncology-r https://www.gerpac.eu/physicochemical-and-microbiological-stability-of-spironolactone-oral-suspension-without-potentially-harmful-excipient https://www.gerpac.eu/etude-de-stabilite-physicochimique-et-microbiologique-d-une-suspension-buvable-de-spironolactone-sans-excipient-a-effet-notoire https://www.gerpac.eu/qualification-of-a-new-cytocontrol-r-balance-prototype-under-isolator https://www.gerpac.eu/dispensation-qualification-pharmaceutique-pq-et-consideration-biopharmaceutique-d-une-solution-d-amyloglucosidase-amg-en-traitement-du-deficit-en-sucrase-isomaltase-dsi https://www.gerpac.eu/supply-pharmaceutical-grading-and-biopharmaceutical-consideration-of-amyloglucosidase-amg-solution-in-congenital-sucrase-isomaltase-deficiency-csid-treatment https://www.gerpac.eu/physicochemical-and-biopharmaceutical-approach-to-a-topical-formulation-of-dabrafenib-for-the-local-treatment-of-langerhansian-histiocytosis https://www.gerpac.eu/approche-physico-chimique-et-biopharmaceutique-d-une-formulation-d-un-gel-de-dabrafenib-pour-le-traitement-local-d-une-histiocytose-langerhansienne https://www.gerpac.eu/adaptation-des-processus-de-preparation-aseptiques-hospitaliers-pour-faire-face-a-la-penurie-nationale-de-curares https://www.gerpac.eu/adaptation-of-hospital-aseptic-processes-to-face-national-shortage-of-curare https://www.gerpac.eu/risk-assessment-of-pharmaceutical-preparations-control-process-by-fmeca-methodology https://www.gerpac.eu/analyse-de-risques-par-la-methode-amdec-du-processus-de-controle-des-preparations https://www.gerpac.eu/surface-monitoring-in-isolators-feedback-on-a-national-survey-of-practices https://www.gerpac.eu/controles-de-surface-des-isolateurs-retour-sur-une-enquete-de-pratiques-a-l-echelle-nationale https://www.gerpac.eu/risk-analysis-to-support-the-implementation-of-dose-banding-circuit-in-cancer-centre https://www.gerpac.eu/analyse-de-risque-et-mise-en-place-d-un-circuit-de-doses-standard-dans-un-centre-de-lutte-contre-le-cancer https://www.gerpac.eu/membrane-filtration-sterility-assay-suitability-test-for-amikacin-eye-drops-50-mg-ml https://www.gerpac.eu/essai-de-sterilite-par-filtration-sur-membrane-essai-d-applicabilite-pour-les-collyres-a-l-amikacine-50-mg-ml https://www.gerpac.eu/quelle-organisation-pour-securiser-la-preparation-des-chimiotherapies-en-garde https://www.gerpac.eu/what-organisation-is-needed-to-ensure-the-safe-preparation-of-on-call-chemotherapy https://www.gerpac.eu/development-and-validation-of-sterility-test-method-by-membrane-filtration-of-ceftazidime-5-eye-drops https://www.gerpac.eu/mise-au-point-et-validation-d-une-methode-d-essai-de-sterilite-par-filtration-sur-membrane-de-collyres-a-la-ceftazidime-5 https://www.gerpac.eu/development-and-physico-chemical-stability-study-of-an-oral-liquid-form-of-letermovir-for-pediatric-use https://www.gerpac.eu/mise-au-point-et-etude-de-stabilite-physico-chimique-d-une-forme-orale-liquide-de-letermovir-destinee-a-la-pediatrie https://www.gerpac.eu/un-controle-analytique-des-diffuseurs-de-5-fluorouracile-enfin-envisageable https://www.gerpac.eu/analytical-control-of-5-fluorouracil-dispensers-finally-possible https://www.gerpac.eu/sterilization-of-infusion-bags-is-removing-the-secondary-packaging-safe https://www.gerpac.eu/sterilisation-des-poches-de-perfusion-peut-on-retirer-le-suremballage https://www.gerpac.eu/national-survey-on-the-management-of-urgent-requests-for-injectable-chemotherapy-preparations-outside-of-chemotherapy-reconstitution-units-cru-working-hours https://www.gerpac.eu/enquete-nationale-sur-la-gestion-des-demandes-urgentes-de-preparations-de-chimiotherapies-injectables-en-dehors-des-heures-ouvrables-des-unites-de-reconstitution-des-chimiotherapies-urc https://www.gerpac.eu/production-de-doses-de-vaccins-comirnaty-r-par-la-pharmacie-comment-s-organiser https://www.gerpac.eu/production-of-comirnaty-r-vaccine-doses-by-the-pharmacy-how-to-organize https://www.gerpac.eu/rapid-quantitative-and-qualitative-control-of-oxaliplatin-in-g5-using-a-separative-hplc-method https://www.gerpac.eu/controle-quantitatif-qualitatif-et-rapide-de-l-oxaliplatine-dans-du-g5-par-une-methode-hplc https://www.gerpac.eu/qualification-analytique-et-gravimetrique-d-un-robot-de-production-de-chimiotherapies https://www.gerpac.eu/analytical-and-gravimetric-qualification-of-a-chemotherapy-production-robot https://www.gerpac.eu/the-errors-tray-a-simulation-tool-for-evaluating-professional-practices-in-a-chemotherapy-production-unit https://www.gerpac.eu/le-plateau-des-erreurs-un-outil-de-simulation-pour-evaluer-les-pratiques-professionnelles-au-sein-d-une-unite-de-production-de-chimiotherapie https://www.gerpac.eu/development-and-validation-of-an-assay-method-for-the-determination-of-pyrimethamine-in-an-oral-suspension-by-hplc-uv https://www.gerpac.eu/developpement-et-validation-d-une-methode-de-dosage-de-la-pyrimethamine-en-suspension-buvable-par-hplc-uv https://www.gerpac.eu/premature-deterioration-of-a-transfer-isolator-qualification-of-a-sterilisation-time-in-anticipation-of-replacing-the-damaged-part https://www.gerpac.eu/usure-prematuree-d-un-isolateur-de-transfert-qualification-d-un-temps-de-sterilisation-en-prevision-du-remplacement-du-module-altere https://www.gerpac.eu/validation-of-a-new-medical-device-devoted-for-autologous-serum-eye-drops-sterile-preparation https://www.gerpac.eu/validation-d-un-nouveau-dispositif-medical-pour-la-preparation-sterile-des-collyres-au-serum-autologue https://www.gerpac.eu/design-and-stability-study-of-oral-capsules-and-suspension-of-riboflavin-for-the-treatment-of-metabolic-disease https://www.gerpac.eu/mise-au-point-et-etude-de-stabilite-des-gelules-et-d-une-forme-orale-liquide-de-riboflavine https://www.gerpac.eu/preliminary-study-for-a-microbiological-stability-study-microbiological-integrity-test https://www.gerpac.eu/etude-preliminaire-a-une-etude-de-stabilite-microbiologique-test-d-integrite-microbiologique-de-nos-seringues-en-polypropylene-apres-manipulation https://www.gerpac.eu/implementation-of-measures-to-reduce-chemical-contamination-by-cytotoxics-in-a-centralised-chemotherapy-reconstitution-unit-are-they-effective https://www.gerpac.eu/mise-en-place-de-mesure-destinees-a-reduire-la-contamination-chimique-par-les-cytotoxiques-au-sein-d-une-unite-de-reconstitution-de-chimiotherapies-centralisee-sont-elles-efficaces https://www.gerpac.eu/bilan-apres-3-ans-de-la-mise-en-place-des-doses-standard-dans-une-unite-de-pharmacie-oncologique https://www.gerpac.eu/implementation-of-dose-banding-in-a-pharmaceutical-chemotherapies-preparation-unit-results-after-3-years https://www.gerpac.eu/preparation-of-5-fluorouracil-elastomeric-devices-does-facilimix-r-make-life-easier https://www.gerpac.eu/remplissage-de-diffuseurs-portables-de-fluorouracile-facilimix-r-facilite-t-il-la-vie https://www.gerpac.eu/setting-up-a-fun-training-course-on-the-preparation-of-anticancer-drugs-within-a-regional-hospital-group https://www.gerpac.eu/mise-en-place-d-une-formation-ludique-sur-la-preparation-des-anticancereux-au-sein-d-un-groupement-hospitalier-de-territoire https://www.gerpac.eu/evaluation-of-surface-contamination-by-cytotoxic-drugs-cd-in-the-centralized-cytotoxic-reconstitution-unit-urcc https://www.gerpac.eu/evaluation-de-la-contamination-de-surface-par-les-anticancereux-atc-au-sein-de-l-unite-de-reconstitution-centralisee-des-cytostatiques-urcc https://www.gerpac.eu/harmonisation-of-pharmaceutical-release-practices-for-injectable-chemotherapy-preparations-after-analytical-control https://www.gerpac.eu/harmonisation-des-pratiques-de-liberation-pharmaceutique-des-preparations-de-chimiotherapies-injectables-apres-controle-analytique https://www.gerpac.eu/impact-de-la-temperature-sur-la-stabilite-physico-chimique-des-suspensions-d-azacitidine-zentiva-a-25-mg-ml-conditionnees-en-seringue-de-polypropylene https://www.gerpac.eu/impact-of-temperature-on-the-physico-chemical-stability-of-azacitidine-zentiva-25-mg-ml-suspensions-packaged-in-polypropylene-syringes https://www.gerpac.eu/microbiological-qualification-of-an-automatic-compounding-system-for-the-production-of-chemotherapy https://www.gerpac.eu/qualification-microbiologique-d-un-systeme-de-composition-automatique-pour-la-production-de-chimiotherapie https://www.gerpac.eu/qualification-of-a-mixer-how-to-obtain-the-homogeneity-of-semi-solid-preparations-for-skin-application-sspsa https://www.gerpac.eu/qualification-d-un-melangeur-comment-obtenir-l-homogeneite-de-preparations-semi-solides-pour-application-cutanee-pssac https://www.gerpac.eu/qualification-of-a-mixer-how-to-obtain-the-homogeneity-of-a-mixture-of-powders https://www.gerpac.eu/qualification-d-un-melangeur-comment-obtenir-l-homogeneite-d-un-melange-de-poudres https://www.gerpac.eu/qualification-d-un-nouveau-prototype-de-balance-cytocontrol-r-en-isolateur https://www.gerpac.eu/establishment-of-a-community-of-practice-on-the-safe-handling-of-hazardous-drugs-in-quebec https://www.gerpac.eu/mise-en-place-d-une-communaute-de-pratique-sur-la-manipulation-securitaire-des-medicaments-dangereux-au-quebec https://www.gerpac.eu/qualification-of-a-robotic-system-for-antiblastic-drug-compounding-evaluation-of-the-chemical-contamination-with-a-fluorescein-solution https://www.gerpac.eu/qualification-d-un-robot-pour-la-preparation-de-medicaments-cytotoxiques-evaluation-de-la-contamination-chimique-avec-une-solution-de-fluoresceine https://www.gerpac.eu/media-fill-test-concrete-implementation https://www.gerpac.eu/test-de-remplissage-aseptique-concretement https://www.gerpac.eu/digital-video-control-at-the-centralized-unit-of-chemotherapy-preparation-total-security-of-the-preparation-process https://www.gerpac.eu/le-controle-videonumerique-a-l-ucpc-securisation-totale-du-process-de-preparation https://www.gerpac.eu/exposure-to-cytotoxics-a-wide-scale-measurement-campaign-in-a-hospital https://www.gerpac.eu/exposition-aux-cytotoxiques-large-campagne-de-mesures-dans-un-centre-hospitalier https://www.gerpac.eu/optimization-of-the-preparation-and-control-of-melatonin-capsules https://www.gerpac.eu/optimisation-de-la-preparation-et-du-controle-des-gelules-de-melatonine https://www.gerpac.eu/physical-stability-of-0-02-chlorhexidine-digluconate-eye-drops-in-5-glucose-or-phosphate-buffer-at-refrigerated-and-room-2504 https://www.gerpac.eu/study-of-the-addition-of-l-carnitine-in-pediatric-parenteral-nutrition-binary-mixtures https://www.gerpac.eu/etude-de-l-ajout-de-la-l-carnitine-dans-de-melanges-binaires-de-nutrition-parnterale-pediatrique https://www.gerpac.eu/risk-mapping-within-a-cytotoxic-preparation-unit https://www.gerpac.eu/cartographie-des-risques-au-sein-d-une-unite-de-reconstitution-centralisee-des-cytotoxiques https://www.gerpac.eu/accuracy-and-repeatability-on-a-given-day-of-centralized-preparation-of-covid-19-vaccines-in-a-vaccination-centre https://www.gerpac.eu/justesse-et-repetabilite-un-jour-donne-de-la-preparation-centralisee-de-vaccins-contre-la-covid-19-dans-un-vaccinodrome https://www.gerpac.eu/conduite-de-changement-de-pratiques-nouveau-mode-operatoire-de-la-preparation-des-diffuseurs-portables-d-antibiotique https://www.gerpac.eu/conducting-a-change-in-practice-new-procedure-for-the-preparation-of-portable-antibiotic-dispensers https://www.gerpac.eu/restitution-consensus-stabilite-microbiologique-2149 https://www.gerpac.eu/best-preparation-practices-international-convergence-and-divergence-2150 https://www.gerpac.eu/les-bonnes-pratiques-de-preparation-convergences-et-divergences-internationales-1943 https://www.gerpac.eu/microbiological-stability-consensus-working-group https://www.gerpac.eu/10-could-we-package-atropine-eye-drops-0-1-mg-ml-1-and-0-5-mg-ml-1-in-novelia-r-bottles https://www.gerpac.eu/peut-on-conditionner-les-collyres-d-atropine-a-0-1-mg-ml-et-0-5-mg-ml-dans-les-flacons-novelia-r https://www.gerpac.eu/concours-video https://www.gerpac.eu/video-competition-winner https://www.gerpac.eu/2019-conference-2177 https://www.gerpac.eu/congres-2019-2178 https://www.gerpac.eu/conference-2020 https://www.gerpac.eu/congres-2020-2426 https://www.gerpac.eu/table-ronde-internationale-acces-libre https://www.gerpac.eu/conclusion-round-table https://www.gerpac.eu/conclusion-de-la-table-ronde-internationale https://www.gerpac.eu/irene-kramer-mainz-germany https://www.gerpac.eu/jean-francois-bussieres-montreal-canada https://www.gerpac.eu/farshid-sadeghipour-lausanne-switzerland https://www.gerpac.eu/nicolas-widmer-rennaz-switzerland https://www.gerpac.eu/laurence-floener-luxembourg-luxembourg https://www.gerpac.eu/carmen-lopez-barcelona-spain https://www.gerpac.eu/paul-le-brun-leiden-university-medical-center-the-netherlands https://www.gerpac.eu/valerie-salomon-ansm-paris-france https://www.gerpac.eu/laurence-floener-luxembourg-luxembourg-2403 https://www.gerpac.eu/farshid-sadeghipour-lausanne-switzerland-2405 https://www.gerpac.eu/irene-kramer-mainz-germany-2420 https://www.gerpac.eu/nicolas-widmer-rennaz-switzerland-2404 https://www.gerpac.eu/paul-le-brun-leiden-the-netherlands https://www.gerpac.eu/carmen-lopez-barcelona-spain-2402 https://www.gerpac.eu/jean-francois-bussieres-montreal-canada-2406 https://www.gerpac.eu/valerie-salomon-ansm-paris-france-2439 https://www.gerpac.eu/impact-de-la-concentration-en-calcium-sur-le-dosage-du-magnesium-contenu-dans-les-preparations-de-nutrition-enterale-indicidualisees-destinees-au-service-de-reanimation-neonatale-d-un-centre-hospitalier-general https://www.gerpac.eu/les-videos-en-competition https://www.gerpac.eu/laureats-communications-orales-courtes https://www.gerpac.eu/laureat-concours-videos https://www.gerpac.eu/2016-conference https://www.gerpac.eu/2015-conference-1251 https://www.gerpac.eu/2014-conference-1020 https://www.gerpac.eu/2013-conference-989 https://www.gerpac.eu/2012-conference-798 https://www.gerpac.eu/2011-conference-699 https://www.gerpac.eu/2010-conference-537 https://www.gerpac.eu/2009-conference-95 https://www.gerpac.eu/2008-conference-237 https://www.gerpac.eu/2006-conference-241 https://www.gerpac.eu/2005-conference-328 https://www.gerpac.eu/pharmacotechnie-hospitaliere-pendant-la-crise-covid-retour-d-experiences-nationales https://www.gerpac.eu/fabrication-de-solution-hydroalcoolique https://www.gerpac.eu/frederic-lagarce-chu-angers https://www.gerpac.eu/production-de-medicaments-d-interet-majeur-en-cas-de-penurie https://www.gerpac.eu/creation-d-un-reseau-de-chu-producteurs-dans-le-cadre-du-covid https://www.gerpac.eu/utilisation-de-l-impression-3-d https://www.gerpac.eu/round-table-2400 https://www.gerpac.eu/particulate-air-quality-in-the-insulator-throughout-a-production-period-factors-impacting-contamination https://www.gerpac.eu/qualite-particulaire-de-l-air-dans-l-isolateur-tout-au-long-d-une-periode-de-production-facteurs-impactant-la-contamination https://www.gerpac.eu/conclusion-des-journees-scientifiques https://www.gerpac.eu/ouverture-du-congres-numerique-2020 https://www.gerpac.eu/bacteriophage-loaded-hydrogel-journey-of-a-magistral-preparation https://www.gerpac.eu/bacteriophage-loaded-hydrogel-journey-of-a-magistral-preparation-2276 https://www.gerpac.eu/does-transport-through-a-pneumatic-tube-network-affect-the-physicochemical-stability-of-ready-to-use-infliximab-bags-2271 https://www.gerpac.eu/does-transport-through-a-pneumatic-tube-network-affect-the-physicochemical-stability-of-ready-to-use-infliximab-bags https://www.gerpac.eu/surface-contamination-monitoring-program-with-9-antineoplastic-drugs-in-109-canadian-hospitals-results-obtained-during-the-covid-19-pandemic https://www.gerpac.eu/programme-de-surveillance-de-la-contamination-de-surface-a-neuf-antineoplasiques-dans-109-hopitaux-canadiens-resultats-obtenus-pendant-la-pandemie-a-covid-19 https://www.gerpac.eu/preliminary-study-of-the-impact-of-hydrogen-peroxide-on-three-peptides https://www.gerpac.eu/etude-preliminaire-de-l-impact-du-peroxyde-d-hydrogene-sur-trois-peptides https://www.gerpac.eu/l-oeil-de-marie https://www.gerpac.eu/blood-volumes-study-development-and-application-of-a-challenged-aseptic-simulation-test https://www.gerpac.eu/etude-des-volumes-sanguins-developpement-et-application-d-un-test-de-remplissage-aseptique-optimise https://www.gerpac.eu/the-importance-of-stability-study-in-the-issue-of-tenders-at-ap-hp-pemetrexed-diarginine-zentiva-pmz-case https://www.gerpac.eu/importance-de-la-stabilite-dans-la-problematique-des-appels-d-offre-a-l-aphp-cas-du-pemetrexed-diarginine-de-zentiva-r-pmz https://www.gerpac.eu/comparative-study-of-the-administration-of-capsules-oral-suspension-and-3d-prints-of-amiodarone-by-nursing-staff-in-a-neonatal-unit https://www.gerpac.eu/etude-comparative-de-l-administration-de-gelules-d-une-suspension-buvable-et-d-imprimes-3d-d-amiodarone-par-des-personnels-soignants-d-un-service-de-neonatalogie https://www.gerpac.eu/stability-of-a-4g-l-aqueous-solution-of-idarubicin-stored-in-a-polypropylene-syringue-for-transarterial-chemoembolisation https://www.gerpac.eu/stabilite-d-une-solution-concentree-a-4g-l-d-idarubicine-conditionnee-en-seringue https://www.gerpac.eu/selection-and-formulation-of-antibiotics-mixed-in-fortified-eye-drops-for-the-treatment-of-bacterial-keratitis https://www.gerpac.eu/selection-et-formulation-de-collyres-renforces-antibiotiques-en-association-pour-le-traitement-des-keratites-bacteriennes https://www.gerpac.eu/laureats-masters-pharmacotechnie-hospitaliere https://www.gerpac.eu/continuous-training-of-the-chemotherapy-staff-implementation-and-evaluation-of-a-fun-and-educational-tool-the-trivial-pursuit-r https://www.gerpac.eu/formation-continue-du-personnel-de-l-unite-mise-en-place-et-evaluation-d-un-outil-ludique-et-pedagogique-le-trivial-pursuit-r https://www.gerpac.eu/can-we-use-video-preparation-control-system-for-performance-management-and-training-programs https://www.gerpac.eu/peut-on-utiliser-un-systeme-de-controle-video-de-preparation-pour-la-gestion-de-performance-et-le-parcours-de-formation https://www.gerpac.eu/adaptation-of-a-pharmaceutical-technology-activity-to-covid-19-experiment-in-a-peripheral-hospital-center https://www.gerpac.eu/adaptation-d-une-activite-de-pharmacotechnie-face-au-covid-19-experience-dans-un-centre-hospitalier-peripherique https://www.gerpac.eu/implementation-of-dose-banding-of-nivolumab https://www.gerpac.eu/mise-en-place-de-la-standardisation-de-poches-de-nivolumab https://www.gerpac.eu/robot-pharmoduct-r-of-dedalus-feasibility-study-of-the-implementation-of-automated-campaigns-of-chemotherapy-preparations https://www.gerpac.eu/le-robot-pharmoduct-r-de-dedalus-etude-de-faisabilite-de-la-mise-en-place-de-campagnes-automatisees-de-preparations-de-chimiotherapie https://www.gerpac.eu/chemical-and-physical-stabilities-of-admixture-of-morphine-hcl-and-clonidine-2210 https://www.gerpac.eu/chemical-and-physical-stabilities-of-admixture-of-morphine-hcl-and-clonidine https://www.gerpac.eu/preparation-and-control-of-lidocaine-and-ketamine-injectable-solution-for-mesotherapy https://www.gerpac.eu/preparation-et-controle-d-une-solution-injectable-de-lidocaine-et-de-ketamine-pour-mesotherapie https://www.gerpac.eu/optimization-of-the-control-of-compounded-capsule-preparations-feedback-on-the-implementation-of-an-acceptance-value-for-the-mass-uniformity-test https://www.gerpac.eu/optimisation-du-controle-des-preparations-magistrales-de-gelules-retour-d-experience-sur-l-instauration-d-une-valeur-d-acceptation-de-l-essai-d-uniformite-de-masse https://www.gerpac.eu/stability-of-vancomycin-50-mg-ml-eye-drops-in-low-density-polyethylene-ldpe-multidose-eyedropper https://www.gerpac.eu/stabilite-de-collyres-de-vancomycine-a-50-mg-ml-en-flacon-en-polyethylene-basse-densite-pebd https://www.gerpac.eu/development-of-a-challenged-media-fill-test-for-aseptic-process-qualification-of-a-pediatric-parenteral-nutrition-compounder https://www.gerpac.eu/developpement-d-un-test-de-remplissage-aseptique-challenge-pour-la-procedure-de-qualification-d-un-automate-de-nutrition-parenterale-pediatrique https://www.gerpac.eu/assessment-of-the-installation-of-a-digital-video-control-for-standard-and-experimental-anticancer-injectable-preparations https://www.gerpac.eu/bilan-de-l-installation-d-un-controle-videonumerique-pour-les-preparations-d-anticancereux-et-medicaments-experimentaux-injectables-2214 https://www.gerpac.eu/interest-of-an-analytical-control-by-uv-spectrophotometry-for-the-control-of-phenobarbital-compounded-preparations https://www.gerpac.eu/interet-d-un-controle-analytique-par-spectrophotometrie-uv-pour-le-controle-des-preparations-magistrales-de-phenobarbital https://www.gerpac.eu/application-of-annual-monitoring-of-environmental-contamination-to-limit-the-risk-of-occupational-exposure-to-hazardous-drugs-on-two-hospital-sites https://www.gerpac.eu/application-d-un-suivi-annuel-de-la-contamination-environnementale-pour-limiter-le-risque-d-exposition-professionnelle-aux-medicaments-anticancereux-sur-deux-sites-hospitaliers https://www.gerpac.eu/assessment-of-the-impact-of-covid-19-on-preparatory-practices-and-activity-in-nonsterile-compounding-units-hospital-and-community-pharmacies-2269 https://www.gerpac.eu/assessment-of-the-impact-of-covid-19-on-preparatory-practices-and-activity-in-nonsterile-compounding-units-hospital-and-community-pharmacies https://www.gerpac.eu/a-la-recherche-du-phosphore https://www.gerpac.eu/feasibility-study-for-dose-banding-of-oxaliplatine-dose-standardization-project-of-the-hospital-s-chemotherapy-preparations-unit-2347 https://www.gerpac.eu/feasibility-study-for-dose-banding-of-oxaliplatine-dose-standardization-project-of-the-hospital-s-chemotherapy-preparations-unit-2346 https://www.gerpac.eu/compliant-or-non-compliant-when-the-in-process-controls-and-liberating-analyticals-controls-are-not-aligned https://www.gerpac.eu/conforme-ou-non-conforme-quand-les-controles-in-process-et-analytiques-liberatoires-ne-sont-pas-en-phase https://www.gerpac.eu/impact-of-calcium-concentration-on-the-determination-of-magnesium-in-individualized-parenteral-nutrition-preparations-for-neonatal-intensive-care-service-at-a-general-hospital https://www.gerpac.eu/stability-of-2-5mg-folic-acid-capsules https://www.gerpac.eu/stabilite-des-gelules-d-acide-folique-a-2-5-mg https://www.gerpac.eu/feasibility-study-of-a-blood-derived-eye-drops-preparation https://www.gerpac.eu/etude-de-faisabilite-d-une-preparation-de-collyres-derives-du-sang https://www.gerpac.eu/feasibility-study-for-dose-banding-of-oxaliplatine-dose-standardization-project-of-the-hospital-s-chemotherapy-preparations-unit https://www.gerpac.eu/etude-de-faisabilite-du-dose-banding-d-oxaliplatine-projet-de-standardisation-de-dose-d-anticancereux-a-l-unite-de-preparation-de-chimiotherapie-de-l-hopital https://www.gerpac.eu/qualification-de-l-automate-a-remplissage-volumetrique-imf-medimixmulti-r-pour-la-fabrication-des-nutritions-parenterales-pediatriques-npp https://www.gerpac.eu/qualification-of-an-automated-compounding-device-imf-medimixmulti-r-for-pediatric-parenteral-nutrition-ppn-production https://www.gerpac.eu/estimation-de-la-cinetique-thermique-des-solvants-de-reconstitution-des-chimiotherapies-injectables https://www.gerpac.eu/thermal-kinetic-estimation-of-reconstitution-solvents-for-injectable https://www.gerpac.eu/securisation-du-circuit-de-l-azacitidine-vidaza-r-en-hospitalisation-a-domicile-had https://www.gerpac.eu/securing-azacitidine-vidaza-r-circuit-in-home-hospitalisation https://www.gerpac.eu/etat-des-lieux-national-des-connaissances-et-des-besoins-concernant-les-contaminations-environnementales-aux-cytotoxiques https://www.gerpac.eu/a-national-overview-of-the-knowledge-and-needs-related-to-environmental-cytotoxic-contamination https://www.gerpac.eu/l-interruption-de-tache-une-banalite-du-quotidien https://www.gerpac.eu/task-interruption-an-everyday-life-banality https://www.gerpac.eu/preparations-de-chimiotherapies-non-administrees-na-et-covid-19-quels-impacts https://www.gerpac.eu/non-administered-chemotherapy-preparations-ncps-and-covid-19-what-are-the-impacts https://www.gerpac.eu/declinaison-pratique-d-une-analyse-a-priori-des-risques-a-l-echelle-regionale-relative-a-la-mise-en-place-d-un-automate-de-preparation-de-doses-unitaires-et-nominatives-par-surconditionnement-au-sein-d-une-pharmacie-a-usage-interieur https://www.gerpac.eu/practical-implementation-of-a-preliminary-risk-analysis-on-a-regional-scale-relating-to-the-introduction-of-a-unit-dose-dispensing-system-with-over-packaging-within-a-hospital-pharmacy https://www.gerpac.eu/interet-de-l-analyse-globale-des-risques-agr-pour-la-securisation-de-la-production-des-chimiotherapies https://www.gerpac.eu/the-benefits-of-the-global-risk-assessment-gra-to-secure-the-centralized-production-of-chemotherapies https://www.gerpac.eu/campagne-de-surveillance-d-exposition-professionnelle-aux-cytostatiques https://www.gerpac.eu/monitoring-campaign-for-professional-exposure-to-cytostatics https://www.gerpac.eu/evaluation-des-besoins-en-formulation-pharmaceutique-pour-limiter-l-usage-des-medicaments-inappropries-en-reanimation-pediatrie-et-soins-continus https://www.gerpac.eu/pharmaceutical-formulation-needs-assessment-to-limit-the-use-of-inappropriate-drugs-in-paediatric-intensive-care-and-continuing-care-units https://www.gerpac.eu/retour-d-experience-retex-sur-une-panne-prolongee-de-traitement-d-air-en-zone-de-production-de-cytotoxiques https://www.gerpac.eu/feedback-retex-about-a-prolonged-breakdown-of-air-treatment-in-the-cytotoxic-production-area https://www.gerpac.eu/bonnes-pratiques-de-preparation-2019-des-lots-plus-gros https://www.gerpac.eu/french-2019-good-manufacturing-practice-larger-batchs https://www.gerpac.eu/implementation-d-une-methode-collaborative-pour-l-amelioration-du-processus-de-dispensation-de-medicaments-experimentaux-anticancereux-retour-d-experiences-a-m-6 https://www.gerpac.eu/implementation-of-a-collaborative-method-for-the-improvement-of-the-dispensing-process-of-experimental-anti-cancer-drugs-feedback-at-m-6 https://www.gerpac.eu/mise-en-place-des-car-t-cells-au-sein-d-une-pharmacie-a-usage-interieur-pui https://www.gerpac.eu/implementation-of-car-t-cells-in-a-hospital-pharmacy-department https://www.gerpac.eu/analyse-preliminaire-des-risques-appliquee-a-la-preparation-robotisee-de-poches-de-chimiotherapie https://www.gerpac.eu/preliminary-hazard-analysis-applied-to-a-chemotherapy-compounding-robot https://www.gerpac.eu/formation-et-habilitation-des-preparateurs-en-pharmacie-a-la-reconstitution-des-anticancereux-etat-des-lieux-des-outils-pedagogiques-utilises-en-france https://www.gerpac.eu/training-and-accreditation-of-pharmacy-technicians-in-the-reconstitution-of-anticancer-drugs https://www.gerpac.eu/l-escape-casse-un-jeu-pedagogique-sur-la-conduite-a-tenir-lors-du-bris-d-un-flacon-de-cytotoxique https://www.gerpac.eu/the-escape-casse-an-educational-game-on-the-expected-behaviour-to-adopt-when-a-cytotoxic-bottle-breaks https://www.gerpac.eu/enquete-nationale-sur-la-formation-habilitation-actuelle-et-attendue-des-preparateurs-pph-exercant-en-unite-de-reconstitution-des-chimiotherapies-urc https://www.gerpac.eu/national-survey-on-current-and-expected-training-accreditation-of-pharmacy-technicians-pts-in https://www.gerpac.eu/isolateur-des-erreurs-numeriques-utilisation-de-l-outil-drugcam-r-pour-la-formation-continue-des-preparateurs https://www.gerpac.eu/digital-error-isolator-use-of-drugcam-r-for-continuous-training-of-pharmacy-technicians https://www.gerpac.eu/connaissance-d-une-unite-de-production-de-chimiotherapies-et-toi-tu-te-mets-combien-r https://www.gerpac.eu/knowledge-of-a-chemotherapy-production-unit-et-toi-tu-te-mets-combien-r https://www.gerpac.eu/et-si-la-formation-continue-devenait-un-jeu https://www.gerpac.eu/what-if-continuing-education-became-a-game https://www.gerpac.eu/formation-des-preparateurs-developpement-et-mise-en-oeuvre-d-un-programme-d-habilitation-au-preparatoire https://www.gerpac.eu/development-and-implementation-of-an-accreditation-program-for-pharmacy-technicians-in-nonsterile-compounding-units https://www.gerpac.eu/un-concept-d-escape-game-pour-la-preparation-des-medicaments-en-essais-cliniques-en-secteur-sterile-une-formation-ludique-et-utile https://www.gerpac.eu/an-escape-game-concept-for-the-preparation-of-medications-in-clinical-trials-in-the-sterile-sector-a-playful-and-useful-training-course https://www.gerpac.eu/determination-de-l-origine-d-une-apparition-d-impurete-dans-le-cadre-de-preparation-de-collyres-de-vancomycine https://www.gerpac.eu/origin-determination-of-impurities-occurring-during-the-preparation-of-fortified-vancomycin-eye-drop https://www.gerpac.eu/analyse-des-preparations-de-chimiotherapies-non-administrees-na-retour-sur-5-ans-d-experience https://www.gerpac.eu/analysis-of-non-administered-chemotherapy-preparations-ncps-an-update-on-a-5-year-experience https://www.gerpac.eu/radiomarquage-des-polynucleaires-au-18fluoro-desoxy-glucose-fdg-pour-la-detection-de-foyers-infectieux https://www.gerpac.eu/radiolabelling-of-leucocytes-with-18fluoro-desoxy-glucose-fdg-in-infectious-disease-imaging https://www.gerpac.eu/evaluation-en-duree-du-circuit-complet-de-preparation-d-un-cycle-de-vyxeos-r-versus-schema-3-7-traitement-d-induction-d-une-leucemie-aigue-myeloide https://www.gerpac.eu/production-time-assessment-of-a-vyxeos-r-cycle-versus-3-7-regimen-in-the-induction-treatment-for-acute-myeloid-leukemia https://www.gerpac.eu/mise-en-place-de-la-standardisation-des-doses-d-anticancereux-dans-un-centre-hospitalier-universitaire https://www.gerpac.eu/implementation-of-the-standardization-of-anticancer-doses-in-a-university-hospital https://www.gerpac.eu/production-anticipee-des-intrathecales-en-pediatrie-questionnaire-national-des-pratiques-actuelles https://www.gerpac.eu/anticipated-production-of-intrathecals-in-pediatrics-national-survey-of-current-practices https://www.gerpac.eu/evaluation-de-la-consommation-de-bortezomib-en-fonction-de-la-forme-pharmaceutique-et-du-dispositif-de-prelevement-utilise-lors-de-la-reconstitution https://www.gerpac.eu/bortezomib-consumption-assessment-according-to-the-pharmaceutical-form-and-the-sampling-device-used-during-reconstitution https://www.gerpac.eu/evaluation-des-facteurs-de-deplacement-de-differentes-matieres-premieres-pour-la-preparation-de-sirops https://www.gerpac.eu/pediatric-syrups-impact-of-the-api-row-material-on-the-final-preparation-volume https://www.gerpac.eu/etude-de-la-stabilite-d-un-biosimilaire-du-rituximab-dilue-dans-du-nacl-0-9-en-poche-de-polyolefine-avec-excursion-prolongee-de-temperature-a-25oc https://www.gerpac.eu/stability-study-of-a-biosimilar-of-rituximab-after-dilution-in-nacl-0-9-polyolefin-bags-with-prolonged-temperature-excursion-to-25oc https://www.gerpac.eu/bilan-de-l-installation-d-un-controle-videonumerique-pour-les-preparations-d-anticancereux-et-medicaments-experimentaux-injectables https://www.gerpac.eu/assessment-of-the-installation-of-a-digital-video-control-for-standard-and-experimental-anticancer-injectable-preparations-2423 https://www.gerpac.eu/comparaison-d-une-methode-de-titrimetrie-automatisee-a-la-titrimetrie-manuelle-sur-des-echantillons-d-une-unite-de-production https://www.gerpac.eu/comparing-automated-titrimetry-method-to-manual-titrimetry-on-samples-from-a-production-unit https://www.gerpac.eu/developpement-et-validation-d-une-methode-de-dosage-de-gelule-de-clonidine-par-hplc-uv https://www.gerpac.eu/development-and-validation-of-an-analytical-method-for-the-dosage-of-clonidine-capsule-by-hplc-uv https://www.gerpac.eu/development-and-validation-of-a-fluconazole-quantification-method-for-the-stability-study-of-an-investigational-medical-product https://www.gerpac.eu/l-outil-drugcam-c-en-unite-de-chimiotherapie-permet-il-d-atteindre-le-risque-zero https://www.gerpac.eu/does-the-drugcam-c-chemotherapy-control-system-allow-to-reach-zero-risk https://www.gerpac.eu/peut-on-arriver-a-100-de-controles-automatises-pour-les-preparations-d-anticancereux https://www.gerpac.eu/is-it-possible-to-achieve-100-automated-controls-in-a-chemotherapy-production-unit https://www.gerpac.eu/assessment-of-hygiene-practices-related-to-radiopharmacy-shielded-workstations https://www.gerpac.eu/assessment-of-hygiene-practices-related-to-radiopharmacy-shielded-workstations-2208 https://www.gerpac.eu/etude-de-stabilite-physico-chimique-et-microbiologique-d-un-collyre-fortifie-de-vancomycine-a-25mg-ml-conserve-entre-2-et-8oc-dans-un-flacon-en-polyethylene-basse-densite-pebd https://www.gerpac.eu/physicochemical-and-microbiological-stability-study-of-vancomycin-25-mg-ml-eye-drops-stored-at-2-8oc-in-low-density-polyethylene-ldpe-containers https://www.gerpac.eu/developpement-et-validation-d-une-methode-de-dosage-du-fluconazole-pour-l-etude-de-la-stabilite-d-un-medicament-experimental https://www.gerpac.eu/validation-d-un-conditionnement-primaire-de-poches-pretes-a-emploi-pour-l-administration-d-anticancereux-stabilite-microbiologique-et-integrite-physique https://www.gerpac.eu/validation-of-ready-to-use-bags-for-anticancer-drug-administration-microbiological-stability-and-physical-integrity https://www.gerpac.eu/seringues-de-noradrenaline-au-bloc-operatoire-precision-de-la-preparation-et-apport-de-la-pharmacie https://www.gerpac.eu/norepinephrine-syringes-in-the-operating-room-accuracy-of-preparation-and-pharmacy-supply https://www.gerpac.eu/etude-de-stabilite-des-bains-de-bouche-de-morphine-a-0-2-pour-la-mucite-induite-par-une-chimiotherapie-a-haute-dose https://www.gerpac.eu/stability-study-of-0-2-morphine-mouthwashes-for-high-dose-chemotherapy-induced-mucositis https://www.gerpac.eu/official-opening-of-virtual-meeting https://www.gerpac.eu/caracteristiques-des-dosages-d-antineoplasiques-de-prestataires-de-services-bases-en-amerique-du-nord https://www.gerpac.eu/characteristics-of-north-american-providers-of-antineoplastic-drug-dosage https://www.gerpac.eu/etude-de-stabilite-du-durvalumab-en-flacon-apres-ouverture-et-en-solution-diluee-dans-des-poches-de-nacl-0-9-en-polyolefine https://www.gerpac.eu/anticipated-production-of-intrathecals-in-pediatrics-towards-to-microbiological-stability-study https://www.gerpac.eu/stability-study-of-durvalumab-solutions-in-its-opened-vials-and-after-dilution-and-storage-in-0-9-nacl-infusion-polyolefin-bags https://www.gerpac.eu/preparations-pharmaceutiques-de-formes-orales-solides-d-amiodarone-produites-par-impression-3d-au-sein-d-une-pharmacie-a-usage-interieure https://www.gerpac.eu/solid-oral-dosage-forms-of-amiodarone-produced-by-3d-printing-within-a-hospital-pharmacy https://www.gerpac.eu/anticipated-production-of-intrathecals-in-pediatrics-towards-to-microbiological-stability-study-2278 https://www.gerpac.eu/preparation-of-ready-to-use-5-mug-ml-norepinephrine-syringes-to-manage-anesthesiainduced-arterial-hypotension https://www.gerpac.eu/preparation-de-seringues-de-noradrenaline-pretes-a-l-emploi-de-5-mug-ml-pour-gerer-l-hypotension-arterielle-induite-par-l-anesthesie https://www.gerpac.eu/reevaluation-des-pratiques-en-regard-de-la-contamination-chimique-liee-a-l-activite-de-production-de-chimiotherapies-application-de-tests-a-la-fluoresceine https://www.gerpac.eu/masters-communication-2407 https://www.gerpac.eu/evaluation-pharmaceutique-et-clinique-de-4-dispositifs-medicaux-de-perfusion-continue-de-5-fu-565 https://www.gerpac.eu/2018-conference-2175 https://www.gerpac.eu/congres-2018-2174 https://www.gerpac.eu/l-utilisation-d-un-dispositif-de-transfert-en-systeme-clos-dtsc-pour-l-administration-de-diffuseurs-portables-permet-elle-une-deconnexion-securisee https://www.gerpac.eu/videos-presentation https://www.gerpac.eu/finding-phosphorus https://www.gerpac.eu/risk-analysis-by-the-fmeca-method-of-the-pharmaceutical-circuit-of-injectable-experimental-drugs https://www.gerpac.eu/analyse-des-risques-par-la-methode-amdec-du-circuit-pharmaceutique-des-medicaments-experimentaux-injectables https://www.gerpac.eu/production-of-major-therapeutic-interest-drugs-example-of-pancuronium-bromide https://www.gerpac.eu/production-de-medicaments-d-interet-therapeutique-majeur-exemple-du-bromure-de-pancuronium https://www.gerpac.eu/environmental-microbiological-surface-non-conformities-in-clean-areas-2019-retrospective-analysis https://www.gerpac.eu/non-conformites-microbiologiques-environnementales-de-surface-en-zone-a-atmosphere-controlee-analyse-retrospective-de-l-annee-2019 https://www.gerpac.eu/development-and-application-of-a-sterility-test-for-the-preparation-of-technetium-99m-radiolabelled-red-cells-using-a-rapid-alternative-method-2197 https://www.gerpac.eu/development-and-application-of-a-sterility-test-for-the-preparation-of-technetium-99m-radiolabelled-red-cells-using-a-rapid-alternative-method https://www.gerpac.eu/medicaments-anticancereux-confinez-les-isolateurs-ou-robots https://www.gerpac.eu/accuracy-in-pharmaceutical-technology https://www.gerpac.eu/pthp-journal-1428 https://www.gerpac.eu/pharmaceutical-technology-in-hospital-pharmacy-journal https://www.gerpac.eu/revue-pharmaceutical-technology-in-hospital-pharmacy https://www.gerpac.eu/le-dernier-numero-pthp-consultable-en-un-clic https://www.gerpac.eu/la-precision-en-pharmacotechnie https://www.gerpac.eu/feasibility-study-of-autologous-blood-derived-eye-drops-comparison-of-autologous-serum-as-preparations-versus-plasma-rich-in-growth-factor-prgf-preparations https://www.gerpac.eu/etude-de-faisabilite-de-collyre-autologue-derive-du-sang-comparaison-de-preparations-de-serum-autologue-sa-et-de-preparations-de-plasma-enrichi-en-facteurs-de-croissance-prgf https://www.gerpac.eu/lean-six-sigma-application-dans-une-unite-de-pharmacotechnie-hospitaliere https://www.gerpac.eu/sending-a-man-to-mars-in-an-artificial-closed-environment https://www.gerpac.eu/fecal-microbiota-transplantation-from-the-raw-material-to-the-pharmaceutical-preparation https://www.gerpac.eu/transplantation-de-microbiote-fecal-de-la-matiere-premiere-a-la-preparation-magistrale https://www.gerpac.eu/formulation-and-follow-up-of-an-encapsulated-freeze-dried-form-of-fecal-microbiota https://www.gerpac.eu/formulation-et-suivi-d-une-forme-per-os-encapsulee-lyophilisee-de-microbiote-fecal https://www.gerpac.eu/theranostic-et-radiopharmacie-exemple-technique-de-la-prise-en-charge-des-tumeurs-neuro-endocrines-gallium-68-lutetium-177 https://www.gerpac.eu/l-homme-vers-mars-en-ecosysteme-clos-artificiel-1967 https://www.gerpac.eu/theranostics-and-radiopharmacy-technical-example-of-neuro-endocrine-tumour-management-gallium-68-lutetium-177 https://www.gerpac.eu/proposition-d-un-modele-d-estimation-des-capacites-de-production-d-une-unite-de-preparation-d-anticancereux-sous-isolateur-1637 https://www.gerpac.eu/modulation-de-formulation-galenique-d-une-forme-topique-a-base-de-thiosulfate-de-sodium-pour-le-traitement-de-calcifications-ectopiques-1640 https://www.gerpac.eu/mise-au-point-et-etude-de-stabilite-physico-chimique-et-microbiologique-d-une-forme-orale-liquide-de-nicardipine-a-visee-pediatrique-1641 https://www.gerpac.eu/developpement-de-solutions-hydroalcooliques-colorees-de-chlorhexidine-pour-l-antisepsie-du-champ-operatoire-procedes-de-preparation-efficacites-antimicrobiennes-et-colorantes-et-etude-de-stabilite https://www.gerpac.eu/etude-de-la-stabilite-physico-chimique-et-bacteriologique-des-preparations-hospitalieres-standards-de-nutrition-parenterale-pediatrique https://www.gerpac.eu/etude-de-stabilite-physico-chimique-et-microbiologique-d-un-collyre-d-atropine-a-0-1-mg-ml-1 https://www.gerpac.eu/seringues-pretes-a-l-emploi-de-melphalan-une-course-contre-la-montre https://www.gerpac.eu/revision-des-bonnes-pratiques-de-preparation https://www.gerpac.eu/evaluation-de-la-contamination-particulaire-en-isolateur-selon-la-version-2016-de-l-iso-14644-aux-differents-stades-de-la-fabrication-d-une-poche-d-anticancereux https://www.gerpac.eu/impact-du-procede-de-fabrication-sur-la-contamination-chimique-environnementale-d-une-unite-de-production-des-cytotoxiques https://www.gerpac.eu/evaluation-de-la-contamination-chimique-lors-de-la-preparation-des-chimiotherapies-en-isolateur-et-sur-le-robot-kiro-oncology-r https://www.gerpac.eu/evaluation-de-la-fiabilite-du-controle-gravimetrique-in-proces-d-un-automate-de-preparations-steriles-injectables https://www.gerpac.eu/an-alternative-approach-to-transfer-pre-sterilised-multi-wrapped-products-the-welsh-experience-1483 https://www.gerpac.eu/validation-d-une-methode-de-dosage-rapide-par-spectrometrie-uv-raman-pour-le-controle-de-teneur-des-preparations-utilisant-des-formulations-complexes https://www.gerpac.eu/formulation-d-une-solution-visqueuse-de-budesonide-0-1mg-ml-dans-le-traitement-de-l-oesophagite-a-eosinophile-chez-l-enfant https://www.gerpac.eu/etude-de-faisabilite-de-la-mise-en-place-d-un-automate-de-preparations-au-sein-des-unites-de-production-des-anticancereux-upa-de-l-assistance-publique-hopitaux-de-marseille-ap-hm https://www.gerpac.eu/improving-quality-management-capacity-with-process-mapping-1465 https://www.gerpac.eu/simupac-360o-premiere-unite-de-preparation-des-anticancereux-injectables-en-parcours-immersif-a-360o-pour-la-formation-du-personnel https://www.gerpac.eu/nouvel-isolateur-etude-preliminaire-du-passage-du-peroxyde-d-hydrogene-h2o2-au-sein-de-differents-dispositifs-medicaux https://www.gerpac.eu/y-a-t-il-une-diffusion-du-bht-et-de-l-antioxydant-425-dans-les-preparations-fabriquees https://www.gerpac.eu/standardisation-des-nutritions-parenterales-pediatriques-npp-de-la-formulation-a-la-realisation https://www.gerpac.eu/methode-de-detection-pour-l-etude-de-la-permeabilite-a-l-agent-de-sterilisation-des-dispositifs-medicaux-utilises-sous-isolateur https://www.gerpac.eu/interactions-contenant-contenu-medicaments-ophtalmiques-et-flacons-multidoses https://www.gerpac.eu/gene-therapy-and-car-t-cells-feedback-and-description-of-the-planned-circuit-at-the-oncopole https://www.gerpac.eu/therapie-genique-et-car-t-cells-retour-d-experience-et-description-du-circuit-envisage-a-l-oncopole https://www.gerpac.eu/support-the-pooling-of-centralized-cytotoxic-preparation-units-cpu-an-innovative-approach-conducted-by-the-ile-de-france-regional-health-agency https://www.gerpac.eu/accompagner-la-mutualisation-des-unites-de-production-centralisees-de-chimiotherapie-upc-une-demarche-novatrice-de-l-ars-ile-de-france https://www.gerpac.eu/impact-of-internal-vial-pressure-and-excipient-formulation-on-chemical-contamination-risk-for-injectable-drugs-manufactured-in-robot https://www.gerpac.eu/impact-de-la-pression-interne-des-flacons-et-de-la-composition-excipiendaire-sur-le-risque-de-contamination-chimique-pour-la-preparation-robotisee-de-medicaments-injectables https://www.gerpac.eu/characterization-infrared-imaging-and-modeling-of-aerosol-dynamics-for-automated-room-decontamination https://www.gerpac.eu/caracterisation-imagerie-infrarouge-et-modelisation-de-la-dynamique-des-aerosols-pour-la-decontamination-automatisee-des-salles https://www.gerpac.eu/have-you-checked-for-stranger-things-in-your-automated-dispensing-system-for-pet-radiopharmaceuticals https://www.gerpac.eu/avez-vous-recherche-des-stranger-things-dans-votre-automate-de-dispensation-de-radiopharmaceutiques-pour-tep https://www.gerpac.eu/securing-the-process-of-antineoplastic-drug-preparations-a-multivariate-analysis-of-manufacturing-non-compliances https://www.gerpac.eu/securiser-le-processus-de-fabrication-des-chimiotherapies-une-analyse-multivariee-des-non-conformites-de-fabrication https://www.gerpac.eu/impact-de-l-utilisation-de-perfuseurs-en-polychlorure-de-vinyle-et-en-polyurethane-sur-la-sorption-de-l-infliximab https://www.gerpac.eu/stability-of-dexamethasone-hydrochlorothiazide-phenytoin-and-spironolactone-oral-suspensions-compounded-with-additives-free-suspending-vehicle https://www.gerpac.eu/stabilite-des-suspensions-orales-de-dexamethasone-d-hydrochlorothiazide-de-phenytoine-et-de-spironolactone-avec-le-syrspend-r-sf-ph4-dry-comme-vehicule-de-suspension https://www.gerpac.eu/choosing-a-predictive-model-of-osmolarity-to-control-parenteral-nutrition-solutions-pns https://www.gerpac.eu/choix-d-un-modele-predictif-d-osmolarite-pour-les-poches-de-nutrition-parenterale-pnp https://www.gerpac.eu/standard-paediatric-parenteral-nutritions-spn-stability-study-of-binary-and-ternary-mixtures-for-neonatology https://www.gerpac.eu/nutritions-parenterales-pediatriques-npp-standards-etude-de-stabilite-de-melanges-binaires-et-ternaires-destinees-a-la-neonatalogie https://www.gerpac.eu/l-uv-pls-une-methode-non-separative-pour-doser-la-morphine-dans-un-vehicule-complexe-pour-forme-buvable https://www.gerpac.eu/mass-spectrometry-coupled-to-diode-array-detection-lcms-dad-a-useful-tool-for-efficient-and-improved-stability-testing https://www.gerpac.eu/la-spectrometrie-de-masse-couplee-a-la-detection-uv-barrette-de-diodes-lcms-dad-un-outil-pour-les-etudes-de-stabilite https://www.gerpac.eu/the-use-of-capillary-eletrophoresis-for-the-anticancer-drugs-analysis-in-chemotherapies-produced-by-a-hospital-pharmacy https://www.gerpac.eu/utilisation-de-l-electrophorese-capillaire-pour-l-analyse-d-agents-anticancereux-contenus-dans-des-chimiotherapies-produites-en-milieu-hospitalier https://www.gerpac.eu/return-on-7-years-experience-of-automation-of-the-production-of-chemotherapies https://www.gerpac.eu/retour-de-7-ans-d-experience-d-automatisation-de-la-production-des-chimiotherapies https://www.gerpac.eu/article1784 https://www.gerpac.eu/elaboration-d-un-outil-de-formation-en-ligne-au-secteur-de-delivrance-nominative-automatisee-dna https://www.gerpac.eu/1st-cruathlon-of-the-regional-cancer-group-oncauvergne https://www.gerpac.eu/1er-urcathlon-du-reseau-regional-de-cancerologie-oncauvergne https://www.gerpac.eu/productivity-assessment-of-different-workflow-organizations-for-sterile-preparations-by-a-robot https://www.gerpac.eu/evaluation-de-la-productivite-de-differentes-organisations-pour-la-production-de-preparations-steriles-par-un-robot https://www.gerpac.eu/feedback-after-the-implementation-and-the-first-three-months-production-of-an-automated-chemotherapy-compounding-system https://www.gerpac.eu/retour-d-experience-sur-l-installation-et-les-3-premiers-mois-d-exploitation-d-un-robot-de-preparation-des-chimiotherapies https://www.gerpac.eu/escape-room-a-fun-and-effective-way-to-learn-good-manufacturing-practices https://www.gerpac.eu/auriez-vous-pense-qu-apprendre-les-bonnes-pratiques-de-fabrication-pouvait-etre-fun-validation-d-un-nouvel-outil-pedagogique https://www.gerpac.eu/a-comparison-of-common-trends-of-microorganisms-isolated-from-nhs-aseptic-manufacturing-units-in-the-north-of-england-1862 https://www.gerpac.eu/a-comparison-of-common-trends-of-microorganisms-isolated-from-nhs-aseptic-manufacturing-units-in-the-north-of-england https://www.gerpac.eu/determination-of-cleanroom-cleanliness-through-airborne-particle-monitoring-should-we-be-using-faster-flow-rate-particle-counters-1773 https://www.gerpac.eu/determination-of-cleanroom-cleanliness-through-airborne-particle-monitoring-should-we-be-using-faster-flow-rate-particle-counters https://www.gerpac.eu/evaluation-of-the-surface-antineoplastic-contamination-of-ready-to-use-gemcitabine-bags https://www.gerpac.eu/evaluation-de-la-contamination-chimique-de-poches-de-gemcitabine-pretes-a-l-emploi https://www.gerpac.eu/application-of-wipe-samples-to-assess-practices-and-limit-the-risk-of-occupational-exposure-to-hazardous-drugs-in-two-hospitals-from-vial-receipt-to-drug-administration https://www.gerpac.eu/application-des-prelevements-de-surface-pour-evaluer-les-pratiques-et-limiter-le-risque-d-exposition-professionnelle-aux-medicaments-anticancereux-sur-deux-sites-hospitaliers-de-la-reception-des-medicaments-a-l-administration-aux-patients https://www.gerpac.eu/occupational-exposure-of-nurses-to-cytotoxic-agents-preliminary-results-of-a-comparative-assessment-of-two-administration-devices https://www.gerpac.eu/risque-d-exposition-professionnel-des-infirmieres-aux-cytotoxiques-resultats-preliminaires-d-une-evaluation-comparative-de-deux-systemes-d-administration https://www.gerpac.eu/evaluation-of-the-chemical-contamination-in-the-analytical-control-circuit-of-sterile-injectable-preparations https://www.gerpac.eu/evaluation-de-la-contamination-chimique-du-circuit-du-controle-analytique-des-preparations-steriles-injectables https://www.gerpac.eu/intelligence-artificielle-et-interactions-medicamenteuses https://www.gerpac.eu/artificial-intelligence-and-drug-interactions https://www.gerpac.eu/hospital-pharmaceutical-technologies-of-the-future https://www.gerpac.eu/la-pharmacotechnie-hospitaliere-du-futur https://www.gerpac.eu/big-data-dans-le-domaine-de-la-cancerologie https://www.gerpac.eu/big-data-in-the-field-of-cancer-research https://www.gerpac.eu/microbiological-stability-what-recommendations https://www.gerpac.eu/microbiological-stability-what-recommendations-1519 https://www.gerpac.eu/stability-studies-recent-trend-and-future-prospects https://www.gerpac.eu/evolution-et-perspectives-dans-les-etudes-de-stabilite https://www.gerpac.eu/prediction-des-interactions-chimiques-revenir-sur-les-fondamentaux https://www.gerpac.eu/predicting-chemical-interactions-back-to-basics https://www.gerpac.eu/stability-and-interaction-studies-recent-trends-and-future-prospects-container-content-interactions https://www.gerpac.eu/evolution-et-perspectives-dans-les-etudes-de-stabilite-et-d-interactions-interactions-contenu-contenant https://www.gerpac.eu/etude-multicentrique-de-contamination-de-surface-par-dix-antineoplasiques-dans-81-hopitaux-canadiens-en-2017 https://www.gerpac.eu/chemical-contamination-assessment-a-review https://www.gerpac.eu/innovative-approach-for-the-decontamination-of-nanoparticles https://www.gerpac.eu/chemical-contamination-assessment-a-review-1496 https://www.gerpac.eu/innovative-approach-for-the-decontamination-of-nanoparticles-1495 https://www.gerpac.eu/european-resolution-on-good-reconstitution-practices-improving-patient-safety-by-risk-control-of-parenterals-injectable-medicines https://www.gerpac.eu/european-resolution-on-good-reconstitution-practices-improving-patient-safety-by-risk-control-of-parenterals-injectable-medicines-1478 https://www.gerpac.eu/round-table-aseptic-preparations-dose-banding-automation-robotic-facilities-in-process-and-post-process-controls https://www.gerpac.eu/table-ronde-standardisation-des-doses-automatisation-equipement-controles https://www.gerpac.eu/la-plateforme-de-e-learning-du-gerpac https://www.gerpac.eu/the-gerpac-e-learning-platform https://www.gerpac.eu/virtual-reality-a-solution-for-training-in-hospital-pharmacy https://www.gerpac.eu/la-realite-virtuelle-au-service-de-la-formation-en-pharmacie-hospitaliere https://www.gerpac.eu/automatisation-de-la-preparation-des-doses-a-administrer-quelles-solutions-pour-quels-objectifs https://www.gerpac.eu/automation-of-dose-preparation-to-be-administered-what-solutions-for-which-objectives https://www.gerpac.eu/development-of-a-unit-dose-drug-distribution-robot-project-in-a-ght https://www.gerpac.eu/conception-d-une-d-activite-d-automatisation-de-la-dispensation-individuelle-nominative-a-l-echelle-d-un-ght https://www.gerpac.eu/terrorist-chemical-threat-research-and-operational-countermeasures https://www.gerpac.eu/risque-chimique-terroriste-recherche-et-contre-mesures-operationnelles https://www.gerpac.eu/particulate-contamination-of-solutions https://www.gerpac.eu/contamination-particulaire-des-solutions https://www.gerpac.eu/pilot-study-evaluating-the-efficacy-of-four-cleaning-solutions-and-two-types-of-mops-in-delimited-areas-of-a-floor-contaminated-with-cyclophosphamide https://www.gerpac.eu/etude-pilote-evaluant-l-efficacite-de-quatre-solutions-de-nettoyage-et-deux-types-de-bandeaux-de-lavage-pour-reduire-la-contamination-par-cyclophosphamide-d-une-surface-au-sol-pre-determinee https://www.gerpac.eu/pharmaceutical-technology-imperatives-and-opportunities-1849 https://www.gerpac.eu/pharmaceutical-technology-imperatives-and-opportunities https://www.gerpac.eu/master-2-communication https://www.gerpac.eu/communications-master-2 https://www.gerpac.eu/table-ronde-les-medicaments-de-therapie-innovante https://www.gerpac.eu/round-table-advanced-therapy-medicinal-products-amtps https://www.gerpac.eu/the-paedform-project https://www.gerpac.eu/the-paedform-project-1845 https://www.gerpac.eu/research-in-the-field-of-paediatric-drug-formulation https://www.gerpac.eu/la-recherche-dans-le-domaine-de-la-formulation-des-preparations-en-pediatrie https://www.gerpac.eu/medicines-safety-paediatric-formulations-provided-by-hospital-pharmacies https://www.gerpac.eu/medicines-safety-paediatric-formulations-provided-by-hospital-pharmacies-1841 https://www.gerpac.eu/rapid-microbiological-sterility-test-for-cytotoxic-batch-control-is-drug-complexation-effective-for-restoring-microbiological-growth https://www.gerpac.eu/master-communication-lille-university https://www.gerpac.eu/formulation-and-stability-study-of-low-dose-midazolam-capsules-for-clinical-trial https://www.gerpac.eu/exposure-of-healthcare-workers-to-cytotoxic-drugs https://www.gerpac.eu/carcinogens-in-hospitals-identification-construction-of-limit-values-and-prevention-of-exposures https://www.gerpac.eu/evaluation-of-a-training-video-support-on-how-to-prepare-and-control-a-cytotoxic-frug-during-pharmacy-resident-night-shift https://www.gerpac.eu/formulation-of-an-oral-liquid-solution-of-carbimazole-and-validation-of-a-stability-indicator-assay-method https://www.gerpac.eu/pilot-study-assessing-the-safety-and-ease-of-use-of-a-closed-system-to-administer-single-agent-infusional-chemotherapy-within-an-oncology-day-unit-2123 https://www.gerpac.eu/optimisation-of-preparation-process-of-0-2-mg-hydrochlorothiazide-capsules-using-a-design-of-experiments https://www.gerpac.eu/lean-six-sigma-implementation-in-pharmaceutical-technology-unit-hospital https://www.gerpac.eu/robotization-of-antineoplastic-drugs-preparation-towards-a-risk-reduction-for-staff-of-pharmacotechny-unit https://www.gerpac.eu/la-robotisation-des-preparations-des-chimiotherapies-anticancereuses-vers-une-reduction-des-risques-pour-les-personnels-des-unites-de-pharmacotechnie https://www.gerpac.eu/efficiency-of-4-solutions-in-removing-23-conventional-antineoplastic-drugs-from-stainless-steel-surface https://www.gerpac.eu/efficience-de-4-solutions-pour-decontaminer-23-medicaments-anticancereux-conventionnels-de-surfaces-en-acier-inoxydable https://www.gerpac.eu/fastidious-chemical-decontamination-after-cyclophosphamide-vial-breaking-in-a-compounding-unit https://www.gerpac.eu/difficulte-de-la-decontamination-chimique-apres-un-incident-de-bris-de-flacon-de-cyclophosphamide-dans-une-unite-de-preparation https://www.gerpac.eu/development-of-a-composite-score-to-decide-which-hospital-service-should-benefit-from-the-patient-specific-automatic-unit-dose-distribution-system https://www.gerpac.eu/developpement-d-un-score-composite-de-priorisation-pour-le-deploiement-de-la-dispensation-individuelle-nominative-automatisee-dina https://www.gerpac.eu/the-radiopharmacy-of-errors-a-serious-game-to-strengthen-quality https://www.gerpac.eu/radiopharmacie-des-erreurs-un-serious-game-pour-renforcer-la-qualite https://www.gerpac.eu/a-radiopharmaceutical-based-method-to-investigate-container-content-interactions https://www.gerpac.eu/utilisation-innovante-de-medicaments-radiopharmaceutiques-pour-l-etude-d-interactions-contenant-contenu https://www.gerpac.eu/performance-qualification-of-laminar-flow-hot-cell-for-aseptic-vial-filling-during-radiopharmaceutical-production https://www.gerpac.eu/qualification-de-performance-d-une-enceinte-blindee-destinee-a-la-repartition-aseptique-des-medicaments-radiopharmaceutiques https://www.gerpac.eu/establishment-of-optimized-methodology-by-gc-ms-for-hazard-evaluation-of https://www.gerpac.eu/mise-en-place-d-une-methodologie-optimisee-par-gc-ms-pour-l-evaluation-du-risque-d-icc-au-cours-d-un-developpement-pharmaceutique https://www.gerpac.eu/comparative-study-of-healthcare-workers-exposure-to-cytotoxic-between-a-french-and-a-tunisian-hospital https://www.gerpac.eu/etude-comparative-de-l-exposition-du-personnel-aux-cytotoxiques-entre-un-hopital-francais-et-un-hopital-tunisien https://www.gerpac.eu/developpement-d-un-outil-pour-l-evaluation-de-la-contamination-surfacique-aux-medicaments-anticancereux-en-milieu-professionnel https://www.gerpac.eu/does-the-use-of-a-closed-system-transfer-device-dtsc-for-administration-with-elastomeric-pumps-allow-a-safe-disconnection https://www.gerpac.eu/vacuum-packaging-impact-on-cold-sensitive-drugs-example-of-5-fluorouracil https://www.gerpac.eu/impact-de-la-mise-sous-vide-sur-des-molecules-thermosensibles-exemple-du-5-fluorouracile https://www.gerpac.eu/minimising-the-risks-associated-with-the-procurement-and-supply-of-unlicensed-medicines https://www.gerpac.eu/minimising-the-risks-associated-with-the-procurement-and-supply-of-unlicensed-medicines-2107 https://www.gerpac.eu/exploration-of-a-new-tool-for-antineoplastic-agents-dosage https://www.gerpac.eu/exploration-d-un-outil-analytique-innovant-pour-le-dosage-des-anticancereux https://www.gerpac.eu/physical-emulsion-stability-of-mixtures-of-propofol-and-remifentanil-hydrochloride-2104 https://www.gerpac.eu/physical-emulsion-stability-of-mixtures-of-propofol-and-remifentanil-hydrochloride https://www.gerpac.eu/evaluation-d-un-support-video-de-formation-a-la-preparation-des-medicaments-cytotoxiques-en-garde https://www.gerpac.eu/formulation-d-une-solution-buvable-de-carbimazole-et-validation-d-une-methode-de-dosage-indicatrice-de-stabilite https://www.gerpac.eu/pilot-study-assessing-the-safety-and-ease-of-use-of-a-closed-system-to-administer-single-agent-infusional-chemotherapy-within-an-oncology-day-unit https://www.gerpac.eu/optimisation-du-process-de-fabrication-de-gelules-d-hydrochlorothiazide-0-2-mg-grace-a-un-plan-d-experience https://www.gerpac.eu/test-de-sterilite-microbiologique-rapide-pour-le-controle-de-cytotoxiques-fabriques-en-lots-la-complexation-est-elle-efficace-pour-restaurer-la-croissance-microbiologique https://www.gerpac.eu/stabilite-de-collyres-de-voriconazole-a-1-dans-des-conditionnements-en-verre-ou-innovants https://www.gerpac.eu/formulation-et-etude-de-stabilite-de-gelules-de-midazolam-faiblement-dosees-dans-le-cadre-d-un-essai-clinique https://www.gerpac.eu/exposition-professionnelle-des-personnels-de-sante-aux-cytotoxiques https://www.gerpac.eu/tool-development-for-assessing-antineoplastic-drugs-surface-contamination-in-healthcare-services-and-other-workplaces https://www.gerpac.eu/en-seance-pleniere-1110 https://www.gerpac.eu/en-seance-pleniere-1252 https://www.gerpac.eu/en-seance-pleniere https://www.gerpac.eu/en-seance-pleniere-1626 https://www.gerpac.eu/en-seance-pleniere-1825 https://www.gerpac.eu/ateliers-1957 https://www.gerpac.eu/en-seance-pleniere-1956 https://www.gerpac.eu/the-relaxation-area-1962 https://www.gerpac.eu/e-presentations-1963 https://www.gerpac.eu/workshops-1961 https://www.gerpac.eu/e-posters https://www.gerpac.eu/le-coin-detente-1958 https://www.gerpac.eu/in-plenary-session-1960 https://www.gerpac.eu/session-3-cuap-automatisation-de-la-preparation-des-doses-a-administrer-et-demarche-qualite https://www.gerpac.eu/session-3-preparation-of-automated-doses-dispensing-quality-policy https://www.gerpac.eu/session-3-nouvelles-bonnes-pratiques-de-preparation-reglementation-francaise https://www.gerpac.eu/session-4-conception-d-une-installation-pour-la-fabrication-des-mti https://www.gerpac.eu/session-2-conception-d-une-unite-de-preparation-des-doses-a-administrer-automatisee https://www.gerpac.eu/session-6-escape-game-en-production-laissez-vous-prendre-au-jeu-1938 https://www.gerpac.eu/session-4-mise-en-oeuvre-d-outils-pedagogiques-pour-la-formation-d-operateurs-en-unite-de-preparations-de-cytotoxiques https://www.gerpac.eu/session-6-production-escape-game-join-in-the-fun-1936 https://www.gerpac.eu/session-5-civas-centralized-intravenous-additive-service-1935 https://www.gerpac.eu/session-5-centralized-intravenous-additive-service-civas https://www.gerpac.eu/session-4-designing-an-installation-to-manufacture-advanced-therapy-medicinal-products-atmps https://www.gerpac.eu/session-3-new-best-practices-for-preparation-french-regulations https://www.gerpac.eu/session-2-designing-a-unit-for-preparing-doses-to-be-administered-1932 https://www.gerpac.eu/session-1-content-container-interactions https://www.gerpac.eu/session-1-interactions-contenant-contenu https://www.gerpac.eu/formulation-and-control-of-a-pediatric-oral-hospital-preparation-of-0-1-ferrous-fumarate https://www.gerpac.eu/formulation-et-controle-d-une-preparation-hospitaliere-orale-pediatrique-de-fumarate-ferreux-a-0-1 https://www.gerpac.eu/long-term-stability-of-an-infusion-containing-ketamine-morphine-and-lorazepam-in-syringe-at-5-3oc https://www.gerpac.eu/long-term-stability-of-an-infusion-containing-ketamine-morphine-and-lorazepam-in-syringe-at-5-3oc-1977 https://www.gerpac.eu/faecal-microbiota-pharmaceutical-technology-aspects-2130 https://www.gerpac.eu/le-microbiote-fecal-aspects-pharmacotechniques https://www.gerpac.eu/did-our-fabrication-process-impact-on-azacitidine-stability https://www.gerpac.eu/did-our-fabrication-process-impact-on-azacitidine-stability-2072 https://www.gerpac.eu/contamination-des-surfaces-par-les-medicaments-anticancereux-au-sein-d-un-service-de-soins https://www.gerpac.eu/antineoplastic-drugs-surface-contamination-inside-a-healthcare-service https://www.gerpac.eu/bacteriophages-sharing-pharmaceutical-experience-around-a-clinical-case https://www.gerpac.eu/bacteriophages-partage-d-experience-pharmaceutique-autour-d-un-cas-clinique https://www.gerpac.eu/etude-de-la-sensibilite-des-milieux-de-culture-apres-bio-decontamination-pour-utilisation-dans-un-isolateur https://www.gerpac.eu/study-of-the-sensitivity-of-culture-media-after-bio-decontamination-for-use-in-an-isolator https://www.gerpac.eu/stabilite-chimique-de-l-amoxicilline-dans-le-diffuseur-portable-anapa-r https://www.gerpac.eu/chemical-stability-of-amoxicillin-in-non-electrically-driven-portable-infusion-pump-anapa-r https://www.gerpac.eu/stability-study-of-a-ternary-parenteral-nutrition-admixture-after-addition-of-human-insulin https://www.gerpac.eu/etude-de-stabilite-d-un-melange-de-nutrition-parenterale-ternaire-apres-ajout-d-insuline-humaine https://www.gerpac.eu/evaluation-de-l-efficacite-du-rincage-post-perfusion-des-tubulures https://www.gerpac.eu/assessment-of-efficacy-of-post-infusion-tubing-rinsing-in-reducing-cytotoxic-contamination https://www.gerpac.eu/microbiological-contamination-mc-within-the-parenteral-nutrition-pn-isolator-multicentric-survey-on-microbiological-control-practices https://www.gerpac.eu/pousses-microbiologiques-au-sein-de-l-isolateur-de-l-unite-de-nutrition-parenterale-unp-etude-multicentrique-des-pratiques-de-controle-microbiologique https://www.gerpac.eu/evaluation-d-un-dispositif-d-administration-securise-sur-la-reduction-du-risque-d-exposition-aux-anticancereux-des-infirmieres-une-etude-comparative-prospective https://www.gerpac.eu/evaluation-of-a-safe-infusion-device-on-reducing-occupational-exposure-of-nurses-to-antineoplastic-drugs-a-comparative-prospective-study https://www.gerpac.eu/enquete-sur-la-realisation-des-preparations-pour-les-patients-ambulatoires https://www.gerpac.eu/national-survey-on-preparations-for-outpatients https://www.gerpac.eu/renouvellement-d-isolateurs-sans-interruption-de-l-activite-de-production-un-defi-qui-genere-des-risques https://www.gerpac.eu/renovating-isolators-without-activity-production-interruption-a-challenge-which-generates-risks https://www.gerpac.eu/etude-des-pratiques-de-reconstitution-du-patisiran-application-du-resume-des-caracteristiques-du-produit-rcp-aux-pratiques-professionnelles https://www.gerpac.eu/etude-de-faisabilite-d-une-preparation-de-ceftazidime-20-mg-ml-pour-injection-intravitreenne https://www.gerpac.eu/feasibility-study-for-a-preparation-of-ceftazidime-20-mg-ml-for-intravitreal-injection https://www.gerpac.eu/benefice-de-la-qualite-operationnelle-dans-les-performances-de-production-de-preparation-hospitaliere-au-sein-d-un-nouveau-plateau-technique https://www.gerpac.eu/benefit-of-operational-quality-in-hospital-preparation-production-performance-within-a-new-technical-platform https://www.gerpac.eu/how-efficiently-can-tilmanocept-syringes-be-prepared https://www.gerpac.eu/comment-preparer-les-seringues-de-tilmanocept-de-maniere-efficace https://www.gerpac.eu/research-of-the-most-efficient-model-for-automated-dose-dispensing-add-to-be-administered-in-a-medicine-unitbe https://www.gerpac.eu/recherche-du-modele-de-production-le-plus-efficient-pour-une-preparation-des-doses-a-administrer-automatisee-dans-un-service-de-medecine https://www.gerpac.eu/study-of-patisiran-reconstitution-practices-enforcement-of-the-summary-of-product-characteristics-spc-in-professionals-practices https://www.gerpac.eu/which-organization-to-optimize-vidaza-r-production https://www.gerpac.eu/quelle-organisation-pour-optimiser-la-production-de-vidaza-r https://www.gerpac.eu/qualification-of-a-volumetric-automated-compounding-device-to-optimize-the-production-of-parenteral-nutrition-bags https://www.gerpac.eu/qualification-d-un-automate-de-remplissage-volumetrique-en-vue-d-optimiser-la-production-des-poches-de-nutrition-parenterale https://www.gerpac.eu/masters-communications-bordeaux-angers https://www.gerpac.eu/masters-communication-lille https://www.gerpac.eu/masters-communications-lille https://www.gerpac.eu/masters-communications-bordeaux-angers-1971 https://www.gerpac.eu/moderators-2144 https://www.gerpac.eu/moderateurs-2143 https://www.gerpac.eu/moderators-2158 https://www.gerpac.eu/moderateurs-2157 https://www.gerpac.eu/moderators-2146 https://www.gerpac.eu/moderateurs-2145 https://www.gerpac.eu/moderators-2142 https://www.gerpac.eu/moderateurs-2141 https://www.gerpac.eu/method-development-and-validation-for-assessment-of-sulfadoxine-and-pyrimethamine-by-hplc-uv https://www.gerpac.eu/developpement-et-validation-d-une-methode-de-dosage-de-la-sulfadoxine-et-de-la-pyrimethamine-par-hplc-uv https://www.gerpac.eu/parenteral-nutrition-mixtures-controls-by-inductively-coupled-plasma-optical-emission-spectrometer-influence-of-proteins-on-electrolyte-assay https://www.gerpac.eu/etude-des-interruptions-de-taches-lors-de-la-production-de-chimiotherapies https://www.gerpac.eu/study-of-tasks-interruptions-during-the-production-of-chemotherapies https://www.gerpac.eu/risk-analysis-of-the-chemotherapy-circuit-produced-in-standard-doses https://www.gerpac.eu/analyse-de-risque-du-circuit-des-chimiotherapies-produites-en-doses-standards https://www.gerpac.eu/analyse-de-risques-du-processus-de-production-des-chimiotherapies-quelles-evolutions-apres-le-deploiement-de-l-outil-de-controle-drugcam-r https://www.gerpac.eu/risk-analysis-of-the-chemotherapy-production-process-what-changes-after-the-deployment-of-the-drugcam-r-control-tool https://www.gerpac.eu/parenteral-nutrition-process-from-medical-prescription-to-nurse-administration-without-re-transcription https://www.gerpac.eu/un-circuit-de-nutrition-parenterale-sans-retranscription-de-la-prescription-a-l-administration https://www.gerpac.eu/gestion-des-risques-en-nutrition-parenterale-cartographie-des-risques-associes-au-circuit-de-preparation https://www.gerpac.eu/risk-management-in-parenteral-nutrition-risk-mapping-associated-with-the-preparation-process https://www.gerpac.eu/error-simulation-in-a-centralized-cytotoxic-unit-a-playful-exercise https://www.gerpac.eu/urc-des-erreurs-une-formation-ludique https://www.gerpac.eu/securisation-des-preparations-orales-liquides-au-chu-grenoble-alpes https://www.gerpac.eu/securing-extemporaneous-oral-liquid-preparations-at-chu-grenoble-alpes https://www.gerpac.eu/better-manging-risks-carrying-out-risk-mapping-in-a-pharmacy-production-unit https://www.gerpac.eu/mieux-gerer-les-risques-realisation-d-une-cartographie-des-risques-dans-une-unite-de-pharmacotechnie https://www.gerpac.eu/la-paillasse-des-erreurs-mise-en-situation-dans-un-laboratoire-de-controle-qualite https://www.gerpac.eu/mistakes-benchtop-simulation-case-in-a-quality-control-laboratory https://www.gerpac.eu/global-risk-analysis-applied-to-outsourcing-sterile-injectable-drugs https://www.gerpac.eu/analyse-globale-des-risques-de-la-sous-traitance-des-preparations-injectables-steriles-dans-le-cadre-d-un-regroupement-hospitalier https://www.gerpac.eu/pedagogie-par-simulation-en-pharmacotechnie-place-du-test-de-remplissage-aseptique-dans-l-habilitation-des-preparateurs https://www.gerpac.eu/simulation-in-pharmaceutical-technology-education-role-of-the-aseptic-filling-test-in-pharmacy-technician-authorisation https://www.gerpac.eu/use-a-fmeca-failure-modes-effects-and-criticality-analysis-multidisciplinary-on-the-paediatric-parenteral-nutrition-process https://www.gerpac.eu/realisation-d-une-amdec-analyse-des-modes-de-defaillance-de-leurs-effets-et-de-leur-criticite-pluridisciplinaire-sur-le-circuit-de-la-nutrition-parenterale-pediatrique https://www.gerpac.eu/spectrometrie-d-emission-atomique-a-plasma-micro-onde-notre-nouvelle-methode-de-dosage-des-ions-dans-les-poches-de-nutrition-parenterale-pediatrique https://www.gerpac.eu/controles-des-melanges-de-nutrition-parenterale-par-spectrometre-a-emission-optique-couple-a-un-plasma-induit-influence-des-proteines-sur-le-dosage-des-electrolytes https://www.gerpac.eu/compatibilite-visuelle-du-vyxeos-r-lors-d-administration-en-y-avec-une-selection-de-medicaments-injectables https://www.gerpac.eu/evaluation-du-controle-liberatoire-en-utilisant-un-programme-de-simulations-d-erreurs https://www.gerpac.eu/assessment-of-pharmaceutical-control-release-of-chemotherapy-preparations-using-errors-simulation-program https://www.gerpac.eu/microwave-plasma-atomic-emission-spectrometry-a-new-method-for-measuring-ions-in-paediatric-parenteral-nutrition-bags https://www.gerpac.eu/la-performance-de-prelevement-d-une-seringue-est-elle-liee-a-son-volume https://www.gerpac.eu/in-process-gravimetric-control-validation-of-antineoplasic-preparations-by-the-accuracy-profile-and-total-error-calculation-analysis https://www.gerpac.eu/validation-du-controle-gravimetrique-in-process-des-preparations-antineoplasiques-par-analyse-du-profil-d-exactitude-et-calcul-de-l-erreur-totale https://www.gerpac.eu/developpement-et-validation-d-une-methode-de-dosage-du-citrate-de-clomifene-pour-l-etude-de-la-stabilite-d-un-medicament-experimental https://www.gerpac.eu/development-and-validation-of-a-clomifene-citrate-quantification-method-for-the-stability-study-of-an-investigational-medical-product https://www.gerpac.eu/in-process-gravimetric-control-coupled-with-vial-recognition-and-dematerialization-of-chemotherapy-production-an-option-to-promote-the-autonomy-of-operators-and-the-safety-of-chemotherapy-preparations https://www.gerpac.eu/controle-gravimetrique-in-process-couple-a-la-reconnaissance-flacon-et-dematerialisation-de-la-production-de-chimiotherapie-vers-une-autonomie-totale-des-manipulateurs-et-une-securisation-renforcee-des-preparations https://www.gerpac.eu/optimization-of-sampling-of-injectable-anticancer-drug-preparations-and-improvement-of-analytical-control-in-a-centralized-preparation-unit https://www.gerpac.eu/optimisation-de-l-echantillonnage-des-preparations-de-medicaments-anticancereux-injectables-et-amelioration-du-controle-analytique-au-sein-d-une-unite-de-preparation-centralisee https://www.gerpac.eu/conformite-des-prelevements-volumetriques-d-anticancereux-quelles-seringues-pour-quels-volumes https://www.gerpac.eu/anticancer-drug-preparations-conformity-of-volume-taken-what-size-syringue https://www.gerpac.eu/is-syringe-sampling-performance-related-to-its-volume https://www.gerpac.eu/visual-compatibility-of-vyxeos-r-during-y-site-administration-with-selected-drugs https://www.gerpac.eu/impact-of-polyvinylchloride-and-polyurethane-infusion-set-upon-infliximab-sorption https://www.gerpac.eu/uv-pls-an-analytical-method-for-control-quality-of-morphine-in-a-complex-vehicle-for-oral-liquid-form https://www.gerpac.eu/quelle-alternative-au-collyre-de-ticarcilline https://www.gerpac.eu/comprimes-a-desagregation-buccale-pour-la-pediatrie https://www.gerpac.eu/nouvelles-normes-iso-14644-1-et-14644-2-pour-les-salles-propres https://www.gerpac.eu/analyse-lean-d-une-unite-de-production-des-chimiotherapies https://www.gerpac.eu/contamination-interne-par-les-medicaments-anticancereux-des-personnels-de-sante-dans-les-pays-en-developpement-exemple-de-la-mauritanie https://www.gerpac.eu/manipulation-securitaire-des-cytotoxiques-dans-les-pays-en-developpement-comment-progresser https://www.gerpac.eu/surface-contamination-in-homes-of-home-care-patients https://www.gerpac.eu/gerpac-study-phase-2-surface-contamination-in-control-laboratories https://www.gerpac.eu/formulation-des-formes-dermiques-hospitalieres https://www.gerpac.eu/pharmacotechnie-des-medicaments-de-therapies-innovantes-mti https://www.gerpac.eu/melanges-de-nutrition-parenterale-et-medicaments https://www.gerpac.eu/european-recommendations https://www.gerpac.eu/mise-en-place-d-une-interface-entre-chiomio-r-et-un-logiciel-d-hemato-oncologie-pediatrique https://www.gerpac.eu/other-publications https://www.gerpac.eu/isolators-qualifications-and-maintenance-clean-rooms-controlled-environments-ans-containment-laboratories-aspec-gerpac https://www.gerpac.eu/autres-publications https://www.gerpac.eu/espace-d-echanges-du-cuap-problematique-du-controle https://www.gerpac.eu/moderators-1868 https://www.gerpac.eu/moderateurs-1867 https://www.gerpac.eu/session-1-maintenance-of-an-isolator-in-hospital-pharmacy-periodical-inspections-and-qualifications https://www.gerpac.eu/session-4-creating-learning-tools-to-train-operators-in-cytotoxic-preparation-units-using-quizzes-card-games-and-video https://www.gerpac.eu/session-2-methods-for-stability-testing-and-container-content-compatibility-studies https://www.gerpac.eu/sessions-3-an-automated-compounding-cytotoxic-unit https://www.gerpac.eu/workshop-distribution-channel-of-injectable-preparations-from-pharmacy-to-patient https://www.gerpac.eu/130-evaluation-of-the-stability-of-a-10mg-ml-cefuroxime-solution-for-intracameral-injection-in-new-sterile-vials-940 https://www.gerpac.eu/fiabilite-de-la-preparation-des-chimiotherapies-double-controle-ou-systeme-gravimetrique https://www.gerpac.eu/viability-of-microorganisms-in-cytotoxic-drugs-and-antiviral-drug-solutions https://www.gerpac.eu/viabilite-des-microorganismes-dans-les-medicaments-cytotoxiques-et-les-antiviraux https://www.gerpac.eu/compliance-example-early-discontinuation-of-tamoxifen https://www.gerpac.eu/tolerance-of-oral-therapy https://www.gerpac.eu/toxicite-des-formulations-oculaires https://www.gerpac.eu/cytotoxiques-oraux-risques-iatrogenes https://www.gerpac.eu/exemple-d-observance-arret-precoce-du-tamoxifene https://www.gerpac.eu/tolerance-des-traitements-oraux https://www.gerpac.eu/formulation-des-formes-ophtalmiques-a-l-hopital https://www.gerpac.eu/stabilite-des-preparations-ophtalmiques https://www.gerpac.eu/education-therapeutique-comment-preparer-le-patient-a-devenir-un-acteur-de-son-traitement https://www.gerpac.eu/session-1-maintenance-d-un-isolateur-en-pharmacotechnie-hospitaliere-controles-et-qualifications-periodiques https://www.gerpac.eu/intellifill-i-v-1889 https://www.gerpac.eu/moderators-1870 https://www.gerpac.eu/moderateurs-1869 https://www.gerpac.eu/moderators-1866 https://www.gerpac.eu/session-3-conception-d-une-unite-automatisee-de-preparations-d-anticancereux https://www.gerpac.eu/moderateurs-1865 https://www.gerpac.eu/session-2-methodes-d-etudes-de-la-stabilite-physico-chimique-et-des-interactions-contenu-contenant https://www.gerpac.eu/espace-e-presentation https://www.gerpac.eu/the-relaxation-area-1887 https://www.gerpac.eu/workshops-1885 https://www.gerpac.eu/in-plenary-session-1886 https://www.gerpac.eu/e-presentations-1888 https://www.gerpac.eu/le-coin-detente-1828 https://www.gerpac.eu/ateliers-1826 https://www.gerpac.eu/stabilite-a-long-terme-du-lorazepam-dans-les-seringues-en-polypropylene-de-chlorure-de-sodium-0-9-a-5-3-o-c https://www.gerpac.eu/stabilite-a-long-terme-d-une-perfusion-contenant-du-paracetamol-de-l-alizapride-du-ketorolac-et-du-tramadol-dans-un-flacon-en-verre-a-5-3oc https://www.gerpac.eu/evaluation-of-reprotoxic-risk-assessment-in-a-control-laboratory-cl-choice-of-a-new-method-for-the-calcium-dosage-in-parenteral-nutrition-preparation https://www.gerpac.eu/moderators https://www.gerpac.eu/moderateurs https://www.gerpac.eu/ouverture-des-journees https://www.gerpac.eu/development-of-colored-hydroalcoholic-solutions-of-chlorhexidine-for-surgical-field-antisepsis-preparation-process-antimicrobial-and-coloring-efficiencies-and-stability-study https://www.gerpac.eu/study-of-chemical-stability-and-bacteriological-contamination-of-standardized-pediatric-parenteral-nutrition https://www.gerpac.eu/physical-chemical-and-microbiological-stability-study-of-0-1-mg-ml-1-atropine-eye-drops https://www.gerpac.eu/ready-to-use-syringes-of-melphalan-a-race-against-time https://www.gerpac.eu/updated-guidelines-for-the-preparation-of-medical-products-in-healthcare-establishment-and-pharmacy https://www.gerpac.eu/evaluation-of-particulate-contamination-in-an-isolator-in-accordance-with-the-2016-version-of-iso-14644-at-the-various-stages-of-manufacture-of-a-cancer-medication-bag https://www.gerpac.eu/impact-of-process-on-chemical-environmental-contamination-of-a-cytotoxic-production-unit https://www.gerpac.eu/evaluation-of-the-chemical-contamination-related-to-the-manual-cytotoxic-production-in-an-isolator-and-a-new-robotic-drug-preparation-system-kiro-oncology-r https://www.gerpac.eu/reliability-assessment-of-gravimetric-in-process-control-of-an-iv-compounding-robot https://www.gerpac.eu/an-alternative-approach-to-transfer-pre-sterilised-multi-wrapped-products-the-welsh-experience https://www.gerpac.eu/validation-of-a-quick-dosage-method-by-uv-raman-spectroscopy-for-the-content-control-of-preparations-with-complex-formulation https://www.gerpac.eu/formulation-of-a-0-1-mg-ml-viscous-solution-of-budesonide-for-the-treatment-of-eosinophilic-esophagitis-in-children https://www.gerpac.eu/implementation-of-an-automated-production-system-in-assistance-publique-hopitaux-de-marseille-anticancer-drugs-production-units-a-feasibility-study https://www.gerpac.eu/improving-quality-management-capacity-with-process-mapping https://www.gerpac.eu/simupac-360o-the-first-french-digital-cytotoxic-preparation-unit-developed-in-virtual-tour-for-staff-training https://www.gerpac.eu/new-sterilizer-preliminary-study-of-hydrogen-peroxide-h2o2-diffusion-through-different-medical-devices https://www.gerpac.eu/routine-detection-method-for-permeation-risk-assessment-of-isolator-sterilizing-agent https://www.gerpac.eu/container-content-interactions-ophthalmic-drugs-and-multi-dose-flasks